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Abstract
The urokinase-type plasminogen activator (uPA) is a serine protease 
involved in processes such as cell migration and invasion through the 
activation of the extracellular protease plasmin responsible of the degradation 
of the proteins of the extracellular matrix. The ability of the cells to migrate 
and to invade the surrounding tissues plays a fundamental role in many 
normal and pathological processes such as fibrinolysis, wound healing, 
angiogenesis, embryogenesis, gametogenesis, ovulation, mammary gland 
involution and tumor metastasis. Due to its high destructive potential, 
localized activation of plasminogen is regulated by a complex network of 
molecular interactions involving both specific inhibitors (PAI-1 and PAI-2), 
and cell bound receptor (uPAR) and the synthesis of every component of the 
plasminogen activator system is tightly regulated by a number of factors like 
hormones, growth factors and cytokines.
On the other hand, the restricted expression of uPA in the organism to a 
very few cell types (kidney and lung), its inducibility by different stimuli and 
its overexpression in tumours and several transformed and tumoral cell lines, 
indicate that uPA regulation occurs also at the level of gene expression.
The gene encoding uPA and its 5’ flanking region have been sequenced and 
characterized in human, mouse and pig. Both in v ivo  and in vitro studies of 
progressve 5'deletions of the regulatory region of uPA, have revealed the 
presence of positive and negative cis-acting sequences and of specific 
contributions of the proximal regulatory regions to cell-type specific expression 
of the gene, suggesting the presence of multiple array of cis-acting sequences 
specific for different transcription factors that direct uPA expression in a cell- 
type specific manner.
In the human uPA promoter the enhancer is located between -2100 and 
-1870 from the transcriptional start site and contains two binding sites for the
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transcription factor API and PE A3 which are important for both the 
constitutive and regulated expression of the gene. Furthermore, the 
cooperation between the two API sites is required for TP A inducibility and is 
mediated by other proteins called Upstream Enhancer Factors (UEF).
A negative cis-acting element has been localized between -1870 and -1570 
and contains a binding site for a multiproteic complex (NF-kB/c-rel) that 
mediates the inducibility by TP A in HeLa and FlepG2 cell lines.
Much evidence, however, indicates that the regulation of uPA is mainly 
negative.
The studies described in this thesis have led to the identification of negative 
regulatory elements that may play an important role in the establishment of a 
silenced phenotype in a cell-type specific manner.
The analysis of promoter activity in cell lines not expressing (HeLa and CVl) 
and expressing uPA (PC3) allowed the identification of at least three regions 
that play different roles in the silencing of the uPA gene in different cell lines, 
named SI (-1870/-1428), 82 (-787/-537) and S3 (-537/-86).
Of the three only S2 shows cell-type specificity, as it is active only in cells 
that do not express uPA; SI and S3, on the other hand, could act as modulators 
of uPA gene expression in those cells that express uPA. All of them negatively 
regulate the activity of the minimal promoter, suggesting that they can 
interfere with the formation of a competent pre-initiation complex at the start 
site of transcription.
A dissection analysis of silencer S2 detected the presence of multiple 
silencing units, although the deletion of a single one does not have any effect 
on the activity of the promoter. Transcription from a heterologous promoter is 
affected only when more than one copy of a single unit is cloned in front of it, 
suggesting that in the context of the whole S2 region each unit acts 
synergistically with the others in the silencing of the gene. DNase I 
footprinting analysis of S2 showed that this region is extensively protected by
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nuclear extract from uPA producing (PC-3) and not producing (HeLa) cell lines, 
with few differences between them. However, the LMSA analysis of the 
complexes indicated that their molecular composition may be different in the 
two cell lines tested.
In particular, in HeLa cell extract, a single strand binding activity seems to 
bind S2 and it may be responsible for the assembly of a negative-acting complex 
that would prevent the loading of a competent transcription initiation 
complex at the start site of transcription.
Furthermore, the presence of two binding sites for proteins belonging to the 
HMG-box containing protein family, suggested that the assembly of a 
stereospecific complex is required for the activity of silencer S2, although it is 
not clear if their activity is required for the silencing of the gene or for the 
inactivation of the inhibition in those cells that express uPA as in HepG2 cell 
line. In these cells uPA is expressed at a very low basal level, but its expression 
is inducible by TPA. In this cell line S2 is not active; on the contrary its 
presence is required for basal expression of uPA.
The presence in S2 of a sequence matching the transforming growth factor fi 
inihibitory element (TIL), described to be important for mediating the 
inhibition of TPA induction by TGF-fil of the stromelysin gene, has led me to 
investigate the role of this element on S2 activity in HepG2 cells. Transient 
transfection analysis of uPA promoter deletions showed that, at least in this 
system, the TIL is not involved in the regulation of uPA expression.
Preliminary results, shown in appendix 2, have suggested another 
interesting aspect of the negative regulation of uPA expression by the p53 
tumor suppressor gene product, although no p53 binding to uPA promoter has 
been shown so far.
In conclusion, the studies presented in this thesis have showed that a 
complex array of regulatory sequences, in addition to the enhancer and
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minimal promoter, appear to regulate uPA transcription, some of which are 
cell-type specific.
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1. Introduction 
Prologue
Regulation of gene expression in eukaryotes is involved in a wide variety of 
tissue-specific (Weissman and Singer, 1991), developmental (Biggin and Tjian, 
1989), cell-cycle (Weinberg, 1996) and signal-responsive events (Kerr et al,  1990; 
O'Brien and Granner, 1991).
The nuclear genes of eukaryotic organisms are transcribed by one of three 
RNA polymerases. RNA polymerase I (Pol I) is utilised exclusively for the 
expression of genes encoding the 5.8S, 18S, and 28S ribosomal RNAs (rRNA). The 
form II enzyme (Pol II) transcribes all genes encoding mRNAs, as well as those 
that specify certain small nuclear RNAs (snRNAs). All tRNA genes, as well as the 
genes for 5S rRNA and the remaining snRNAs, are transcribed by RNA 
polymerase III (Pol III).
All three eukaryotic polymerases maintain considerable sequence similarity 
in their largest subunit (Allison et al,  1985) and have five subunits in common 
(Young, 1991). Transcription requires that the polymerases associate with 
promoter regions and form a stable initiation complex.
Studies on the purified enzymes demonstrated that they are incapable of 
accurate class-specific promoter recognition, that is accomplished by a set of 
auxiliary factors distinct for each class of genes.
The promoter structure varies with each gene family showing a different 
array of DNA sequence elements and configuration. However all promoters have 
a core sequence element which is recognised by a factor that binds DNA 
specifically and provides a nucléation site for complex formation.
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The class II Basal Promoter Apparatus
Class II genes promoters contain combinations of DNA sequences;
1) a core or basal promoter element defined as "minimal DNA elements that 
are necessary and sufficient for accurate transcription initiation by RNA pol II in 
reconstituted cell-free system". The best characterised core-promoter elements are 
the TATA-box (consensus TATAa/tAa/t; Breathnach and Chambon, 1981), located 
at about 25 base pairs (bp) upstream of the transcription start site and a 
pyrimidine-rich (consensus YYANt/aYY) initiator element (Inr) located near the 
transcription start site (Smale and Baltimore, 1989).
Different promoters may contain both, one or neither of these elements 
denoted as TATA+Inr+, TATA+Inr“, TATA"Inr+ or TATA'Inr" (Weis and 
Reinberg, 1992).
2) proximal promoter elements that occur between 50 and 200 bp upstream of 
cap site and are the site of binding for transcriptional activators able to modulate 
transcription
3) distal enhancer elements located far from the transcription initiation site 
in either direction and orientation respect to the start site.
Transcription initiation by Pol II is precisely regulated by transcription factors 
that interacts with these three classes of DNA targets and also with each other.
Accurate transcription by Pol II is accomplished by the assembly of a 
multiproteic complex in which the interaction of general transcription factors 
(GTFs) either with promoter elements or with each other by protein-protein 
interaction leads to the recruitment of RNA pol II in a competent transcription 
initiation complex (Weil et al,  1979; Reinberg and Roeder, 1987a,b; Reinberg et al,  
1987).
So far 8 general initiation factors (TFII A, TFII B, TFII D, TFII E, TFII F, TFII H, 
TFII I, TFII J) have been isolated and cloned from human, rat. Drosophila a n d
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yeast, showing a remarkable conservation at the level of polypeptide sequences 
(Okhuma et al,  1991, Peterson et ai, 1991, Malik et al,  1991, Ha et al,  1991, Ranish 
et al,  1992, Aso et al,  1992, Cortes et al,  1992).
Studies w ith  purified  recom binant com ponents  and analysis of 
in te rm edia tes  that rem ain stable to various nuc lease-pro tec tion  and 
electrophoretic mobility shift assays (Buratowski et a l ,  1989), coupled to 
mutagenesis techniques and x-ray crystallography (Burke and Kadonaga, 1996) 
suggest a stepwise model of pre-initiation complex (PIC) assembly on the AdML 
promoter in vitro. The pathway can be divided as follows (Figure 1.1):
1) TBP (TATA binding-protein) binds the TATA element through minor 
groove contacts forming a stable complex that results in a distortion (bend) of 
the DNA that brings sequences upstream and downstream of the TATA 
element into a closer apposition (Nikolov and Burley, 1994). Furthermore, as 
a consequence of this orientation, the upper surface of TBP is exposed and 
available for protein-protein interaction, with a large number of proteins 
(Timmers and Sharp, 1991; Meisterernst and Roeder, 1991, Meisterernst et al., 
1991). TBP can bind TATA element either alone or in a TFII D multisubunit 
complex containing TBP-associated factors (TAFs; Tanese et al, 1991). The 
other factors are then recruited sequentially into the initiation complex in 
the following order: II A, II B, II F with Pol II, II E, II H and II J. TFIIA, 
although not essential for formation of a functional PIC, can bind stably to 
this complex (Buratowski et al, 1989; Maldonado et al,  1990) through direct 
contacts with TBP and with upstream DNA sequences (Geiger et al,  1996; 
Tan et al,  1996). TFIIA has also an important role of stabilisation of TBP- 
DNA interactions in those situation when the affinity of the complex is 
altered by mutations in the DNA binding of TBP (Imbalzano et al, 1994) or in 
promoters with weak TATA elements. Furthermore one function of TFIIA is
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to remove, by way of its association with TFIID, TBP-bound negative co­
factors that associate and negatively regulate TFIID activity and prevent 
binding of TFIIB to the PIC (see "The human general co-factors"; Dr2; Cortes 
et al,  1992).
2) Binding of TFIIB, through direct contacts both with TBP and sequences 
upstream and downstream of the TATA element (Nikolov et al,  1995), has a 
function in TFIIF-RNA pol II recruitment and in start site selection by RNA 
pol II (Leuther et al,  1996; Li et al,  1994). Like TFIIA, TFIIB also stabilises 
TBP-TATA complex (Imbalzano et al, 1994; Kim and Roeder, 1994). Binding 
of TFIIA and TFIIB to TBP does not show overlapping contacts and no direct 
contacts with each other.
3) The recruitment of the preformed TFIIF-RNA pol II complex through TFIIB 
interaction with both TFIIF and RNA pol II, follows the binding of TFIIB 
(Leuther et al,  1996). TFIIF plays a direct role in promoting targeting of RNA 
pol II through these interactions, destabilizing the non-specific RNA pol II- 
DNA interaction to non-specific sites (Flores et al., 1991). TFIIF is also 
implicated in transcriptional elongation although the subunits involved are 
different from those implicated in initiation (Kephart et al,  1994; Tanef al., 
1995). The RNA pol II recruited to the PIC is not-phosphorylated on the 
carboxy-terminal domain (CTD) of its largest subunit (formllA; Lu et al.,
1991). The CTD consists of a heptapeptide (consensus YSPTSPS) repeated 26 
times in Yeast, 43 in Drosophila and 52 in man, that becomes extensively 
phosphorylated during the initiation of transcription (form IIO; Baskaran et 
nZ., 1993).
4) Binding of TFIIF, through direct interactions with RNA pol II and TFIIF and 
TBP (Maxon et al,  1994), just upstream of start site is consistent with the 
proposed functions in promoter melting (Robert et al, 1996).
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T A T A
IBP 
TFIIA
TFIIB
TFIIF
R N A  p o l II
CTD
TFIIE
TFHH
IATP DNA melting
PICopen 
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I
TFIIB
TFIIE
TFIIH
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TFIIF
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▲
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Pre-initiation
complex
closed
Termination
CTD Elongation complex 
Fig. 1.1: Model for potential pathway of transcription complex assembly
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5) TFIIH entry is the last step of PIC assembly. The direct contacts with TFIIE 
(Maxon et al., 1994; Okhuma et al, 1995) results in an increased stability of 
bound TFIIE, important because TFIIE mediates the stimulation of CTD 
phosphorylation by TFIIH (Lu et al, 1992; Ohkuma et al, 1995; Akoulitchev 
et al., 1995). The region covered by the PIC complex extends to position +30 
(van Dyke et al, 1988; Buratowski et al, 1989).
Comparative studies of free versus PIC-bound TFIIB (Nikolovcf al., 1995) or 
DNA-bound TBP suggested conformational changes in factors during PIC 
assembly. Following the formation of the stable (closed) complex, the PIC is 
activated to an unstable (open) complex, in the presence of ATP and other 
ribonucleoside triphosphates (Holstege et ai,  1996; Jiang et ai,  1996). DNA is 
melted and transcription initiated, followed by promoter clearance and recycling 
of PIC components (Zawel et al., 1995). The melting of DNA is sustained by a ~ 10 
bp region just upstream of the start site and is dependent upon TFIIH helicase 
activity (Drapkin et al,  1994; Serizawa et al, 1993; Roy et al ,  1994; Pan and 
Greenblatt, 1994).
After transcription initiation the melted region in the open complex extends 
downstream (Holstege et al., 1996). Phosphorylation of RNA pol II CTD is also 
associated with the transition from initiation to elongation suggesting a role for 
CTD phosphorylation, by TFIIH kinase activity, in promoter clearance (O'Brien et 
al., 1994; Yankulov et al., 1996; Goodrich and Tjian, 1994; Payne et al., 1989; 
Laybourn and Dahmus, 1990).
It has been proposed that upon CTD phosphorylation the initiation complex 
undergoes a conformational change resulting in reversion of interaction between 
CTD-TBP (Usheva et al., 1992) and RNA pol II-TFIIE (Maxon et al., 1994) as well as 
interactions between RNA pol II and cofactors binding CTD, once the accessory 
functions of these cofactors in activator stimulated PIC assembly or initiation are
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complete (Koleske and Young, 1995; Barberis et al., 1995; see RNA pol II 
holoenzyme). At or following termination the CTD is dephosphorylated by a 
CTD-specific phosphatase. This event is required for the polymerase reentry in the 
competent form (form IIA) in a new round of PIC assembly (Chambers et al.,
1995).
Assembly of PIC on promoters that lack TATA motif requires either the 
direct or indirect interaction of general transcription factors with other core 
promoter element, as initiator (Figure 1.2). Several functionally distinct initiator 
elements are reported to direct transcription from TATA-less promoter (Weis and 
Reinberg, 1992). In two cases, AdML and the murine terminal deoxynucleotidyl 
transferase (TdT) promoter initiator element, it has been shown that TFIID is 
required for the assembly of a functional PIC (Pugh and Tjian, 1991; Zhou et al,
1992). The interaction with initiator elements could be mediated by the binding of 
TAFs with DNA, with the result to bring TBP to promoter where the assembly of 
PIC could proceed as described for TATA containing promoter (Kaufmann and 
Smale, 1994; Purnell et al, 1994). For other initiator element, such as that found in 
the adeno-associated virus (AAV)P5 promoter, the presence of an initiator 
binding protein, in addition to TFIID, has been postulated (Beaupainct al,  1990). It 
has been proposed that YYl, a protein that function both as an activator and 
repressor, may bind to this initiator. However, transcription in vitro from the 
AAVP5 promoter requires only YYl, TFIIB and RNA polymerase II, suggesting 
that YYl can functionally substitute for TBP in the nucléation of an active 
transcription complex (Usheva and Shenk, 1994). Other Inr-binding factors have 
been identified and include TFII I, USF and E2F (Carcamo et a l ,  1991). 
Eurthermore, in Drosophila TATA-less promoters a downstream  prom oter 
element (DPE) has been shown to function synergistically with Inr elements 
(Burke and Kadonaga, 1996). DPE element mediates Inr-dependent site-specific
Introduction 8
binding of TFIID, through TAFnbO, to the promoter (Burke and Kadonaga, 1997). 
In conclusion, PIC assembly pathways might vary depending on specific element 
and the promoter context, at least with respect to the formation of stable 
intermediates and general factors requirements, increasing the possibility of 
selective gene regulation by activators and repressors with core promoter-specific 
functions (Martinez et a l ,  1995; Kaufmann et al., 1996).
c > AdML; TdT initiator
AAV P5 promoter C >
Poin
-C I
TAf
Inr
+ 1
> Drosophila TATA-less promoter
Fig. 1.2: Assembly of active transcription complex at TATA-less promoters.
+1 indicates the start site of transcription; Inr indicates the initiator element and DPE the 
downstream promoter element.
The failure of in vitro  reconstituted transcription to respond to activators 
supports the idea of the existence of intermediary factors. So far three types of 
intermediary factors have been described:
1) The mediator, which associates with RNA polymerase II to form a 
holoenzyme;
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2) TBP Associated Factors (TAFs), which associate with TATA-binding 
protein (TBP) to form the general transcription factor TFIID;
3) The Upstream Stimulatory Activity (USA), isolated from hum an cells, 
whose characterisation is still in progress.
The R N A  Pol II holoenzyme ("mediator")
Both genetic and biochemical studies of the Saccharomyces cerevisiae RNA 
polymerase II have led to the identification of a multi-protein complex associated 
to the carboxy-terminal repeat domain (CTD) of RNA pol II, together with TFIIF, 
TFIIB and TFIIH, forming what is called the RNA pol II holoenzyme (Kim et al,  
1994). This complex, termed the mediator (Hengartner et al,  1995; Koleske and 
Young, 1994), is required for transcriptional activation in vitro as well as in vivo 
and it contains about 20 polypeptides including GAL 11 (Chen S.et al, 1993; Fassler 
and Winston, 1989), SUGl (Swaffield et al, 1995) and SRB proteins (suppressors of 
RNA polymerase B; Nonet and Young, 1989; Thompson et al,  1993). Among the 
SRB proteins are the product of the essential genes SRB 4, SRB 6 and SRB 7, 
whose temperature-sensitive mutation leads to an immediate shutdown of all 
mRNA synthesis at the non-permissive temperature and of two non-essential 
genes, SRB 2 and SRB 5 that are also important for Pol II transcription as deletion 
of these genes diminishes transcriptional activity in yeast nuclear extracts.
Studies of genes involved in glucose repression in yeast led also to the 
identification of proteins in the mediator. Mutations in these genes, termed SSN 
for suppressors of snfl, are able to suppress growth defects of a mutant lacking the 
SNFl protein kinase required to relieve glucose repression of gene expression. 
Sequence comparison indicated that SSN 5, SSN 2, SSN 3 and SSN 8 are identical 
to the product of SRB 8, SRB 9, SRB 10 and SRB 11 genes (see Table 1.1). These 
genes are non-essential and have been suggested to function in repression of 
many polymerase II promoters. This was shown for two other SSN genes whose
Introduction 10
SRB counterpart has not been isolated yet, SSN 4 and SSN 7. They are identical to 
Sin 4 and Rox 3 which were isolated from screens for mutants affecting repression 
of the H O  and CYC7  promoters (Table 1.1). These, together with other two 
polypeptides implicated in transcriptional repression, R G R l  and G A L I I ,  have 
been demonstrated to be part of the holoenzyme, suggesting a role for the 
mediator complex in mediating transcriptional repression as well as activation. 
The identification of yeast Pol II holoenzyme offers another view for initiation 
complex formation with the pre-assembled holoenzyme to be recruited to 
promoters through interaction with the already bound TFIID.
SSN GENE A l t e r n a t e  n a m e A c t i v i t y R e fe r e n c e s
SSN 1 M lG l Transcriptional repressor, 
maybe target of SNF 1 kinase
Vallier and Carlson, 1994
SSN 2 SRB 9; SCA 1 Hengartner et al. , 1995; 
Song et al. , 1996
SSN 3 SRB 10; UME 5; cyclin-dependent kinase cyclm Strich et al. , 1989 
Surosky et al. , 1994;
ARE 1 pair to SSN 8 Thompson et al ., 1993
SSN 4 SIN 4; TSF 3 role in general transcriptional Song et al ., 1996 
Chen et al. , 1993
SSN 5 SRB 8; ARE 2 Song et al. , 1996; 
Hengartner et al. , 1995
SSN 6 CYC 8 Transcriptional repression of many 
genes in complex with TUP 2
Schultz et al. , 1987
SSN 7 ROX 3 Essential for viability Song et al. , 1996; 
Rosenblum-Vos et al. , 1991
SSN 8 SRB 11 Cyclin-dependent kinase cyclin 
pair to SSN 3
Kuchin et al. , 1995 
Liao et al. , 1995
Table 1.1: The SSN gene family
The TATs
Different lines of evidence indicate that TFII D plays a central role in 
mediating activation, functioning as a target for activators, and in directing
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nucléation of an initiation-competent complex containing the general factors and 
RNA polymerase II.
TFII D, infact, appears to be the only GTF with sequence specific DNA 
binding activity and there are several lines of evidence suggesting that it is the 
first component to assemble on the core promoter, directing the recruitment of 
Pol II and other GTFs (Hernandez, 1993; Pugh, 1996).
TFII D is a multi-protein complex composed by TATA-binding protein (TBP) 
and a set of associated factors: the Pol II TAFs (TAFns).
TBP was first purified from yeast as a single polypeptide of 27 KDa (Hahncf 
al,  1989). Cloning of the gene allowed the identification of TBP homologues from 
other eukaryotes and to the discovery of TAFs. The complex purified from 
human and Drosophila showed that TFII D consists of TBP and at least eight 
associated TAFs ranging in size from about 18-250 KDa (Dynlacht et al,  1991; 
Tanese et al,  1991; Chenet al,  1994a).
The human and Drosophila TAFns are highly conserved (Chen et al, 1994a; 
Chiang and Roeder, 1995) and several homologues have been identified in yeast 
where they are essential for viability (Reese et al,  1994; Poon et al, 1995; Verrijzer 
et al,  1994). As listed in Figure 1.3 human TFII D contains homologues of seven of 
the eight Drosophila TAFs (dTAFs); a human homologue of dTAFnl50 that is 
missing in hTFII D may correspond to a component of the initiator-element factor 
(GIF) described by Kaufmann et al (1996). In yeast, TFII D homologue of 
d T A F n l lO /h T A F n l3 0  and the homologue of the human TAFnl05, found by 
Dikstein et al (1996a) to be a B-cell specific TAF, are missing.
Although the stoichiometry and the arrangement of TBP-TAFs interaction 
in TFII D is not known yet, it has been shown that Drosophila TAFp250 is critical 
in the assembly of TFII D (Chen et al, 1994a) and in the stabilisation of TBP-TATA 
interaction.
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Other TAFns interact directly with TBP and with each other allowing the 
formation of multiple combinations able to mediate the integration of different 
signals to the basal transcription machinery (Burley and Roeder, 1996).
Different biological activities have been ascribed to TAFns leading to the 
view of TFII D as a highly versatile complex:
• TBP-TAFs complex is involved in promoter recognition. TBP is essential 
for transcription by all three eukaryotic RNA polymerases, as revealed by studies 
with mutated TBP (Cormack and Struhl, 1992; Schultz et al,  1992). The specificity 
for a distinct class of genes is to address to its association with different sets of 
TAFs, able to discriminate between different core promoter structure. So different 
TBP-TAF complexes are thought to direct class-specific promoter recruitment of 
the three RNA polymerases (Hernandez, 1993; Table 1.2).
While Pol I and Pol III require TBP-TAF association for transcription of class 
I and III genes, TBP alone can sustain basal transcription from TATA-containing 
class II gene. However Pol II TATA-less prom oters require TAFns for 
transcription. While TBP recognises the TATA-box, other downstream elements 
are recognised by different TAFs allowing TFII D to bind promoter elements, 
either individually or in combination, and to activate different array of 
promoters. Furthermore the association with an Inr binding protein and the 
presence of other DNA sequences, often located downstream of the transcription 
start site, as the downstream promoter element (DPE; Burke and Kadonaga, 1996), 
can modulate basal promoter strength by determining promoter strength and the 
start site of transcription (Verrijzer et al,  1994; Kaufmann et al,  1996). In the 
presence of TATA-box and Inr elements an efficient nucléation process requires 
minimally a TBP-dTAFn250-dTAFnl50 complex, whereas in the absence of Inr 
these TAFns can inhibit the TATA-binding activity of TBP. So, depending on the
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prom oter architecture, TAFns can modulate the stability of TFIID promoter 
interactions (Verrijzeref al., 1995; Hansen and Tjian, 1995).
Polymerase Class o f  genes Core element TBP/TAF complex References
RNA Pol I rRNA genes UCE/UBF SLl Comai et al. , 1992
RNA Pol II protein coding TATA/TBP TF IID Hernandez, 1993
genes Inr/IBP TAFs
snRNA PSE SNAPc Sadowski
et o/. , 1993
RNA Pol III 55 RNA Box C/TFIIIA
Hernandez, 1993
hU6 PSE Tijan and
Maniatis, 1994
TATA TFIIIB Bartholomew
e t al. , 1991
Table 1.2: Promoter recognition properties of different TBP/TAF complexes
• Another function ascribed to TFII D is the alteration of promoter topology 
as revealed by DNasel protection analysis on the AdML promoter. The analysis of 
the sequence of dT A Fn30a , dTAFn40 and dTAFn60 and of their hum an 
homologues revealed that they are related in sequence and structure to the 
histone proteins H2B, H3 and H4 respectively (Burley and Roeder, 1996) 
supporting the hypothesis that these TAFs bind DNA in a core-histone manner 
regulating promoter topology and hence transcription by multiple contacts of 
TFIID with core promoters, or facilitating basal-factor contacts, or mimicking a 
nucleosome. This latter hypothesis can explain the observation made by Segil et 
o/. (1996).
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TBP
D. melanogaster H.sapiens S.cerevisiae
38   43   27
Features
TATA-box binding subunit
TAFIIs
250/230
150
110
80/85
60/62
40/42
30a /28 
22
306
250
130
100
80
31/32
20 ■
15 —I
28
68
53
30
18
130/145
150
90
60
17
68/61
40
67
25/23
47
30
19
equivalent to CCGl, HMG box, 
Bromodomains
downstream promoter contacts
contacts Spl (Q-rich activator) 
contacts TFIIA
WD-40 repeats
histone H4 similarity 
contacts TFIIE, TFIIF
histone H3 similarity
contacts acidic activators (VP16, p53
contacts TFIIB
histone H2B similarity
contacts multiple activators
contacts estrogen receptor
B-cell specific
Figure 1.3: Evolutionary conservation and properties of TFIID subunits from human. Drosophila and 
yeast.
Where a particular TAF has been assigned different molecular weights, all molecular weights are 
listed. dTAFII30a/28 and dTAFII22 and their human homologues arise via alternative splicing 
(adapted from Burley and Roeder, 1996).
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that during  mitosis 10% to 20% of TFIID is retained in the condensed 
chromosome. This group hypothesised that the nucleosome-like structure of 
TFIID permits its incorporation into condensed chromosome marking promoter 
DNA for reactivation after mitosis.
• TFII D shows catalytic activity, retaining the capability to acetylate histones 
and to phosphorylate the basal-factor TFII F. Acétylation of histones changes the 
packaging of DNA in the nucleosome by weakening histone-DNA interaction, 
allowing access of activators and general factors to DNA . The histone acetylase 
activity (HAT) resides in TAFn250 (Mizzen et ai,  1996). This activity is conserved 
from yeast to human, conferring to TFII D an important role in controlling access 
of nucleosome-bound promoter sequences to the basal machinery in vivo. 
Furthermore TAFII250 displays a kinase activity (Dikstein et al,  1996b) which can 
phosphorylate itself and the basal factor TFII F. It is not clear yet if the 
phopshorylation of TFII F influences activator dependent recruitment of RNA pol 
II into the PIC or affects the initiation/elongation properties of the polymerase.
• Although TBP can replace TFII D in basal transcription, it fails to support 
activated transcription leading to the coactivator model, that assumed that at least 
some of the subunit of TFIID serve functionally to link transcription activation 
domains with the basal transcription complex (Pugh and Tjian, 1990; Dynlacht et 
al., 1991). A series of experiments aimed to reconstitute dTFIID from its 
recombinant subunits, showed that addition of TAFs to TBP restored activation 
confirming that most if not all transcriptional activators require TAFns for 
activation at least in vitro (Chen et al, 1994a). These experiments led to the notion 
that activators exert their action through direct interaction with TAFns, allowing 
TFIID to integrate multiple signals from different regulators.
From these studies, aimed to identify TFII D-activators interaction, it came 
out that different classes of activation domains (such as acidic. Gin-rich, lie-rich)
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bind distinct TAFns in the TFII D complex. A list of TAFns/activators interaction 
is reported in table 1.3.
TAFII Activator References
dTAF„110 Spl Chen et al. , 1994a
Bicoid Jacq et a l  , 1994
dTAFii40 VP16 
p53 (acidic)
Sauer et al. , 1995
dTAF„150 NTF-1 (lie-rich) Chen et al. , 1994a
dTAFi,60 Hunchback
hTAFii30 estrogen receptor Thut et al. , 1995
hTAFiiSS
Table 1.3: TAFijs-activators interaction
CTF; Pro-rich
Data from in vitro studies are supported by m vivo experiments on a 
temperature-sensitive (ts) Hamster cell line (ts-13), carrying an amino acid 
substitution in TAFn250 (Sekiguchi et al, 1991), where the defect affected only a 
subset of genes at the non permissive temperature (Wang and Tjian, 1994). These 
results confirmed the idea that individual TAFns may be required only by a subset 
of activators in the cell.
The current model for TAFns enhancing of transcription is that activators- 
TA Fns contacts lead to increased recruitment of TFII D to the core promoter 
(Pugh, 1996). This model would account for the synergistic activation by multiple 
activators, as demonstrated by experiments on Drosophila activators Bicoid and 
Hunchback (Sauer et al,  1995). Each activator alone gives a modest level of 
activation. Synergism requires both dTAFnllO (that binds Bicoid) and TAFn60 
(binding Hunchback) in the TFIID complex, allowing simultaneous contacts 
between activators and TFIID. This hypothesis is also supported by in vivo studies
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(Colgan and Manley, 1992; Klein and Struhl, 1994), which suggest that TFIID 
binding can be rate-limiting in the cell and activators can affect promoter 
occupancy (Figure 1.4).
TAP
TA
Pol II
TATA
Fig. 1.4: Model of synergistic transcriptional activation by multiple activators-TAFIIs contacts
The human general co-factors or Upstream Stimulatory A ctiv ity  (USA)
Studies aimed to determine the minimal requirements for activation in 
vitro  suggested the involvement of other cofactors in addition to the TAFs and 
the general machinery.
Biochemical fractionation of mammalian cellular extracts and reconstitution 
of a functional activator-driven transcription led to the identification of a set of 
co-factors, distinct from TAFs, termed the human general co-factors (Meisterernst 
et a l ,  1991).
In the beginning these co-factor have been isolated as a crude fraction able to 
enhance stimulation of transcription by activators and termed USA (u,pstream 
stimulatory activity). Later it was shown that this fraction contains both positive 
and negative activities termed PCs and NCs, respectively (positive and negative 
co-factors).
Members of the PCs are PCI, PC2, Dr2 (D repressor 2)/PC3, ACF (activating 
co-factors) and PC4, CofA (co-factor A), PC 5, PC 6 and HMG-2 (Meisterernst et a l ,
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1991; Kretzschmar et al, 1994; Merino et al, 1993; Kretzschmar et al, 1993; Ge and 
Roeder, 1994a,b; Maldonado and Reinberg, 1995; Zawel et al,  1995; Halle et al,  
1995; Shykind et al,  1995; Stelzer et al,  1994; Lieberman, 1994). After the cloning of 
the gene encoding the co-factor PC4 it was shown that it interacts both with TFIIA 
and the activator domain of the acidic activator VP16. By interaction with TFIIA a 
role for PC4 in recruitment of TFIID to the TATA-box has been ascribed, 
functioning as a bridge between activator and basal machinery (Figure 1.5a).
On the other hand it has been suggested that the co-factors might stimulate 
the interaction between the activators and the basal machinery by altering the 
topology of the promoter (i.e. HMG proteins; Shykind et a!., 1995; Stelzer et al,  
1994) and affecting the accessibility of DNA in the chromatin. Other PCs are 
involved in processes following the binding of TFIID (i.e. PC2 and PC5; Halle et 
a/., 1995).
Among the negative co-factors are A da /M otl (Auble et al,  1994) and the 
negative co-factors NCI and NC2 (Meisterernst and Roeder, 1991; Meisterernst et 
a!., 1991; Inostroza et al., 1992). A da/M otl releases TBP from DNA and thereby 
represses transcription. NCI binds TBP in a manner that competes with TFIIA and 
results in repression of basal but not activator-dependent transcription 
(Meisterernst and Roeder, 1991). NCI has been identified to be HMG-1 (Ge and 
Roeder, 1994b).
NC2 binds TBP and represses basal transcription by competing with TFIIA 
and TFIIB thus inhibiting the assembly of the initiation complex (Figure 1.5b). The 
protein consists of two subunit (NC2a and N C 26/D rl; Inostroza et al,  1992; 
Goppelt et al,  1996; Mermelstein et al,  1996), also defined as the repressor-co- 
repressor complex Drl-DRAP (Mermelstein et al,  1996; Kim et a l ,  1997). 
Furthermore NC2 displays homology with the histones fold motif of histones
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H2A and H2B and it has been shown to be necessary for the dimerization of the 
two subunits of NC2 (Goppelt et a l ,  1996; Mermelstein et a l ,  1996).
FIIA TFIID
TATA
B
TFIIBTFIIA
NC2Rkr \
TATA
Fig. 1.5: Models for interaction of the human general co-factors with the basal transcriptional 
machinery.
A: Positive cofactors (PCs) enhance the interactions between activators and TFIID. B: The basal 
repressor NC2 interacts with TBP and blocks the access of both TFIIA and TFIIB preventing the 
assembly of an active pre-initiation complex.
NC2 is conserved between yeast and man suggesting for it an essential role in 
controlling the overall basal activity in the cell, maybe through mechanisms 
aimed to modulate the topology of transcription complexes during initiation and 
elongation of transcription in a chromatin folded DNA.
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In some cases, the same cofactor has been identified, by different laboratories, 
either as positive or negative cofactor (see PC3/Dr2; Merino et a!., 1993; 
Kretzschmar et al,  1993). This discrepancy can be explained by the fact that some 
negative factors repress basal transcription, but this repression is overcome by 
activators so that the net fold activation is greater in their presence than in their 
absence. Furthermore, PCs repress basal transcription at higher concentrations.
The identification of three different groups of cofactors, the hum an general 
co-factors, the TAFs and the RNA polymerase II holoenzyme-associated mediator, 
sharing the same function of activation of transcription, suggested that they might 
cooperate functionally to support activators function, possibly depending on the 
organism and the specific gene. It has been proposed that the mediator generally 
function in yeast to facilitate recruitment of the RNA polymerase holoenzyme, 
although recent reports describe the identification of a m am m alian RNA 
polymerase II holoenzyme (Kim et al, 1994; Chao et al., 1996; Maldonado et al.,
1996). This holoenzyme would cooperate with the human general co-factors by 
the interaction between these and TAFs (Kretzschmar et al., 1994; Ge and Roeder, 
1994a).
The distinction, at least in vitro, between yeast and the higher eukaryotes in 
the requirement of TAFs for activated transcription made necessary to establish 
the role of yeast TAFs in vivo.
While analysis of mutant TAF genes revealed that they are essential for cell 
viability, experiments of TAFs depletion showed that cell growth rapidly stopped 
but transcriptional activation of actively transcribed genes, induced subsequent to 
TAF depletion, was not affected. Together these results led to the conclusion that 
TAFs are not generally required for transcriptional activation in yeast (Walker et 
al, 1996; Moqtaderi et al., 1996).
Introduction 21
It is possible that the mechanism of gene regulation in higher eukaryotes had 
acquired additional complexity as the result of the larger number of genes that 
need to be regulated and as the activation in metazoan responds both to 
developmental and physiological signals. It has been then hypothesised that TAFs 
evolved to mediate alternative pathways of promoter recognition independent of 
the TATA motif and also to acquire a coactivator function in response to the 
increased requirement for expression and regulation of more complex genomes.
Regulation of RNA pol II transcription
Eukaryotic genes are expressed in v ivo  at very low levels (or not at all). 
Regulation of gene expression upon developmental and physiological stimuli is 
mediated by the action of a large number of regulatory proteins that recognise 
specific sequences (enhancers and silencers) located upstream or downstream the 
core promoter. The complexity of the combinatorial interaction of factors 
involved in the formation of the transcription initiation complex and the 
multiple steps that can be rate-limiting, provides several targets of regulation of 
polymerase activity by factors able to activate or repress transcription. Among 
these are a) the recognition of promoter sequences by TFIID; b) the recruitment of 
TFIIB, essential for RNA pol II entry and c) the escape of RNA pol II from the 
promoter, controlled by TFIIH. The specificity of regulation of gene expression by a 
relatively small number of transcription factors is provided by the modular 
structure of both regulatory proteins and the enhancers (silencers): a typical 
transcription factor is infact constituted by a DNA binding-domain, a 
multimerization domain, allowing the formation of homo- and heterodimers, 
and a transactivation domain. These domains can be combined in different 
fashion giving raise to new sets of factors; the enhancers show a combination of 
different transcription factors binding-sites, whose arrangement provide the
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potential to create unique nucleoprotein complexes forming heterodimers within 
and among families of transcription factors (Tijan and Maniatis, 1994).
Recent studies have shown that the activity of some enhancers (or silencers) 
requires proteins that function as architectural components suggesting that 
activation (repression) depends on the assembly of a highly specific three- 
dimensional nucleoprotein complex, facilitating multiple protein-DNA and 
protein-protein interactions (reviewed in Tijan and Maniatis, 1994 and Werner 
and Burley, 1997; Figure 1.6). Examples of such proteins are the members of the 
high-mobility group (FIMG) proteins that have the properties of inducing a sharp 
bend in the DNA helix (Grosschedl et al., 1994). Some of them binds DNA non- 
specifically (HMG-1 and UBF; Pauli et al.,, 1993; Jantzen et al.,, 1990). Others, as 
LEF-1 (lymphoid enhancer factor 1; Giese et al.,, 1991) and SRY (sex determining 
factor; Van de Wetering and Clevers, 1992) bind in a sequence-specific manner 
their target promoter. In the case of LEF-1, several experiments on the activation 
of the T-cell receptor a  enhancer provided a model for its function as architectural 
protein. Upon its binding to the TCRa enhancer a sharp bend is induced in the 
DNA helix allowing the interaction of other activators that bind sequences 
flanking the LEF-1 binding site on either side (Giese et al.„ 1995).
The product of HMG-I(Y), which is unrelated to HMG-domain proteins, 
plays the same role as LEF-1 in the virus-inducible enhancer of the B-interferon 
gene but, besides altering DNA structure, it also directly contacts both NF-kB and 
ATF-2, the two activator proteins, inducing conformational changes that augment 
their interaction with DNA and with each other (Thanos and Maniatis, 1992; Du 
et al.,, 1993).
On the other side, YYl represses c-fos promoter by bending DNA and then 
preventing interactions between the CREB-activator protein, whose binding site is
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located upstream of YYl, and components of the basal transcription machinery 
(Natesan and Gilman, 1993).
Protein-induced changes in DNA structure may also involve the formation 
of three-dimensional DNA loops, with proteins that mediate tight wrapping of 
DNA through extended protein-DNA contacts. The best example is given by the 
nucleosome and several examples of positioned nucleosomes that help cross-talk 
between enhancer element and promoters, or juxtaposition of binding site 
otherwise located far apart, have been described (Perlmann and Wrange, 1988; 
Thomas and Elgin, 1988; Schild et al., 1993). Furthermore several DNA binding 
proteins that mimic nucleosome-like structure are involved in the formation of 
nucleosome-like particles (Putnam et al,  1994).
Finally, the observation that, on some promoters, TFIID or Pol II itself is 
p rom oter-engaged  before activation implies a lternative  pa thw ay s for 
transcriptional control (Rougvie and Lis, 1988; Chen et al,  1994b).
Positive control
Activators work enhancing the efficiency with which the basal transcription 
complex is assembled in an active form by contacting multiple components of the 
basal transcriptional machinery. As it is already outlined in the "Basal promoter 
apparatus" section, interactions between activators and the components of the 
basal pol II machinery can be either direct between transcription factors and the 
GTFs as well as mediated by coactivators (mediator, TAFs, UAS; Triezenberg, 
1995). The regulation can occur at the level of 1- stimulation of basal transcription 
apparatus, 2- by counteracting chromatin-mediated repression, 3- by affecting the 
efficiency of elongation process.
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HM G-I(Y)
HM G-I(Y)
HM G-I(Y)
D
h is to n e  coreh is to n e  core
Fig. 1.6: Models for architectural roles of proteins in the assembly of higher-order nucleoprotein 
complexes.
A: The TCRa enhancer complex. B: 6-interferon enhancer complex. C and D: wrapping of DNA 
around a histone core leads to juxtapose two binding sites recognised by the same transcription factor 
/i.e. the glucocorticoid receptor (GR, panel C) in the long terminal repeat of the MMTV, on the same 
surface of the histone core or to facilitate interaction between enhancer and promoter elements (panel 
D; i.e. the vitellogenin gene promoter, Schild,1993). For further explanations see text. The figure has 
been adapted from Grosschedl, 1995.
1- Direct physical interactions have been demonstrated between acidic 
activators and TBP (Inglesef a l ,  1991), TFIIB (Lin and Greene, 1991; Roberts et a l ,  
1993), and TFIIH (Xiao et a l ,  1994). Multiple lines of evidence suggest that the 
targeting of TFIIB by activators is especially relevant (Hahn, 1993). The association 
of TFIIB is a rate-limiting step in PIC assembly (Lin and Greene, 1991; Ha et a l ,
1993). This is reasonable since TFIIB interacts with other components of the 
initiation complex as TBP, RNA pol II and TFIIF (Ha et a l ,  1993). Binding of 
activators as VP16 would induce a conformational change in TFIIB so to expose
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1994). Furthermore, as TFIIB is released from the complex when RNA pol II exits 
the promoter, a possible function of activators could be to increase the rate of 
TFIIB reassociation or retain TFIIB at the promoter, maintaining the promoter in 
a state accessible to the polymerase and capable of multiple initiation events. 
Direct interaction between TFIIH and activators can be involved in the 
modulation of TFIIH enzymatic activities, important for transcription initiation 
(Xiao et a!., 1994; Tong et a!., 1995).
In vivo footprinting studies have shown that many transcriptional 
activators binding sites appear to be occupied simultaneously (Rigaud et al,  1991). 
This is consistent with the view that two or more activators can exert synergistic 
effects on transcription through concerted interactions with multiple components 
of the PIC (Metz et al,  1994; Chi et al,  1995; Ge and Roeder, 1994a,b). As discussed 
above (see "The TAFs"), it has been recently demonstrated that synergy between 
two different activators (Bicoid and Hunchback) bound to the same promoter, 
results, at least in part, from specific interactions with two distinct dTAFns that 
enhance TFIID recruitment (Sauer et al., 1995).
2- Another level of regulation of transcription is the chromatin packaging of 
DNA in cells. Chromatin is a nucleoproteic complex whose unit is composed of 
an octamer of four different histones (H2A, H2B, H3 and H4), termed the 
nucleosome, and 146 base pairs of DNA wrapped around it. Nucleosomes repress 
transcription by blocking access of transcription factors to DNA (Felsenfeld, 1992; 
Adams and Workman, 1993). Chromatin structure on promoters has been shown 
to be dynamic, so that it can be altered during regulatory events in the absence of 
DNA replication (Schmid et al,  1992; Becker, 1994). It has also been shown that 
changes in chromatin structure accompany induction of tissue-specific genes 
during development and differentiation (Gross and Garrard, 1988). In vitro 
transcription analysis on reconstituted chromatin showed that repression by
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nucleosome can be prevented by incubating DNA with TFIID prior to nucleosome 
assembly (Workman and Roeder, 1987). It has been suggested that activators 
alleviate chromatin mediated repression by changing the nucleosome structure, 
allowing binding of GTFs to the core promoter (Workman et at., 1988; Taylor et 
al,  1991; Workman et al., 1991).
A conserved multiprotein complex of ~ 2 MDa (the SWI/SNF complex; 
Peterson et al,  1994; Côté et al,  1994) with the function of mediating changes in 
chromatin structure, has been identified by genetic screens and biochemical 
analysis in yeast. Drosophila (Tamkun et al., 1992; Elfring et al,  1994) and 
mammals (Kwon et al,  1994 ; Wang et al., 1996).
Genetic studies of transcriptional regulation in the yeast Saccharomyces  
cerevisiae led to the identification of a number of SWI (refer to yeast mating-type 
switching: Stern et al., 1984; Breeden and Nasmyth, 1987) and SNF (abbreviation 
for sucrose non fermenting, Neigeborn and Carlson, 1984) genes as positive 
regulators of a subset of promoters. The observation that mutation either in SWI 
or SNF genes lead to a reduced activation of transcription suggested that both SWI 
and SNF proteins could be components of the same protein complex, as 
confirmed by co-purification through multiple chromatographic steps. The 
purified SWI/SNF complex contains SWIl, SWI2/SNF2, SWI3, SNF5, SNF6 and 
SN Fll in addition to five polypeptides (p78, p68, p50, p47 and p25; Cairns et al,  
1994; Côté et al,  1994).
A relation between SWI/SNF protein function and disruption of chromatin 
structure has come from two observations:
a) mutations in genes encoding chromatin components (such as the core 
histones) suppresses the defects in growth and transcription due to swi and snf 
mutations (Hirschhorn et al, 1992),
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b) the absence of either SWI2/SNF2 or SNF5 results in a decreased 
transcription and alteration of chromatin structure in the promoter region of 
SUC2 gene and these effects can be overcome by a reduction in the level of the 
core histones H2A and H2B (Hirschhorn et al., 1992). This observation also 
suggests that SWI and SNF protein might facilitate the function of transcriptional 
activators by antagonising the repressive action of chromatin. The SWI/SNF 
complex contains a DNA-stimulated ATPase activity (SWI2/SNF2 subunit; 
Laurent et al., 1993). Experiments of binding of GAL4 activator to nucleosome 
reconstituted DNA in the presence of SWI/SNF purified complex and ATP 
suggested that SWI/SNF complex has a role in destabilizing histone-DNA 
interaction increasing the binding of transcription factors to the histone-bound 
DNA (Côté et al, 1994), although the exact nature of this structural change is not 
known yet. The SWI/SNF complex, at least concerning its function, is conserved 
in higher eukaryotes. Functional homologues of SWI2 have been identified in 
Drosophila (brahma; Tamkun et al, 1992) and humans, where there are two genes 
closely related to brm and SWI2 (Khavari et al, 1993; Muchardt and Yaniv, 1993; 
Chiba et al,  1994): BRGl (brm/SWI2-related gene 1 or hSNF2a) and hbrm 
(hSNFB). They are both involved in transcriptional activation in vivo and, using 
an antibody against BRGl, Kwon et al (Kwon et al, 1994) identified in HeLa cells 
two different protein complexes, termed hSWI/SNFA and hSWI/SNFB, with 
chromatin remodelling activity in vitro, as good candidates for the hum an 
counterpart of the yeast SWI-SNF complex. Also a human gene (INIl) shows 
similarity to ySNF5 and it has been shown to associate with BRGl and co- 
fractionate with hSW I/SNF (Kalpana et al,  1994). These data suggest an 
evolutionary conserved function of the SWI-SNF complex in d isrupting  
nucleosome structure in an ATP dependent manner, leading to increase binding 
of transcription factors. Another question to address concerns the targeting of
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SWI/SNF complex to the promoter. There are no clear evidences that activators 
can exert this function, although interaction between the retinoblastoma gene 
product Rb and SWI/SNF has been reported (Dunaief et a!., 1994). Cofractionation 
studies, aimed to characterise factors that copurify with the RNA pol II 
holoenzyme in yeast, have however out lighted that the SWI/SNF complex can 
be found, although not always, associated to the holoenzyme through interactions 
with the mediator proteins (Wilson et al., 1996). So SWI/SNF complex could be 
targeted by associating with the holoenzyme.
Another activity with a function of ATP-dependent chromatin remodelling, 
leading to increased transcription factors binding, has been purified by Wu et al 
from Drosophila embryo extracts and termed NURF (nucleosome rem odelling  
factor; Tsukiyama and Wu, 1995). NURF is composed by 4 polypeptides one of 
which (ISWI) shows a significant identity to SWI2/SNF2 at the level of ATPase 
domain (Tsukiyama and Wu, 1995). A human gene, hSNF2L, also shows 75% 
identity to ISWI over its entire length appearing as the hum an homologue of 
ISWI (Okabe et al, 1992). A putative yeast homologue has been identified (YB95; 
Tsukiyama et al, 1995).
From these findings it can be hypothesised that NURF and SWI/SNF 
complexes represent two distinct classes of ATP-dependent nucleosome 
reorganising activities that are used in different circumstances and from different 
subsets of genes (Fig. 1.7).
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Fig. 1.7: The SWI/SNF and NURF complexes.
The ATP-dependent activities of these complexes enhance the accessibility to DNA of transcription 
factors (Pugh, 1996).
An alternative mechanism for controlling transcription in a chromatin 
environment (reviewed in Wade et a l ,  1997) is provided by enzymes able to 
induce post-translational modification in the histones. Several transcriptional 
regulators, besides TAFn250, have been found to act as enzymes that acetylate 
histones. In S.cerevisiae transcription factors with acidic activation domains 
recruit a trimeric coactivator complex, ADA2-ADA5-GCN5 (Guarente, 1995) 
which contacts the basal transcription machinery. In higher eukaryotes numerous 
transcription factors, including steroid receptors, use the coactivator p300/CBP in 
association with another factor P/CAF. These factors have catalytic function as 
acetyltransferase and act by modifying the amino-terminal tails of particular 
histones (Brownell et a l ,  1996; Ogryzko et a l ,  1996), with the result of 
destabilization of nucleosome and increased access of components of basal 
transcription machinery to the promoter (Lee et a i ,  1993). The activity of 
acetyltransferase-associated factors is balanced by the presence of regulators that 
deacetylate histones, resulting in a repression of transcription (Ayer et al., 1995;
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Taunton et al., 1996). If persistence of gene activity requires continuous activity of 
the acetyltransferase, histone acétylation would represent a mechanism to 
modulate transcription (Figure 1.8).
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Fig. 1.8: Acétylation and deacetylation of histones change nucleosome structure, influencing 
transcription.
Several coactivators contain an histone acetyltransferase activity that facilitate the disruption of 
nucleosomes and recruitment of the basal transcription machinery (A). The presence of histones 
deacetylases can reverse the action of these coactivators, leading to a fine regulation of 
transcriptional activity. Ac indicates acétylation
Other post-transcriptional modifications of histones can modulate the 
stability of nucleosome, as phosphorylation, ubiquitination, méthylation or ADP- 
ribosylation (reviewed in Matthewes and Watyerborg, 1985; Bradbury, 1992). 
Transcriptional regulators containing such activities have been identified.
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3) Preliminary studies indicate that activators may influence the role that 
TFIIH plays during promoter clearance. Complexes containing TF IlE/IIH pause 
between +12 and +18, after which a large fraction of them resumes elongation. It 
has been shown that activators affect the efficiency of elongation by decreasing the 
extent of abortive transcription and increasing the proportion of complexes that 
overcome the +12 to +18 stalling (Yankulov et al,  1994).
Negative control
Negative regulators of eukaryotic gene expression can inhibit transcription 
by interfering with any step in transcription initiation. Several mechanisms of 
repression have been proposed, some of which are referred as passive (involving 
or interfering with activator proteins function) and active (involving direct effect 
of repressor proteins through specific repressive domains on the general 
transcription complex).
Passive repression
Blocking of activator function is realised by different mechanism (Figure 1.9):
a) Interference with activator nuclear localisation. This is one of the earliest 
step at which a factor can interfere with the activity of a transcriptional activator, 
inhibiting the transport of the activator from the cytoplasm into the nucleus. This 
is obtained by the formation of a complex between a repressor protein and the 
positive factors in which the nuclear localisation signal of the activator protein is 
masked by the binding of the repressor, preventing nuclear import (Beg et ai,
1992). One example of such mechanism is described by the Rel/NFkB family of 
transcription factors (reviewed in Blank et al., 1992). Different inhibitor proteins of 
the IkB family can interfere with the activities of different sets of Rel dimers 
(Zabel and Baeuerle, 1990; Geisler et al., 1992; Inoue et al., 1992; Kerr et al., 1992). 
Upon induction by several stimuli, that lead to NF-kB activation, IkBs are
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phosphorylated and degraded by the ubiquitin-proteasome pathway, allowing NF- 
kB to translocate to the nucleus and to activate the target genes (reviewed in 
Thanos and Maniatis, 1995).
Another example comes from the glucocorticoids receptor (GR) that, in the 
absence of its ligand, is also retained in the cytoplasm in a complex which includes 
the 90 KDa heat shock protein, hsp 90 (Pratt et al, 1992).
b) Interference with the assem bly of m ultisubunit activators. Some 
repressors work by competing for association with one of the activator subunits, 
preventing the formation of a functional activator. Many activators bind DNA 
either as homo- or hetero-multimeric complexes. Such interactions are mediated 
by specialised dimerization domains such as the leucine zipper (Landschulz et al,  
1988; Vinson et al,  1989), the POU domain (reviewed in Wegner et al,  1993), the 
basic region helix-loop-helix (Murre et ai,  1989a,b), and the ability to form 
different complexes within a family of related protein gives an enormous source 
of regulatory targets, since different dimeric complexes may differ in DNA binding 
and in transactivation properties (see for examples Descombes and Schibler, 1991; 
Ron and Habener, 1992). This kind of interference can be exerted in two ways: i) a 
negative acting factor can form a complex which fails to bind DNA so that the 
repressing activity is due to titration of positive transcription factors. An example 
comes from families of bH-L-H factors and their helix-loop-helix negative-acting 
coregulators. Id and extramacrochaete (emc), which, although able to dimerize 
with other H-L-H factors, lack a DNA binding domain (reviewed in Jan and Jan,
1993).
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Fig. 1.9: Models of negative control
A: Interference with activator nuclear localisation; B: Interference with assembly of multisubunit 
activators; C: Interference with activator DNA binding; D: Interference with activity of DNA-bound 
activators; E: Interference with access of general transcription machinery to DNA, Among the 
mechanisms of active repression are the interference with pre-initiation complex assembly, the co­
repressor model and the positioning of nucleosomes over the TATA-box with recruitment of silencing 
proteins, as Pc-G, with the formation of a closed compacted chromatin structure.
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Similarly the I-POU domain protein (Inhibitory POU: Treacy et al., 1991) and 
the CHOP-10 (C /  EBP-homologous p.rotein; Ron and Habener, 1992) down- 
modulate the DNA binding activity of their respective dimerization partners; ii) 
the repressor can form a complex that is able to bind DNA, but lacks domains 
required for transcriptional activation. This type of regulation involves two steps: 
competition for binding site and sequestration of a transcription factor in a non 
functional complex. An example is given by the proto-oncogene product c-myc 
that activates transcription when it is complexed with its partner max fmyc 
auxilliary factor; Amati et al,  1993; Littlewood et al., 1992). When present in 
excess, max is a negative regulator of transcription by forming homodimers that 
bind DNA but do not activate transcription (Amin et al,  1993; Gu et al., 1993). 
Other examples have been described including two members of the CREB family 
(CREM and CREB-2; Foulkes et al,  1991; Karpinski et al,  1992); C/EBP-related 
factor LIP (Descombes and Schibler, 1991; Ron and Habener, 1992); two members of 
the AP-1 family Jun B (Chiu et al, 1989) and FosB-s (Nakabeppu and Nathans,
1991). In these latter examples negative regulators are the product of alternative 
splicing or of alternative use of translation initiation codon, of genes encoding 
also the activator form (reviewed in Foulkes and Sassone-Corsi, 1992).
c) Interference with activator DNA binding. Some repressors work by 
competing with a functional activator for binding to the same or overlapping 
recognition site, preventing the binding of the activator by steric hindrance. 
Transcription factors belonging to the same family may show similar or identical 
DNA binding specificity as Drosophila homeodomain-containing proteins; the 
cyclic-AMP response element binding factor (CREB) and the activator protein 1 
(API) factors, where the specificity of CREB activity, and hence the antagonism 
between CREB and API at a non-consensus binding site, is modulated by cAMP 
dependent phosphorylation of CREB (Masquilier and Sassone-Corsi, 1992; Lamph
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et al,  1990); the members of the Spl family of activators (Hagen et ai,  1994). In 
these examples it is clear that the negative effector may simply be the weaker of 
two activators. Another important example comes from the nuclear hormone 
receptors family. Very many negative regulatory processes involve the nuclear 
hormone receptors and several act through cross-talk with the Fos and jun proto­
oncogene products (API factor) regulatory pathway. The API factor is involved in 
proliferative state of the cell (Ransone and Verma, 1990) while the steroid/thyroid 
hormones are found to induce differentiation, or to maintain cells in a quiescent 
state. An antagonism between the proliferative function of API and the 
differentiative function of nuclear hormone receptors has been described 
involving a reciprocal interference with transcriptional activation (Yang-Yen et 
al., 1990; Schule et al,  1990a; Jonat et al,  1990). Furthermore while binding of the 
receptor to DNA is not required for its negative regulatory activity, the zinc-finger 
DNA binding domain is necessary maybe because of an involvement of protein- 
protein interaction with the components of API complex. On the other hand the 
leucine zipper domain (the dimerization domain) of c-jun and the N-terminal 
region of c-Fos are implicated in negative regulation of GR function (Schule et al., 
1990a). Interactions between receptor and API factors have been demonstrated 
both Ï71 vitro (Touray et al., 1991) and in vivo (Yang-Yen et ai,  1990) and several 
mechanisms have been proposed: i) the interaction mutually inhibits DNA 
binding of the two classes of proteins (this is true in vitro [Yang-Yen et al., 1990] 
but it is not known whether it occurs also in vivo [Jonat et ai,  1990]); ii) the 
activity of API complex may be modulated by the formation of a ternary complex 
of A P l/T R E /G R  (Jonat et al,  1990); iii) binding to a GRE (Glucocorticoid 
responsive element) is required. This kind of binding interference has been 
showed for the osteocalcin promoter (a RARE overlaps an API binding site; 
Schule et al., 1990b) and the a-fetoprotein promoter where a GRE overlaps an API
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consensus site (Zhang et al., 1991; Guertin et al., 1988); iv) occupation of a 
composite response element. This mechanism has been described for the 
proliferin gene, where GR is active when c-Jun/cFos heterodimer occupies the 
API site but not when c-Jun homodimer binds the element (Miner and 
Yamamoto, 1991; Diamond et al, 1990; Yoshinaga and Yamamoto, 1991).
d) Interference with the activity of DNA bound activators. In many 
promoters repressor binding sites are adjacent to, although not overlapping, 
binding sites for transcriptional activators. A repressor could block activator 
function by directly contacting the adjacent DNA-bound activator and masking 
the protein domain responsible for transcriptional stimulation. Binding to DNA 
is not strictly required as for GAL 80, a regulator of galactose metabolism in yeast, 
that acts by masking the activation domain of GAL4 (Ma and Ptashne, 1988). 
Similarly in mammals the retinoblastoma gene product Rb modulates the activity 
of DNA binding factors with which it interacts, blocking the contact between the 
activation domain and the polymerase complex (Weintraub et al., 1992).
e) Activation occurs through the action of intermediary factors or cofactors 
(Ptashne and Gann, 1990; Pugh and Tjian, 1990; Martin et al., 1990). A large excess 
of transcription factor, in vitro, can lead to repression of activated transcription by 
a squelching mechanism, in which cofactors are titrated off (Gill and Ptashne,
1988). Squelching has been observed also in vivo w ithout artificially high 
concentrations of the negatively acting factor (Meyer et al, 1989), suggesting that 
the cofactors might be limiting for some transcription activation processes, 
making of squelching a physiologically significant mechanism of regulating gene 
expression. An example is given by the adenovirus F la  gene product. Besides 
activating transcription of viral genes it is also able to repress transactivation by 
several transcription factor. A model for Fla  action is that it interferes with the 
transmission of the activating signals by interaction with cofactors, or with
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polymerase complex (Rochette-Egly et al,  1990). Furthermore the interaction of 
F la  with TFIID has been demonstrated allowing for both positive and negative 
effect on transcription (Horikoshi et al., 1991).
Active repression
An efficient mode to repress genes controlled by multiple activators is to 
interfere directly with the general transcrip tion m achinery, inhibiting 
transcription initiation by a disruption of the polymerase complex at the promoter 
or by impairing the catalytic activity of the complex. Repressor proteins could 
interfere with the assembly of GTFs and sterically block the addition of subsequent 
proteins; interact w ith the general transcription m achinery and prevent 
disassembly step (it will freeze the assembly); recruit another factor into the 
general factor assembly that could act through either of the previous mechanism.
Although they share mechanism of interaction with the basal machinery, 
while the general repressors of basal transcription do not show any specific DNA 
binding activity (Drl, Dr2. NCI, NC2, see also "The human general cofactors"), 
specific repressor proteins function is mediated by the recognition of specific cis- 
regulatory elements in the promoters. DNA sequences recognised by repressor 
proteins have been termed either negatively acting sequences or silencers, 
although these terms are not completely interchangeable. Silencer, by analogy 
with enhancer, is referred to a sequence that act at a great distance and 
independently of orientation, although some have exhibited a varying degree of 
dependence upon position and orientation. Like the enhancers, they are 
composite in structure or show increased effects on transcription with increased 
copy number (Lee et al., 1991; Savagner et al., 1990; Nishiyama et al., 1994). Many 
negative cis-regulatory sequence, with the properties of a silencer, have been 
identified in genes encoding growth-hormone (Larsen et al., 1986), insulin (Nir et 
ai,  1986), renin (Burt et al,  1989; Barrett et al., 1992), interleukin-2 receptor a  chain
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(Smith and Greene, 1989), immunoglobulin Kappa light chain (Pierce et al., 1991); 
immunoglobulin heavy chain (Imler et al., 1987), T cell-receptor a  chain (Winoto 
and Baltimore, 1989), a-fetoprotein (Muglia and Rothman-Denes, 1986), vimentin 
(Parrel et al,  1990), collagen II (Savagner et al,  1990) and e-globin (Gao et al,  1989).
Repressors, like activators, have been shown to consist of modular structure, 
containing separable DNA binding and repression domains as reported for the 
Wilm's tum or gene product WTl (M adden et a l ,  1993), the Drosoph i la  
develomental regulators even-skipped (eve; Han and Manley, 1993), engrailed 
(en; Jaynes and O'Farrell, 1991) and Kruppel (Kr; Licht et al,  1990), the thyroid 
hormone receptor gene c-erbA and its viral counterpart v-ErbA (Baniahmad et al,
1992), although no clear aminoacid sequence similarities exist between the 
repressing domains of different active repressors. However, they show a common 
richness in alanine, glutammine and /o r  proline residues as in eve, WTl, Kr, en, 
or domains rich in charged aminoacids (v-ErbA). Another motif is the carboxy- 
terminal WRPW (Trp,Arg,Pro,Trp) domain of Drosophila Hairy related bHLH 
repressor protein, which interacts with the Groucho family proteins of corepressor 
(Fisher et al,  1996). Schnabel and Abate-Shen (Schanbel and Abate-Shen, 1996) 
demonstrated that the transcriptional repressing activity of HoxA7 resides in its 
hom eodom ain , suggesting  for hom eodom ains an add it ion a l  role in 
transcriptional control beside their function in DNA binding. Furthermore they 
showed that residues in the N-terminal-arm of the homeodomain play a role in 
the differential repressing activity of various Hox proteins, leading to the 
hypothesis that these residues are necessary for distinguishing the functional 
action of homeodomain proteins in vivo.
By analogy with transcriptional activation that involves communication 
with every component of the transcriptional machinery through direct and 
indirect contacts, mechanisms of repression involving promoter occlusion or
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interaction with the basal transcription complex have been described (Hansen et 
al., 1981; DeLuca and Schaffer, 1988; Okhuma et al, 1990). Many activators show 
also repressive function depending on the arrangement of their binding sites with 
respect to the promoter. Dissection of the mechanism by which they operate as 
transcriptional repressor led to models involving either interaction with 
corepressor molecules or directly with components of the basal transcription 
apparatus. The yeast Leu3p protein, involved in the regulation of genes required 
for branched-chain aminoacid biosynthesis and nitrogen metabolism, represses 
gene expression by forming a complex with Motlp/TFIID. It is not clear yet if 
M otlp mediates Leu3p function by destabilization of TBP-DNA interaction or 
whether a stable TBP-Motlp-DNA complex, promoted by Leu3p binding at the 
promoter, may prohibit the subsequent association of downstream  general 
transcription factors (Wade and Jaehning, 1996). Similarly ICP4 activates most 
HSV genes while strongly repressing activated transcription from other 
promoters containing strong ICP4 binding sites near the start site of transcription. 
As a general inhibitor of activated transcription it has been postulated that 
repression by ICP4 must involve a global alteration of the general transcription 
complex that blocks activation but still enables basal transcription. Gu et al (1995) 
showed that ICP4 is complexed with TFIID/TFIIB and suggested that binding to 
DNA of this tripartite  complex causes a conformational change in the 
transcription complex that is unable to respond to positive factors, allowing only 
basal transcription. Alternatively, it has been proposed that the presence of ICP4 
might interfere with the access of other general cofactors as PC4 and p l5  (Ge and 
Roeder, 1994a; Kretzschmar et al, 1994).
Other repressors act directly on basal transcription. The fly even-skipped 
protein (eve; Um et al, 1995), the murine homeodomain protein MSX-1 (Catron 
et al,  1995; Zhang et al,  1996), the unliganded human thyroid receptor (v-Erb A
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protooncogene gene product; Fondell et al, 1993) and the adenovirus E1B-55K 
protein (Yew et al,  1994) repress transcription by direct interaction. The even- 
skipped repressor protein interacts directly with the TATA binding protein (Um et 
al., 1995), while the product of v-Erb A gene can bind TFIIB (Fondell et al,  1993). 
MSX-1 mediates repression via alanine-plus-proline rich regions and interacts 
with basal factor complexes in gel shift assays (may be TBP; Catron et al., 1995). 
Regarding eve, two model for transcriptional repression have been proposed: i) 
binding to TBP (or TFIID) would interfere with the binding of other GTFs or ii) 
interaction eve/TBP destabilizes DNA-TFIID binding. Some of these interactions 
may be mediated by corepressors such as the Groucho protein in D.melanogaster 
(Paroush et al., 1994).
The recruitment of a corepressor adds another important level of regulation, 
because the interaction between the DNA binding protein and the corepressor can 
be regulated.
In yeast, SSN6/TUP1 repressor is involved in transcriptional repression of 
several diverse sets of gene including a-specific, haploid-specific, and glucose- 
repressible genes. This complex interacts with a variety of specific DNA binding- 
proteins (Keleher et ah, 1992), making of this complex a general transcriptional 
corepressor whose specificity is dictated by the DNA binding specificity of protein 
partners. A target for SSN6/TUP1 repressor is the cyclin-kinase complex associated 
to the holoenzyme (the product of SRB 10, the kinase, and SRB 11, the cyclin). It is 
not clear yet whether this repressor acts by modulating the activity of the kinase or 
uses the interaction for tethering to the transcription machinery apparatus 
(Kuchin et ah, 1995; Liao et ah, 1995).
Studies of transcription in vitro support the idea that histone proteins can act 
as transcriptional repressors of eukaryotic genes, probably by preventing TFIID 
access to the DNA (Knezetic and Fuse, 1986; Wasylyk and Chambon, 1979).
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Incubation of TFIID with the template DNA prior to nucleosome assembly 
prevents the nucleosomal inhibition of transcription, which suggests that it is 
TFIID binding that is inhibited by the presence of histone complexes (Workman 
and Roeder, 1987; Knezetic et al, 1988). Specifically positioned nucleosomes have 
been observed at both repressed and activated promoters and have been proposed 
to be involved in transcriptional regulation by placing regulatory sites in an 
inaccessible place on the nucleosome in the case of repression or enhancing 
expression by juxtaposing activator binding sites in the case of activation 
(reviewed in Lu et al., 1994). Some repressor proteins might block transcription 
from a target promoter by directing the formation of a positioned nucleosome 
over the TATA-box (Roth et al,  1990). Studies of a glucose-repressed gene also 
show a correlation between SSN6/TUP1 repression and the presence of a 
positioned nucleosome in the initiation region (Perez-Ortin et al,  1987; Matallana 
et al., 1992). Thus occlusion of promoter DNA by a positioned nucleosome might 
contribute to transcriptional repression by SSN6/TUP1. It is not clear yet what 
determines nucleosome positioning but it has been proposed that either DNA 
sequences (Thoma and Simpson, 1985; Simpson, 1991) or DNA binding protein 
that create a boundary in chromatin (Fedor et al., 1988) or proteins that actively 
position nucleosomes at adjacent sequences (Roth et al, 1990) might contribute to 
this.
As already mentioned in the "positive control" section, there is a general 
correlation between core histone acétylation and gene activity. Conversely, it has 
been thought that core histone deacetylation leads to transcriptional repression. 
This is consistent with the finding of a mammalian histone deacetylase (FIDACl; 
Taunton et al,  1996) that is related to the yeast Rpd3 protein which is required for 
full repression as well as full activation of gene expression (Vidal and Gaber, 
1991). Several recent papers suggest that transcriptional repression by a sequence-
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specific DNA-binding protein can be mediated by the recruitment of a deacetylase 
(Rpd3, HDACl, HDAC2) to the promoter region. The recruitment seems to be 
mediated by other molecules working as corepressors (Sin3, N-Cor/SMART; 
reviewed in Wolffe, 1997).
Chromatin mediated silencing
Silencing at telomeres and at HML and HMR
Silencing may involve changes in chromatin structure by establishing 
specific structural domains. This is sustained by the finding of factors that through 
binding to silencer are required either for nuclear scaffold attachment or 
transcriptional repression (Hofmann et a!., 1989; Shore, 1994).
One of the best studied mechanism of repression occurs at the yeast Mating 
Type loci and near telomeres.
The budding yeast exists as haploid cells of a or a  mating-type, which can 
mate to form a / a  diploids. The genes involved in determining mating-type reside 
at three unlinked loci: MAT, HML and HMR. The mating-type of a haploid cell is 
determined by the allele, MAT a or MAT a, present at the MAT locus. Yeast cells 
can switch their mating-type by replacing the allele at MAT with an allele of the 
opposite mating type copied from either HML or HMR. The genes at the HM loci 
are transcriptionally inactive. The silent mating type loci HML and HMR have 
flanking sequences called the E and I elements that are required in cis for 
repression of gene expression (Laurenson and Rine, 1992; Brand et al., 1987; Eigure 
1.10a). Analysis of the E element revealed three functional sub-elements that 
contribute to the silencer function. A, B and E, none of which is able to cause 
silencing on its own. The A element contains an ARS consensus sequence 
(Campbell and Newlon, 1991), responsible for the binding of ORC (orig in  
recognition complex; Bell and Stillman, 1992) to all four silencers (HML-E, HML-I, 
HMR-E, HMR-I) in vitro (Bell et al,  1993). The E and B elements contain binding
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sites for the transcription factors RAPl and ABFl respectively (Shore and 
Nasmyth, 1987; Diffley and Stillman, 1989). ORC seems to play a critical role in the 
establishment of silencing at HM loci (Fig. 1.10b) as well as ABFl and RIFl(a RAPl 
interacting factor; Hardy et al., 1992). It is not clear yet whether the involvement of 
ORC is caused by a necessary role for replication an d /o r  whether ORC plays a 
more direct role in establishing a refractory chromatin structure (Newlon, 1993). 
What is known is that the repressed state can be established only following the 
passage through S-phase leading to the hypothesis that the establishment might 
be a consequence of replication associated chromatin assembly (Miller and 
Nasmyth, 1984).
It appears, however, that repression at these loci, as well as at telomeres, is 
mediated by a multiproteic complex containing nucleosomes and the product of 
SIR genes (silent information regulator; Rine and Herskowitz, 1987; Aparicio et 
al., 1991). While SIRl, probably through interaction with ORC, appears to act 
exclusively during the establishment of silencing (Chien et al,  1993 ), SIR2, SIR3 
and SIR4 are required for the maintenance of the repressed state (Pillus and Rine,
1989). Recently, SIR 3 has been directly implicated in spreading of the repressive 
state (Fig. 1.10c; Renauld et al, 1993). A direct involvement of histones in 
silencing was suggested by studies on deletion of the aminoterminal part of 
histone 3 and histone 4 that leads to a derepression of HM loci and the genes 
located near telomeres (Kayne et al, 1988). Cenetic studies have also showed that 
SIR3 and SIR4 might interact directly with the histone aminotermini to nucleate a 
repressive structure (Hecht et al,  1995). Furthermore the packaging of HM loci in 
a inaccessible chromatin structure has also been determined by its inaccessibility to 
various enzymatic probes (Loo and Rine, 1994). Interaction between SIR3 and SIR4 
with RAPl has been demonstrated by two-hybrid experiments (Fig. 1.10b; Moretti 
et al, 1994; Cockell et al,  1995).
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The transcriptional state of the silent domain is stably inherited through 
multiple cell cycles and the intact silencer is required for the efficient inheritance 
of the repressed chromatin structures following replication. So the silencer has all 
the information promoting the reformation of the silent chromatin in the 
progeny (Holmes and Broach, 1996).
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Fig.1.10: Model for silencing establishment at HM loci and telomeres in yeast.
A: MAT, HML and HMR are the three loci that contain the regulatory genes for mating-type 
determination. The three subelements and the protein bound to the HMR-E silencer are shown. B: 
Model for silencing at HM loci. C: Model of protein-protein interaction involved in the nucléation 
and propagation of chromatin-mediated gene repression at telomeres. R is for RAPl. 3 and 4 are for 
SIRS and S1R4 respectively (Cockell, 1995).
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Pc-G
The studies on silencing in yeast stress the importance of maintaining stably 
repressed genes, as developmental regulatory genes, in multicellular organisms. 
The homeotic genes of Drosophila (reviewed in Gehring et al,  1994) provide a key 
model for studying mechanisms that maintain state of gene expression during 
development. Homeotic gene expression depends on a set of regulatory factors 
acting earlier in development and of another set of factors that maintain the 
patterns during later development. The homeotic genes encode transcription 
factors required for proper determination of identities of the body segments. Each 
homeotic gene is expressed in a spatially restricted domain along the anterior- 
posterior axis (A/P). The proper regulation of these genes is under the control of 
proteins that repress (gap protein) or activate (pair-rule) their expression by 
competing for binding to nearby or overlapping sites in the promoters (Shimell, et 
al. , 1994; Qian et al,  1993; Zhang and Schultz, 1992; Muller and Bienz, 1992). Later 
in development other classes of proteins are required for the correct maintenance 
of this pattern and genes involved in maintaining the repressive (Polycomb- 
group, Pc-G) or active (Tritorax-group, trx-G) state have been identified. The 
current model for the action of these genes is that they "lock" gene expression in 
an inactive or active state by changing in chromatin structure. Then, Pc-G genes 
would maintain repressed those homeotic genes that were off during earlier step 
of development as trx-G genes maintain active genes there were in a on state. 
Pleiotropic phenotypes of many Pc-G mutations suggested that Pc-G action is not 
limited to homeotic gene expression but rather they exert a more general control 
on oogenesis, neural development and cell proliferation (Phillips and Shearn, 
1990; Paro, 1990; Adler et ai,  1991). So far 13 members of this group have been 
identified by genetic studies six of which have been characterised at molecular 
level: Polycomb (Pc), polyhomeotic (ph). Posterior sex combs (Psc), Enhancer of
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zeste E(z), Polycomb-like (Pci) and extra sex combs (esc). Coimmunoprecipitation 
experiments (Franke et a l ,  1992) and double-immunofluorescence labelling of 
polythene chromosomes (Franke et al., 1992; Rastelli et al., 1993; Lonie et al., 1994) 
indicate that the Pc-G gene products form several large complexes, whose 
composition may vary in a cell-type specific manner playing different roles in 
different tissues during development.
A Pc-G response element (PRF) has been identified in the regulatory region 
of genes of ANT-C and BX-C complexes and it has been demonstrated that it is 
necessary for the establishment of repression of reporter gene expression in germ 
line transfection studies, although so far no DNA binding activity has been 
identified for any of the Pc-G proteins (Simon et al., 1993; Chan et al., 1994; 
Gindhart and Kaufman, 1995). This leaves an open question about the 
mechanism by which these sequences are recognised by the Pc-G proteins. Once 
targeted, the Pc-G would maintain repression of homeotic genes by the creation of 
a locked chromatin structure not accessible to any activator protein (Fig. 1.11).
E n h a n c e rPR E
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Fig. 1.11: Proposed mechanism for stable repression by Polycomb group protein
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This model, termed chromatin accessibility model, is sustained by several 
observations: i) immunoprécipitation of UV-crosslinked Pc proteins showed that 
they are physically associated with sequences corresponding to the entire length of 
Ubx and AbdA  genes. Some of these sequences contain high-affinity binding sites 
as tested by the ability to confer repression on a linked lacZ gene (Orlando and 
Paro, 1993); ii) Pc protein contain a region termed the "chromodomain" that is 
conserved in the Drosophila heterochromatin associated factor (HPl; Paro and 
Hogness, 1991), suggesting a structural similarity between Pc and HPl leading to 
the idea that Pc-G proteins repress transcription by packaging the DNA into an 
heterochromatin-like structure.; iii) the Drosophila gene BRM, whose function 
has been associated with that of the chromatin remodelling SWI/SNF complex in 
yeast, has been isolated as suppressor of Pc mutations (Tamkun et al,  1992); iv) the 
ability of sequence-specific DNA binding protein to interact with Pc-G repressed 
genes is inhibited in a manner similar to inhibition by stable nucleosomes (g and 
Paro, 1995; McCall and Bender, 1996). In this model Pc-G gene products would be 
targeted, by binding to high-affinity binding sites, to nucleate formation of a 
complex that then would spread to adjacent region creating a stable repressed 
chromatin structure (Figure 1.11).
It was found that the Pc chromodomain plays an important role in directing 
Pc-G complexes assembly. Mutations in the chromodomain do not only inhibit 
the binding of the Pc protein to its target genes but also affect the integrity of the 
entire complex (Franke et ai,  1995). Once again the importance of such regulatory 
mechanism is outlined by the identification of mammalian homologues of Pc-G 
gene products, bmi-1, identified as oncogenes in mouse, (Haupt et al, 1991; Van 
Lohuizen et al,  1991) and the human mel-18 (Ishida et al., 1993; Kanno et al.,
1995), show about 43% identity with fly Psc in the region surrounding the RING 
finger motif; the mouse Rae-28 protein contains several regions of sequence
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similarity to the fly ph protein (Nomura et al,  1994); a number of mammalian 
proteins have been described to contain chromodomains as mouse M33 protein 
(Pearce et al., 1992; Saunders et al, 1993), that is a good candidate as a functional Pc 
homologue.
From the examples reported above it is clear that the activity of promoter 
regions depends on the balance of function of complexes that through their effect 
on chromatin structure can lead to repression or activation. In particular several 
line of evidences are consistent with a model in which nucleosome mobility plays 
a key role in determining promoter activity and hence gene regulation. Increased 
nucleosome mobility might result from sliding of nucleosome along DNA or 
from direct transfer of the nucleosome from one to an adjacent segment of DNA. 
Activators, through ATP-dependent remodelling complexes, would act by 
increasing mobility of nucleosomes and might help displace Pc-G complexes 
preventing silencing (Aparicio and Gottschling, 1994; Zink and Paro, 1995), while 
repressors could function by directing formation of a structure that decrease 
nucleosome mobility and by blocking the recruitment of factors that increased 
mobility.
DNA méthylation mediated repression
DNA méthylation has been proposed to have an active role in gene 
regulation (Li et al,  1993; Li et al,  1992). Transient transfection and in vitro 
transcription studies demonstrated that DNA méthylation leads to the repression 
of transcription by interfering with the binding of transcription factor and by 
directing the assembly of specific-nucleoprotein complexes formed by methyl- 
specific DNA binding proteins and histones which potentially block transcription 
factors access (Murray and Grosveld, 1987; Iguchi-Ariga and Schaffner, 1989; Ball et 
al,  1983; Boyes and Bird, 1991; Jost and Hofsteenge, 1992). Specialised chromatin 
structures have also been implicated in maintaining the transcriptionally silenced
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state (Graessmann and Graessmann, 1988; Kass et al,  1994; Hsieh, 1994). Recently 
Kass et al. (1997) have shown that the process of silencing transcription by DNA 
méthylation involves both the inhibition of transcription initiation and the 
removal of engaged transcriptional machinery from active templates, followed by 
a time-dependent assembly of a repressive structure that includes a higher-order 
nucleosomal DNA structure (Kass et ai,  1997).
The plasm inogen activation system
Extracellular targeted proteolysis is essential for cell migration and tissue 
remodelling. One major system involved in these processes is the activation of 
plasminogen. The activation of plasminogen into plasm in leads to the 
degradation of extracellular matrix molecules, as fibronectin and laminin, and 
this event is at the centre of a variety of biological processes such as fibrinolysis, 
wound healing, angiogenesis, tumour metastasis, embryogenesis, gametogenesis, 
ovulation and mammary gland involution (reviewed in Saksela and Rifkin, 1988; 
Plow et al, 1995).
The activation o f  plasminogen
Plasminogen is found in high levels almost ubiquitiously (Raum et al,  1980; 
Isseroff and Rifkin, 1983; Miles and Plow, 1985; Maijar et al,  1986; Saksela and 
Vihko, 1986). Localised activation of plasminogen is regulated by a complex 
network of molecular interactions in which activators (urokinase-type and tissue- 
type plasminogen activators), specific inhibitors (PAI-1, PAI-2, PAI-3, protease 
nexin-I and II, a-2 antiplasmin) and receptors (uPA receptor, plasminogen 
receptor) are involved (see Figure 1.12). Both plasminogen activators (PAs) as well 
as their product, plasmin, belong to the family of serine proteases which also 
include trypsin, chymotrypsin, thrombin, elastase and others. Serine proteases
Introduction 50
contain a catalytic triad in their active site, serine, histidine, aspartic, which are in 
close contact and are important for the proteolytic cleavage (Stryer, 1995).
Plasminogen is activated by the PAs which cleave a single peptide bond 
between Arg 560 and Val 561. The two resulting polypeptides chains of active 
plasmin are held together by a disulphide bond.
uPAR
pro-uPA I
Plasmin
pro-metailo
proteases
PAI-1
PAI-2
PN-1
m etalloproteases
tPA
Fig. 1.12: The plasminogen activation system
The plasminogen activators
Both urokinase-type and tissue-type plasminogen activators (uPA and tPA) 
catalyse the activation of plasminogen but with distinct roles in v ivo.  In the 
absence of fibrin, uPA has a substantial plasminogen activator activity, whereas 
tPA is hardly active. Only binding of tPA to fibrin causes a several fold 
stimulation of its activity (Andreasen et a i ,  1990), playing a crucial role in 
intravascular fibrinolysis (Collen and Lijnen, 1991) and thrombolysis (Nilsson et 
al., 1985). uPA has a more general role in the blood stream primarily in the cell- 
mediated proteolysis during macrophages invasion, wound-healing.
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embryogenesis, invasiveness and metastasis (Dano et al,  1985; Fazioli and Blasi, 
1994; Sappino et ai,  1989; Moscatelli and Rifkin, 1988; Kirchheimer and Remold, 
1989; Baker et al,  1990). However, uPA and tPA knock-out experiments in mice 
have shown that many of the functions of uPA and tPA are shared and that only 
the knock-out of both genes leads to severe effects in the animals (Carmeliet and 
Collen, 1994; 1995). tPA deficient mice show an impaired thrombolysis and 
defective long term potentiation, a process in the brain that is related to learning 
and memory (Frey et al,  1996); on the other hand, inactivation of the uPA gene 
results in occasional spontaneous fibrin deposition, deficiency in wound-healing 
and abolishment of cellular recruitment in response to pulmonary inflammation 
(Gyetko et al., 1996). Combined uPA ' and tPA ' mice show an extensive 
spontaneous fibrin deposition in various organs and totally lack thrombolysis 
after endotoxin injection.
The two activators are product of different genes, the human gene for tPA is 
on chromosome 8, whereas that for human uPA is located on chromosome 10. 
The human tPA gene is 29-32.7 Kb long, consists of 14 exons (Ny et al, 1984) and 
codes for a 70 KDa protein via a 2.7 Kb mRNA (Fisher et al,  1985; Pennica et al., 
1983). The human 6.4 Kb uPA gene contains 11 exons (Riccio et ai,  1985) and 
encodes for a 53 KDa protein via a 2.5 Kb mRNA (Verde et al,  1984). The 
difference in gene size is due to long introns in the tPA gene, which contain 
several open reading frames without a known function (Degen et ai,  1986).
The two PAs are highly similar in their basic structures indicative of a close 
evolutionary relationship, but share less than 40% identity at the aminoacid level 
(Degen et al,  1986). Both uPA and tPA have a similar catalytic domain located in 
the carboxy-terminal part of both enzymes, a growth factor-like domain, which in 
the case of uPA is responsible for the binding to its specific receptor, and kringle 
domains (one in uPA and two in tPA). The additional kringle domain and the
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amino-terminal finger-like domain present in tPA seem to be responsible for its 
binding to fibrin (van Zonneveld et al,  1986).
tiPA and its receptor
uPA is produced from cells as a single-chain pro-enzyme (pro-uPA) and 
converted by limited proteolysis into an active two-chain molecule.
Binding of uPA to its specific cellular receptor (uPAR) (Stoppelli et al., 1985; 
Vassalli et al,  1985) regulates uPA activity by enhancing the rate of conversion of 
pro-uPA into the active two chain molecule (Ellis et al,  1989; Manchanda and 
Schwartz, 1991), localising the proteolytic activity to the cell surface, or inhibiting 
the active enzyme through specific inhibitors (Cubellis et al,  1989; Ellis et al., 
1990). The initiating event in the conversion of pro-uPA to active uPA in vivo is 
still not known. However, in vitro experiments show that plasmin is able to 
activate pro-uPA in solution (Wun et al, 1982), but a twenty-fold increase in uPA 
activation rate is achieved when pro-uPA is on the cell surface (Ellis et al,  1989). 
Proteases other than plasmin, involved in different physiological processes, can 
activate pro-uPA. Among these plasma kallikrein (Ichinose et al, 1986) trypsin 
(Koivunen et al,  1989), thermolysin (Marcotte and Henkin, 1993), cathepsin G 
(Learmonth et al,  1992), cathepsin B (Kobayashi et al,  1991) and L 6 (Goretzki et 
al., 1992), nerve growth factor y (Wolf et al,  1993) and thrombin (Nauland and 
Rijken, 1994).
The urokinase receptor is a heavily glycosylated 50-55 KDa protein made up 
of three homologous repeats of ~ 90 residues each, of which the amino-terminal 
domain is involved in ligand binding (Behrendt et al,  1990; 1991, Roldan et al,
1990), and is anchored to the plasma membrane by a glycosyl-phosphatidylinositol 
(GPI) moiety (Ploug et al,  1991). Glycosylation is necessary for the intracellular 
transport and maturation of the receptor but can also affect the affinity of the 
receptor for uPA (Picone et al, 1989; Moller et al,  1993).
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Although most receptors mediate rapid endocytosis of their extracellular 
ligand, the uPA receptor does not internalise bound active uPA (Stoppelli et al,  
1986a). Cell-surface uPA activity is regulated by the availability of extracellular 
PAIs. Once the uPAR-uPA-PAI-1 complex has been formed at the cell surface it is 
rapidly internalised and degraded (Cubellis et al,  1990). This has been also shown 
with uPA-PAl-2 (Estreicher et a!., 1990) and uPA-PN-1 complexes (Conese et al,
1994). This internalisation event occurs by the interaction of these complexes with 
the alpha2-macroglobulin receptor/low  density lipoprotein receptor-related 
protein (a2M R/LRP; Nykjær et al,  1992). The uPA receptor appears to be 
transiently internalised with the uPA-PATl complex, and rapidly recycled back to 
the surface (Conese and Blasi, 1995; Nykjaer et al., 1997). The ability of inhibitors to 
block surface uPA activity and of uPA receptors to recycle might result in 
continues modulation of migration-competent areas of the cell membrane by 
modifying the location of the proteolytic activity on the cell surface (Fazioli and 
Blasi, 1994). For instance, in non-migrating cells, uPAR is distributed on the cell 
surface at focal contacts or on the apical side (Limongi et al., 1995) whereas in 
actively migrating monocytes uPAR rapidly redistributes at the leading edge of the 
cells (Estreicher et al,  1990).
The biological role o f  uPA
Cells are structurally and functionally integrated through the interactions 
with the extracellular matrix and surrounding cells. Interactions are mediated by 
specific receptors, such as integrins and cadherins, with intracellular domains of 
these receptors connected to the cytoskeleton at focal adhesion, and by a number 
of molecules as fibronectin, laminin, thrombospondin, tenascin and collagen in 
the ECM, and vinculin, actin, a-actinin and paxilin in the cell (reviewed in 
Ridley, 1994; Carraway and Carraway, 1995).
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The important role of uPA in cell migration and invasiveness has been so 
far explained by the ability of uPA to activate plasminogen to plasmin at the cell 
surface promoting degradation of fibrin (Reich, 1978) and extracellular matrix 
(ECM) and basement membrane glycoproteins (Quigley et a!., 1987). Plasmin, in 
turn, activates other matrix-degrading proteases belonging to the metalloproteases 
family such as procollagenase type IV to collagenase (Saksela and Rifkin, 1988) and 
stromelysin (Matrisian, 1990). The activation of the metalloproteases family by 
means of plasminogen activators can therefore result in a synergistic and effective 
degradation of most, if not all, matrix components (Fig. 1.12).
uPA mediated extracellular proteolysis is involved in many physiological 
processes sustaining cell migration as i) the migration of kératinocytes in wound 
healing processes (Grondal-Hansen et al., 1988) which can be stimulated by the 
epidermal growth factor (EGF) (Rorth et al,  1990; Jensen and Rodeck, 1993); ii) the 
trophoblast cell invasion into the uterine wall during the process of mouse 
embryo implantation (Sappino et al., 1989; Teesalu et al,  1996), where each 
component of the system displays a regional expression in the apical pole of the 
implanting zone. In particular, uPA expression is confined to the inner layer 
(extraembryonic throphoblasts), uPAR synthesis is pronounced in the external, 
decidual layer and PAI-1 is confined to the intermediate layer; iii) the migration of 
myoblasts during myogenesis and muscle regeneration (Quax et al,  1992; Munoz- 
Canoves and Felez, 1993). In response to muscle damage satellite muscle cells are 
activated and undergo proliferation, differentiation and fusion, leading to the 
formation of long-multinucleated myotubes (Carlson, 1973). To a degenerative 
period that leads to tissue breakdown follows a remodelling period characterised 
by tissue regeneration (Allbrook, 1981). Plasminogen activation seems to be 
involved in these processes as suggested also by in vitro studies of muscle 
differentiation showing that uPA gene expression is modulated during the
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differentiation of myoblasts into myotubes. The uPA level is high during satellite 
cells proliferation and migration and decrease when myoblasts fuse to myotubes 
(Ibaùez-Tallon, 1997; Munoz-Canoves et al, 1997).
A multitude of studies in a variety of different systems have shown that the 
uPA-uPAR interaction may affect cell migration through multiple mechanisms 
(see figure 1.13). An example is given by the process of angiogenesis. Endothelial 
cell migration is positively regulated by the basic fibroblast growth factor (bFGF) 
(Gualandris and Presta, 1995) and negatively by the transforming growth factor 6 
(TGF-f^). It results in a regulatory circuit with bFGF stimulating uPA and 
collagenase synthesis, uPA in turn activating TGF-6, which eventually decreases 
uPA activity by inducing PATl synthesis (Fazioli and Blasi, 1994). Binding of uPA 
can induce a chemotactic response as shown for human monocytic leukaemia cell 
line THP-1 cells, independently of the catalytic activity (Resnati et a!., 1996).
In recent years, a number of evidence indicate the possibility of a direct 
intracellular signalling as an additional way by which the uPA-uPAR system can 
influence cell migration (Busso et al., 1994; Sitrin et al., 1996; Resnati et al,  1996). 
The recent discovery of substrates of uPA other than plasminogen, such as the 
pro-transform ing growth factor (pro-TGF-B) (Odekon et al., 1994), and the 
precursor from hepatocyte growth factor (pro-HGF) (Naldini et al., 1992) which is a 
cell-migration stimulating protein, provides a role for uPA as modulator of cell 
migration by regulating the activity of other protein factors.
Role o f  uPA in cancer
Due to their destructive potential, extracellular proteolytic enzymes have to 
be precisely and tightly controlled in their spatial and temporal expression. A 
pathological situation where these control mechanisms appear to fail dramatically 
is observed in malignant tumour cells, which exhibits progressive invasion of 
surrounding normal tissues.
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The are commonly found to be expressed by malignant tumours (reviewed 
in Pollanen et ah, 1991). Tumour tissue extracts from colon, breast, lung and 
prostate carcinomas have higher uPA activity than their normal non-transformed 
tissues.
cytoplasm
(uPAR'
uPA
signal transduction signal transduction
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mitogenes
activation of 
plasminogenactivation of pro-HGF 
and pro-MSP
cleavage of fibronectin 
and other ECM proteins
modulation of 
cell-cell and 
cell-ECM 
contact sites
activation of 
latent TGF-fi
CELL M IG R A T IO N
Fig. 1.13: The different mechanisms by which the uPA-uPAR interaction may affect cell migration
uPA is represented by the three linked domains: the growth factor domain (GFD), the kringle 
domain (Kr) and the protease (Pr) domain; ECM, extracellular matrix; pro-HGF, pro-hepatocyte 
growth factor; pro-MSP, pro-macrophage stimulating protein; TGF-6, Transforming growth factor 6. 
Solid lines indicate stimulation and broken lines indicate inhibition (Fazioli and Blasi, 1994).
In addition, PAs are found to be highly expressed in cells which have been 
infected with oncogenic viruses (Zhang and Schultz, 1992), correlating with the
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appearance of certain features of malignant cells such as anchorage independent 
growth, increased motility, reduced cytoskeletal organisation and morphological 
changes. Several data strongly suggest that the presence of high levels of uPA, 
uPAR and PAI-1 in hum an breast cancer may be used as an independent 
prognostic marker for the early relapses of breast cancer patients (Janicke et al,  
1990; Janicke et al,  1991; Grondal-Hansen et al,  1993) as well as for bladder and 
lung cancer (Hasui et al,  1992; Pedersen et al., 1994a, b). Therefore, several 
approaches have been made to use uPA and its receptor as anti-metastatic targets 
(Fazioli and Blasi, 1994). It has been shown in a number of studies that tumour 
invasiveness and metastasis can be blocked or stimulated in several model 
systems by a direct decrease or increase of uPA activity (Dano et al., 1985; Ossowski 
and Reich, 1983; Hearing et al,  1988; Axelrod et al,  1989; Ossowski et al,  1991; 
Mignatti and Rifkin, 1993). Moreover, recent studies show that uPA-deficient 
mice are more resistant to melanoma induction, again confirming the 
contribution of uPA to malignant progression (Shapiro et al., 1996).
Transcriptional regulation o f  the uPA gene
Due to the critical consequences of its activation, uPA expression requires a 
tight regulation. Many of the changes in the levels of uPA synthesis appear to be 
due to changes in the rate of transcription, but also post-transcriptional 
(Henderson et al,  1992; Nagamine et al,  1995) and post-translational mechanisms 
regulate its expression.
Inducers of uPA synthesis
The distribution of uPA in the organism is under normal circumstances very 
restricted. The presence of uPA in normal adult mouse is only detected in very 
few cell types such as the fibroblast-like cells in the gastrointestinal tract, the 
tubular cells in kidney and the pneumocytes in lung (Larsson et al,  1984).
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However, many cell types, often derived from non-uPA expressing tissues, 
produce easily detectable amounts of uPA when transferred to cell culture. The 
increased uPA synthesis most likely reflects the altered growth conditions 
imposed on the cells in culture leading to a highly proliferative state.
The study of uPA synthesis and regulation in cell culture is, however, very 
useful when trying to uncover the regulatory elements responsible for the 
expression of uPA and the mechanisms by which they are activated. In this way, 
uPA synthesis has been shown to be modulated by a large number of stimuli in 
many different cell lines. Reflecting the link between cancer and uPA gene 
expression, many of the uPA inducing agents are involved in growth control 
regulation. Growth factors (such as fibroblast growth factor, transforming growth 
factor-beta, epidermal growth factor), phorbol esters, polypeptidic (FSH, LH, 
pro lac tin , calcitonin) and steroid horm ones (estrogens, p rogesterone, 
dexamethasone and androgens), cAMP, antimitotic drugs (as colchicine and 
cytochalasin B), inflammatory cytokines (like tumour necrosis factor, interleukins 
and interferon y ), oncogenes and UV light, induce uPA gene expression 
(reviewed in Dano et a!., 1985; Blasi and Verde, 1990; Ibahez-Tallon, 1993; 
Nagamine et al,  1995; Besser et al. , 1996).
The transcriptional activation has been shown to be regulated independently 
through several signal transduction pathways involving protein kinase A (PKA), 
protein kinase C (PKC), cytoskeletal reorganisation and okadaic acid-sensitive 
protein phosphatase (Besser et al, 1996).
The uPA gene promoter
The genes encoding uPA and 5' flanking regions have been sequenced and 
extensively characterised in human (Riccio et al,  1985; Verde et al, 1988; Fig. 1.14), 
mouse (Degen et al,  1987) and pig (Nagamine et al,  1984). The length of the 
promoter sequences published so far are different between the three mammalian
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promoters, 2.3 kb, 7 kb and 4.7 kb for the human, murine and porcine genes 
respectively (Riccio et a l ,  1985; Cassady et a l ,  1991). In vitro  and in v ivo  studies 
have revealed the presence of a number of regulatory regions, some of them 
identical between all three mammalian promoters, but surprisingly, the far 
upstream region of the promoters share higher homology than the regions closer 
to the transcription start site.
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Fig. 1.14: The human uPA 5' flanking region
The minimal promoter
The minimal promoter (MP) contains a TATA-box characteristic of many 
regulated genes, which is located 25 bp upstream of the transcription initiation site 
in all uPA promoters, but lacks the typical CAAT box. There are several copies of 
GGGCGG sequences, which are potential binding sites for Spl (four in the human, 
two in the murine and five in the porcine promoter) (Verde et al., 1988; Rossi et 
a l ,  1990).
The uPA enhancer element
The enhancer element is located at 2 kb (human and porcine promoters) and 
at 2.4 kb (murine promoter) upstream of the transcription initiation site (Verde, 
1988 et a l;  Rorth et a l ,  1990; Cassady et a l ,  1991). Two binding sites for the 
transcription factor AP-1, one of which is combined with the binding site for
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PEA3, are present within the 120 bp-long enhancer and are crucial for its activity 
(PEA3/APla and APlb sites) (Nerlov et al., 1991). In addition, a cooperation 
mediating (COM) element is positioned between the combined PEA3/AP1 and the 
API sites (Nerlov et al., 1992). The COM element does not appear to have 
transactivation-mediating activity by itself, but it is important for synergistic 
activation of both AP-1 sites (De Cesare et al,  1996).
A similar enhancer modular structure has been described in the promoters 
of the stromelysin, interleukin-3, and cytokine LD78 genes (Sirum-Connolly and 
Brinckerhoff, 1991; Taylor et al, 1996; Nomiyama et al,  1993). These promoters are 
also regulated through AP-1 sites, and seem to have sequence homologies to the 
uPA enhancer not only in the transactivating elements, but also in the COM 
region.
The PEA3/APlelement
The PEA3/AP1 element is conserved in the human, murine and porcine 
uPA promoters.
The GAGGAAA sequence has been shown to bind proteins of the Ets family, 
while the TGAAGTCA is an octameric AP-1 site, which can be imperfectly aligned 
with the octameric TREs of the c-jun promoter and with the GRE of the 
somatostatin promoter. The uPA APla sites of the murine and porcine enhancers 
are also formed by a non-canonical octameric binding sequence. Similar elements 
with a PEA3 site adjacent to an AP-1 site have been found in several promoters 
such as the polyoma A virus early enhancer and human collagenase enhancers. 
Maximal induction of these genes by growth stimuli requires both the AP-1 and 
the PEA3 binding sites.
It has been found that this PEA3/AP1 element is responsible for uPA gene 
induction through PKC activation by TPA (Rorth et al,  1990; Nerlov et al,  1991), 
protein phosphatase 2A (PP2A) inhibition by okadaic acid (Nagamine and Ziegler,
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1991), cytoskeletal reorganisation by colchicine or cytochalasins (Botteri et al,
1990), as well as for the response to several growth factors (Besser et al., 1995a) and 
oncogenes (Lengyel et al., 1995a,b; Nagamine et al,  1995). Moreover, the 
PEA3/AP1 element has also recently been identified as the target of the uPA 
transcriptional activation by middle-T antigen (Besser et al., 1995b; Urich et al,  
1995), GM-CSF (Granulocyte-macrophage colony stimulation factor; Stacey et al,
1995) and interleukin-1 (Besser et al,  1996).
Recent studies have shown that in vitro the PEA3 site interacts with ets-2, a 
member of the PE A3/ets  family, and in vivo mediates the induction of uPA 
transcription by colony-stimulating factor 1 (CSF-1; Stacey et al., 1995).
De Cesare et al. (1995) have reported that the uPA octameric upstream APla 
site interacts with the dimer formed by c-Jun and ATE-2 and that these 
heterodimers show particular regulatory features distinct from canonical AP-1 
dimers: c-Fos can antagonise the transcriptional induction via c-Jun/ATF-2 since 
c-jun/c-fos heterodimers have a much lower affinity for that site.
The downstream AP-1 site
The downstream AP-lb site is an heptameric non canonical site which differs 
from the TRE canonical sequence because of the central adenine. This element is 
identical in all three uPA enhancers. The two AP-1 sites of the uPA enhancer are 
not functionally equivalent: mutations of the downstream site AP-lb have a 
relatively small effect, reducing inducibility by about 75%, while the upstream site 
A P-la  has a more profound influence (Nerlov et al., 1992). c-Jun/c-Fos 
he te rod im ers  seem to bind the A P-lb  e lem ent (Verde P., personal 
communication).
The COM region
DNasel footprinting and site-directed mutagenesis have identified two areas 
of the COM region (u-COM and d-COM) important for the function of the
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enhancer (Nerlov et al, 1991). Four different factors, uPA enhancer factors (UEF) 1 
to 4, appear to bind to these regions. Mutations within the COM element, affecting 
the binding of the different UEFs impair both inducibility (Nerlov et al,  1992) as 
well as basal level activity (De Cesare et ai,  1996) of the enhancer. Transfection 
and mutagenesis analysis have shown that the COM activity is position- 
dependent but orientation-independent, and that its function appears to be 
structural since it does not have transactivation properties (De Cesare et ai, 1996).
NF-kB sites
Two NE-kB elements at -1580 and -1865 bp have been identified in the 
human uPA promoter. The site at -1580 mediates the induction by phorbol esters 
and tumour necrosis factor in HepG2 cells and HT1080 cells (Hansen et al,  1992), 
while the site at -1865 is involved in the TPA response in HeLa cells (Novak et al.,
1991). Two different dimers have been shown to bind the site at -1580, NE-kB (p50 
and p65 subunits) and a dimer of p65 and c-rel (Hansen et al., 1992). It is not 
known which of these dimers is responsible for the induction. However, the 
induction via this site may be repressed by a negative regulatory element 
upstream of the NE-kB site (Verde et al,  1988; Hansen et al,  1992).
cAMP responsive elements
Although it has been shown that PKA activation by cAMP agonists can 
induce uPA from all three mammalian species studied, the responsive elements 
have only been identified in the human and pig promoters.
Two putative AP2 binding sites in the human uPA promoter, close to the 
transcription start site have been shown to be responsible for PKA-dependent 
induction of uPA gene expression in murine Sertoli cells (Rossi et al., 1990) and 
the nuclear factors binding to them have been identified (Grimaldi et al,  1993a,b).
On the other hand, studies of the porcine uPA promoter in LLG-PKl cells 
(Degen et al., 1985; Nagamine et ai, 1983), indicate that PKA-dependent uPA
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induction seems to be conferred by different elements identified in a DNase I- 
hypersensitivity study (Lee et al,  1994). A cAMP-responsive region at -3.4 kb of the 
porcine uPA promoter was studied in more detail. It is composed of three 
elements, termed A, B, and C, all required for full cAMP responsiveness, 
suggesting that the proteins binding to these sites interact with each other 
(Menoud et a!., 1993; Marksitzer et al., 1995). Menoud et al. (1993) identified the 
protein binding to the C element as the porcine homologue of mouse liver factor 
B (LFB3) and human and rat variant hepatocyte nuclear factor 1 (vHNFl). The A 
and B elements contain CREB-like sequences but the binding proteins for these 
sites are not known. A high homology between the porcine uPA promoter A,B,C 
elements and human upstream sequences has been found, indicative of a similar 
PKA-dependent regulation of the human uPA gene (Ibafiez-Tallon, 1997).
Negative regulatory sites
Several reports indicate that in cells that do not produce uPA the main 
regulatory mechanism may be a negative one. The first indirect evidence is that 
the level of uPA mRNA is increased upon cycloheximide treatment (Stoppelli et 
al., 1986b; Grimaldi et al,  1986; Altus et al., 1987) and that this effect is in part due 
to increased rate of transcription, although an increased stability of uPA mRNA 
cannot be excluded. Secondly, in LLC-PKl cells, in which uPA expression is 
dependent on calcitonin or cyclic AMP treatment (Nagamine et al., 1983), 
recessive calcitonin-independent mutants have been isolated (Flofstetter et al., 
1987). Deletion analysis of the 5' flanking region of human and porcine gene 
prom oter identified a negative regulatory element located in the hum an 
promoter between -1824 and -1572 bp (Verde et al,  1988), and in the porcine 
between -2.7 and -1.6 kb (von der Abe et al., 1990). Furthermore, a repressor acting 
through the NF-kB site at -1865 bp of the human promoter has been described 
(Novak et al,  1991).
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unknown sites
The induction of the uPA promoter can be modulated by other signalling 
pathways. It has been reported that Ca^+ can enhance the induction by cAMP, 
TPA and okadaic acid in LLC-PKl cells although it does not induce the uPA gene 
by itself (Nagamine and Ziegler, 1991). Negative effects on uPA induction by 
cAMP, TPA and interleukin-1 a /b  and all-trans-retinoic acid have been reported 
for anti-inflammatory glucocorticoids. This probably occurs by an indirect 
mechanism, because no putative binding site for the glucocorticoid receptor is 
present in the uPA promoter, and the repression can be blocked by protein 
synthesis inhibitors (Vitti and Hamilton, 1988; Pearson et aL, 1987). The 
m echanisms regulating Ca^+ and glucocorticoid modulation of uPA gene 
expression are not well understood (Nagamine et al., 1995).
Chromatin structure of human uPA gene
Recently, in our laboratory, the regulation of the hum an urokinase gene 
expression has been related to the chromatin structure of the gene (Ibahez-Tallon, 
1997). The analysis has been carried out in cancer cells which constitutively 
express urokinase (PC3), in cells which do not produce uPA (HeLa) and in HepG2 
cells in which urokinase transcription is induced with TPA (Nerlov et al., 1992), 
relating the chromatin structure to the different functional states of the gene.
The DNase I hypersensitive sites (HS) analysis have revealed the presence of 
8 HS sites in the active gene (see Figure 1.15). Three sites (HSl, HS2 and HS3) are 
located in the most 5' part of the promoter (also characterised in our lab.). The 
HS4 site maps in the enhancer element; HS5 corresponds to a putative Z-DNA 
structure; HS6 is localised between -0.7 and -0.55 Kb; HS7 spans the start site of 
transcription and the first intron and HS8 is 3' of the polyA site. Important 
differences between cell types were observed suggesting that a general loosening of
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the chromatin structure over the proximal promoter region (PC3 versus HeLa) 
and local rearrangements (HepG2 - /+  TPA) correlate with uPA transcriptional 
activation. In cell lines not expressing uPA the minimal promoter (revealed as 
HS7) and the proximal regulatory region (identified by HS6) show resistance to 
DNase I, indicative of a compact chromatin organisation and possibly 
inaccessibility to the basal transcription machinery.
Furthermore the chromatin studies on the mouse urokinase gene during in 
vitro myoblast differentiation revealed a pattern of HS in which HS5, 6 and 7 
correspond respectively to the HS4, 6 and 7 of the human gene and are present at 
the myoblast and early myotube stages. An overall decrease in DNasel 
hypersensitivity over the distal promoter region correlates with differentiation.
Due to the quite high level of species conservation between the human and 
murine uPA promoters is important to underline that nuclease hypersensitivity 
associated to the minimal promoter and start site of transcription seems to be a 
necessary condition for both genes to be active. Human HeLa and mouse LB6 cells 
do not express detectable levels of uPA and do not have HS at the start site of 
transcription (see Figure 1.16).
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Fig. 1.15: Schematic representation of DNasel hypersensitive sites of huPA gene in different cell 
lines.
Both the promoter region (-11.8/+1) and the gene (+1/ +9000) of human uPA are represented (Ibanez- 
Tallon, 1997).
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Fig. 1.16: Schematic representation of homologous cis-acting regulative elements, associated to 
DNase I hypersensitivity, in the human and murine uPA promoters (Ibanez-Tallon, 1997).
Aim of the project 67
2. Aim of the project
As described in the introduction, uPA is involved in norm al and 
pathological processes by activating proteolytic reactions at the cell surface and is 
evident that due to its high destructive potential, uPA expression needs to be 
tightly regulated.
The restricted uPA expression in the organisms, very few cell types, and its 
overexpression in tumours and several transformed cell lines, makes of major 
importance to study and characterise the element(s) involved in the negative 
regulation of uPA, in order to understand the mechanisms that lead to high 
expression of the gene in tumour cells.
Progressive 5' deletions of the regulatory region of human uPA, from -2350 
with respect to the transcription start site, fused to the CAT reporter gene, have 
already revealed the presence of positive (the enhancer, up to -1824) and negative 
cis-acting sequences (-1824/ -1572) and of a specific contribution to uPA expression 
of the region -1572 to -72 in the kidney derived A1251 cells, but not in HFSIO 
fibroblasts (Verde et a/.,1988), suggesting the presence of multiple array of cis- 
acting sequences specific for different transcription factors that direct uPA 
expression in a cell-type specific manner.
Furthermore Cannio et al. (1991) described the presence of another negative 
regulatory region (-660/-86) in the proximal region of human uPA promoter, the 
activity of which was dependent on the presence of the enhancer. In particular, he 
m apped  the silencing activity in the region -660/-537 and the enhancer 
dependence in the region -537/-301.
At the beginning of this project I decided to further characterise the silencer 
region described by Cannio et al. but I found out that part of the constructs used in
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that analysis contained several important cloning mistakes so to invalidate all the 
results got that far.
I then decided to characterised again the 5' flanking region of the human 
uPA gene to find out elements that were involved in the negative regulation of 
the gene in cells not producing uPA compared to uPA producing cells (Figure 2.1).
As shown in the figure, the human HT1080 cell line and the human 
prostatic derived adenocarcinoma cell line PC-3 express uPA at high levels; the 
cervical carcinoma derived HeLa cells and the simian fibroblast-like CV1 cell line 
express little if not all uPA, while the human hepatocyte cell line HepC2, 
expresses uPA at a very low basal level inducible upon treatment with phorbol 
ester TPA.
HepG2
HT1080 HeLa PC3 CVl -  +TPA
-
uPA
18S
Fig. 2.1: Northern blot analysis of uPA expression in different cell lines
All the constructs used in the transient transfection analysis are derived 
from the -2212/ -t-30 region of the human uPA promoter driven the expression of 
CAT gene, in order to avoid the presence of great part of the 5'Alu sequence (- 
2350/-2140). On the other hand Verde et al (1988) already showed that the region 
up to -2.2 Kb contains the sequences needed to direct a cell-type specific expression 
of uPA, in culture.
In the second part of the thesis I started the characterisation of the factors that 
might be involved in the establishment of the silenced state of the uPA gene.
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Other aspects of negative regulation of uPA, in different systems (repression 
by TGFfi and control of the expression of uPA during the cell cycle), that have 
raised my interested, are treated in the two appendices, as the results described are 
preliminar and they would need further studies.
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3. Materials and Methods
Cell culture, DNA transient transfection and CAT assay
The cervical carcinoma HeLa, the prostatic derived adenocarcinoma PC-3 and 
the simian fibroblast-like CV-1 cells were grown in Dulbecco's modified Eagle's 
medium (DMEM; Cibco, UK) supplemented with 10% foetal calf serum, penicillin 
(100 U/ml), streptomycin (100 gg/ml) and glutamine (2 mg/ml).
Cells were transfected by the calcium phosphate precipitation technique 
(Craham and van der Eb, 1973). Briefly, cells were plated at a density of 7x10^ per 
100 mm plate 24 hours prior to transfection. A calcium phosphate DNA 
precipitate containing 10 pg of reporter plasmid, 1 pg of EEla-fi galactosidase 
expression vector and carrier DNA (fish sperm DNA, Boehringer Mannheim) up 
to 20 pg (DNA mix), was formed by adding dropwise an equal volume of DNA 
mix to a 2x HBS buffer (1.4 mM Na2HP04, 12 mM glucose, 27.4 mM NaCl, 10 mM 
KCl, 40 mM Hepes) and added to cells for 16 hours. After removal of the 
precipitate cell extracts were prepared 48 hours after transfection by the three 
freeze and thawing cycles of the cells previously resuspended in 100 pi of Tris-HCl 
0.25 M. pH 7.8 (Sambrook et a/.,1989).
The CAT protein produced was quantitated employing a non radioactive 
CAT-ELISA kit (Boehringer Mannheim) and the amount was normalised to 6- 
galactosidase activity (Sambrook et al,19S9).
D NA plasm id construction
All DNA manipulations were carried out by standard techniques (Sambrook 
et a l ,1989) and the constructs verified by restriction analysis and DNA sequencing.
The -2212 to +30 region of the human uPA promoter (EcoRI/Smal in p-uPA- 
CAT-2212; Verde et al,  1988) was cloned in the EcoRI/Smal site of pCEM7Zf(+)
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vector (Promega; p2212). The Hind III/BamHI CAT cassette from pEMBL8-CAT 
(Colantuoni et al, 1987) was cloned in the Hind III/BamHI sites of p huPA2212 
plasmid. The derived plasmid (p2212CAT) is used as the basic construct for all the 
following manipulations.
5' deletions
1870CAT, 660CAT, 787CAT: The fragments EcoRI/EcoRV (-1870/-537) and
EcoRI/Smal (-660/+30) from p-uPA-CAT-1870 and p-uPA-CAT-660, respectively, 
(Verde et al., 1988) are blunt ended and cloned in the blunt Xhol and EcoRV 
(1870CAT) or Smal (660CAT) sites of p2212CAT digested plasmid.
Eor 787CAT the cloned region is Hpal/EcoRV (-787/-537) from p2212.
537CAT and 86CAT (MPCAT): p2212CAT is digested respectively with 
Xhol/EcoRV and Xho I/Eco47III, blunt ended and religated.
Internal deletions
E537CAT (ES3MPCAT), EMPCAT, EAS3CAT: They are obtained by digestion 
and religation of p2212CAT vector with the following restriction enzymes: 
Bsu36I/EcoRV (E537CAT); Bsu36I/Eco47III (EMPCAT); EcoRV/Eco47III (p 
2212AS3CAT).
EH28CAT, E787CAT, E660CAT; The -1428/-537 (StuI/EcoRV), -787/-537
(Hpal/EcoRV) and -660/-537 (AluI/EcoRV) fragments from p2212 were cloned in 
Bsu36I/EcoRV linearized p2212CAT, respectively.
EAS2CAT:  The p2212 plasmid is digested H pal/EcoRV and religated 
(p2212AS2). The StuI/Eco47III from p2212AS2 is then cloned in the StuI/Eco47III 
linearized p2212CAT (EAS2CAT).
ESIMPCAT, SIMPCAT:  They are obtained by StuI and Eco47III digestion and 
religation of p2212CAT and pl870CAT, respectively.
ESIMPCAT, SIMPCAT:  pE787CAT and p787CAT are digested with EcoRV 
and Eco47III and religated to give ,respectively, pES2MPCAT and pS2MPCAT.
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SV40 derived plasmids
The -7S7/-537 S2 region (Hpal/EcoRV in the huPA promoter) is cloned in 
both orientation in the blunt ended Bgl II site (pCATsil and pCATsil inv) and in 
the Xbal site ( pCATsil 3') of pCAT control vector (Promega) which contains the 
SV40 promoter and enhancer.
S2 internal deletions
The deletions of the regions internal to the S2 silencer have been obtained by 
recombinant PCR according to Vallette et al. (1989).
The primers used for primary amplification were the following:
p A l :  5' T T G G T G C T T C T C T T T T G G G  A 3' ( # A l c s )  a n d
5'AGCTCTGCCTTCCTTCTGTCACTCTCAGGTG 3' (#U3BE; - 1 5 0 0 / - 1 4 7 4  in the uPA 
promoter), 5' TCCCAAAAGAGAAGCACCAA 3' (#A1) and 5'AGTGGCAGTCCCCAGATATCA 
3' (#5  low; -5 2 0 /-5 4 0 ) ;  pA2: 5'ATGATGTTACGCATAAACTG3' (#A 2cs) and #U3BE, 5' 
CAGTTTATGCGTAACATCAT 3' (#A2) and #5  low; pA3: 5' ATTACTGAAACAGGGCTTGA 3' 
(#A3cs) and #U3BE, 5'TCAAGCCCTGTTTCAGTAAT 3' (#A3) and #5  low; pA4: 5' 
TTTGATGGTGACTGAAAATT 3' (#A4cs) and #U3BE, 5'AATTTTCAGTCACCATCAAA 3' 
(#A4) and #5  low; pA5: 5'ATGGAACAAAGCCGGGCTTA 3' (#H low; -557/-576) and 
#U3BE.
After mixing together the primary PCR products, the second amplification 
has been carried out using as external primers #U3BE and #5 low (pAl to pA4). 
The final products are digested Stu 1/ EcoRV and cloned in StuI/EcoRV linearized 
p2212CAT (p2212S2Al to A4).
To obtain A5 construct the primary product is directly digested with Stu I or 
Hpal, and cloned in the StuI/ EcoRV digested p2212CAT (p2212S2A5) or in the 
blunt Bgl II site of pCAT control (psilA5), respectively.
For the other S2-SV40 derived constructs the psilA2 to psilA4 plasmids were 
derived by digestion of p2212S2A2 to A4 with Hpal/EcoRV and cloned in the blunt
Materials and Methods 73
ended Bgl II site of pCAT control. psilAl was obtained by PCR using as template 
p2212S2AlCAT construct and the following primers: 5' TCCCAAAAGAGAAGCACCAA 
3' (#A1) and #5 low. The fragment is then digested Hpal/EcoRV and cloned in the 
blunted Bgl II site of pCAT control.
pAlA2, pA3A4, p3' half, p5' half: These construct are obtained by the same 
strategy. In the case of pAlA2 and pA3A4 the DNA templates were psilAl and 
psilA3, respectively. For p 3'-half and p5'-half the template was p2212CAT.
In the first step of amplification the primers are 5' AAGTTGGGTAACGCCAGGGT 
3' (#pCAT up, 341/420 in pCAT contro l vector) and  #A 2cs, 5' 
AGCTTCCTTAGCTCCTGAAA 3' (#EC13; 605/638 in pCAT control) and #A2 (pAlA2); 
#pCAT up and 5' G T G A C T G A A A C A G G G C T T G A  3' (#A3A4cs), 5'
TCAAGCCCTGTTTCAGTCAC 3' (#A3A4) and #EC13 (pA3A4). The se co n d  amplification 
is performed using as external primers #pCAT up and #EC13. The products are 
then digested Sau3AI and cloned in Bgl II site of pCAT control.
The p 5'-half and p3'-half constructs are derived by a single amplification 
step with the fo llo w in g  primers 5' CAGTAATCTGGCCTTGCCTTTCC 3' and #5 low (p3'- 
half), 5' ACTGAAAATTTGCAGCTTGG 3' and 5' TCCCAAAGACCCGTTAACAC 3' (#HpaI) 
for p 5'-half.
The fragments are then digested EcoRV (p 3'-half) and Hpa I (p 5'-half) and 
cloned in blunted Bgl II site of pCAT control.
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Nuclear extract and Southwestern analysis
Nuclear extracts were obtained with a modified method of Dignam et al.,1983 
(Ausubel et al,  1994).
Briefly, HeLa and PC-3 cells were grown in 150 mm plates to 80% confluence 
in DMEM supplemented with 10% foetal calf serum, penicillin (100 U /m l), 
streptomycin (100 gg/ml) and glutamine (2 mg/ml).
After harvesting, the cells are resuspended in a volume equal to 3 packed cell 
volume (pcv) of hypothonic buffer (10 mM HEPES pH 7.9 at 4°C, 1.5 mM MgCl2, 
10 mM KCl, 0.2 mM PMSE, 0.5 mM DTE), swollen on ice for 10 min. and 
homogenised with 10 strokes (type B pestle). The nuclei are pelletted by 
centrifugation at 3300xg for 15 min. and resuspended in 1/2 packed nuclei volume 
(pnv) of low -salt buffer (20 mM HEPES pH 7.9 at 4°C; 25% glycerol, 1.5 mM MgCl2, 
20 mM KCl, 0.2 mM EDTA, 0.2 mM PMSE, 0.5 mM DTT).
In a dropwise fashion a volume equal to 1 /2  pnv of low-salt buffer 
containing 1.6 M KCl (high-salt buffer) was added (0.4 M KCl final concentration) 
and the nuclei were extracted for 30 minutes at 4°C with continuous gentle 
mixing.
After centrifugation the nuclear extract is dialysed against 50 volumes of a 
buffer containing 20 mM HEPES pH 7.9 at 4°C; 20% glycerol; 100 mM KCl; 0.2 mM 
EDTA; 0.5 mM DTT; 0.5 mM PMSE for 4-16 hours. After centrifugation, to remove 
the precipitated protein, the extract is aliquoted, frozen in liquid nitrogen and 
store at -80°C. The protein concentration is determined by the Bradford method 
(BioRad; Bradford M., 1976).
Eor column chromatography fractionation, purified HeLa cells nuclei, 
obtained by 5x10^ growing exponential cells (Ghent, Belgium), are extracted 
according to the method of Dignam et al. (1983). Briefly, the nuclei pellet (10 ml) is 
resuspended in 2.5 volume of buffer C (20 mM Hepes pH 7.9, 25% Glycerol, 0.42 M
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NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSE, Ix Aprotinin, 1 
gg /m l Leupeptin, Igg /m l Pepstatina A, 1 mM Sodium bisulphite) and stirred on 
ice for 60 min. Nuclear extract is then clarified by ultracentrifugation at 40000 rpm 
in the 70.1 Ti rotor (Beckman) at 4°C for 1 hour and dialysed in 50 volume of 
buffer D.
29 OD280 ^re loaded on a 25 ml Heparin Sepharose column (Pharmacia) pre­
equilibrated in Buffer D. The column has been washed with 2 volume of the same 
buffer containing 200 mM KCl (Fraction W; 3.55 OD28O) and eluted with 10 
volume of 200 mM - 1 M KCl linear gradient made in buffer D.
50 g g of fraction W are sized fractionated on a 10% SDS-polyacrylamide gel 
and the protein transferred to a nitrocellulose filter (250 mA, 4 hrs in transfer 
buffer: 191 mM glycine, 25 mM Tris, 20% methanol). The proteins are then 
renatured by incubating the filter in 100 ml of renaturation buffer (lOmM Tris-HCl 
pH 7.5, 10 mM Magnesium Acetate, 10 mM KCl, 10 mM 2-mercaptoethanol, 0.1 
mM EDTA, 10% glycerol, Ix Denhardt's solution) for 2 hours with 3 changes.
Binding is carried out with 5 ml of a mixture containing Ix binding buffer 
(see above) and 5x10^ cpm of labelled oligonucleotide (-100 fmoles) as described in 
the legend of the figure. Competitor DNA is added as fold molar excess.
DNase I  protection analysis and Electrophoretic m obility shift assay (EMSA)
40 to 80 gg of nuclear extract are used in DNase I footprinting experiment. 
The reaction is performed in 50 gl of a mixture containing 25 gl of 2X binding 
buffer (40 mM HEPES pH7.9; 4 mM MgCl2; 100 mM KCl; 1 mM EDTA; 2 mM DTT; 
20% glycerol) and 2 gg of poly dl-C (Pharmacia) and incubated on ice for 30 min. 
After adding 20.000 cpm of ^^P-S2 labelled fragment the incubation proceeds for 30 
min at r.t.
DNase I treatment is performed adding to each sample 50 gl of MgCl2 10 
m M / CaCl2 5mM and DNase I ( In g /gg  of extract) freshly diluted in the same
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buffer. After 2 min. at r.t. digestion was stopped by adding 100 gl stop solution (20 
mM Tris pH 7.5; 200 mM NaCl; 20 mM EDTA; 1% SDS; 100 gg /m l proteinase K; 50 
g g / ml  tRNA) and incubating the samples 30 min. at 60°C. Samples are then 
phenol/ chloroform extracted and DNA is precipitated with 1/10 vol of sodium 
acetate pH 7.0 and 2.5 vol. of cold EtOH.
DNA was then separated on 6% or 8% denaturing polyacrylamide gel, using 
standard Maxam-Cilbert G+A sequencing reaction of the fragment as a marker 
(Sambrook et al,  1989).
Eor EMSA analysis, 3-5 gg of nuclear extract are preincubated on ice for 30 
minutes in 25 gl final volume of a mixture containing 20 mM HEPES pH 7.9; 2 
mM MgCl2; 50 mM KCl; 0.5 mM EDTA; 1 mM DTT; 10% glycerol and 2 gg of poly 
dl-C (Pharmacia). 10 fmoles of labelled oligonucleotide DNA probes and molar 
excess of cold competitors (see legend of figures) are added simultaneously and 
incubated for 30 minutes at room temperature. Nucleoproteic complexes are then 
analysed on 5% polyacrylamide gels in 0.5x TBE run at 7 watts for 90 minutes. 
Prior to loading, gels are prerun at 300 volts for 30'. The gels were dried and 
autoradiographed using intensifying screens at -80°C for 24-48 hours.
Circular permutation assay
The H pal/EcoRV  (-787/-537) S2 region and the annealed synthetic 
o lig o n u c le o tid e  #H (5' TAAGCCCGGCTTTGTTCCAT 3') are cloned in the Xbal site of 
pBend2 plasmid (Kim et al,  1989). Circular permuted fragments are obtained by 
restriction with different restriction enzymes in the tandemly repeated polylinker 
of pBend2. Each fragment is then labelled by Klenow filling in using a^^P-dCTP or 
by Polynucleotide kinase and y^^P-ATP (Sambrook et al.,, 1989) and incubated in 
the presence of titrated amount of human SRY-HMG box (kindly provided by M. 
Bianchi, DIBIT, Milan; Eerrari et al.„ 1992), human SOX-4 HMG box and human
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TCF-1 HMG box provided by M.van de Wetering (University of Utrecht, The 
Netherlands; van de Wetering and Clevers, 1992; van de Wetering et al.,, 1993). 
The binding is carried out in 10 gl (final volume) of a buffer containing 8% Ficoll, 
100 mM NaCl, 10 mM Hepes pH 7.9 for 10 min on ice. Electrophoresis is carried 
out as previously described.
The mobility of protein-DNA complexes was normalised to the mobility of 
free DNA (Rbound/Rfree, vertical axis in the graphs); the distance between the 5' 
end of the probe was normalised to the total length of the probe (flexure 
displacement, orizontal axis in the graphs). The points in the graphs were 
interpolated with a second-order equation by means of least squares algorithm 
(Cricket Graph application on a Macintosh computer).
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4.Results
Cell type specificity of different portions of the uPA gene regulatory region.
DNA constructs carrying different portions of the uPA regulatory region 
(from -2212 to +30) fused to the CAT reporter gene have been transfected in cells 
either not producing (CVl and HeLa cells) or producing high constitutive level of 
uPA (PC-3).
As shown in table 4.1, the transcriptional activity of the minimal promoter (- 
86 to +30; pMPCAT) was unexpectedly higher (about 2.5 fold) in CVl than in PC-3 
and HeLa cells. When I used the full length construct p2212CAT, which includes 
the enhancer, the minimal promoter and the sequences spanning the two regions, 
an increase of only 3 fold over the minimal promoter activity was observed in PC- 
3 cells, while in CVl and HeLa cells the transcriptional activity dropped by about 
three and five fold (Table 4.1). When a fragment containing the enhancer (-2212 to 
-1870) was added upstream of the minimal promoter (pEMPCAT), the activity was 
increased in all three cell lines tested although with different efficiency: seven and 
six fold in the case of CVl and HeLa and 25 fold in PC-3 cells (Table 4.1).
These data showed that the activity of the minimal promoter, cell-type 
dependent, is in all cases increased by the enhancer and that the sequences 
between the enhancer and the minimal promoter modulate enhancer activation 
in a cell-specific way by downregulating transcription.
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_l I i i ■_ p 221 2 CAT
p EMP CAT
p MR CAT
pg  C A T / u n I t  B - 6 A L
P C - 3 C V  1 H e L a
36.0 ± 5.3 (n -6 ) 10.3 ± 3 (n -22) 2.8 ± 1.1 (n-14)
305.0 ± 70.0 (n-3) 220.0 ± 55 (n-7) 76.5 ± 5.0 (n-2)
12.2 ± 2.9 (n -6 ) 30.0 ± 8 (n -6 ) 13.4 ± 5.3 (n-7)
Table 4.1: Cell-type specificity of uPA promoter activity 
Plasmid constructs with the CAT gene under the control of the indicated uPA subunit promoter regions 
were tested, in transient transfection, for CAT activity in cell lines either not producing (CV-1 and 
HeLa) or producing high constitutive level of uPA (PC-3). CAT values are normalised to fi- 
galactosidase activity and they are the means ± standard deviation (SD) of a number of independent 
experiments as indicated in parenthesis.
Multiple silencing activities in the 5' flanking region of the human uPA
gene.
In order to investigate in greater detail the mechanism of negative 
regulation of transcription in the uPA gene, 5' deletions of the p2212 CAT 
construct were tested in CVl and in PC-3 cells (Figure 4.1). Deletion of the 
enhancer region reduced the activity of the construct (compare p2212 to p i870); 
further deletions (up to -537) restored the activity to that of the p2212 construct in 
CV-1, but did not have a significant effect in PC-3 cells. Only the deletion of the 
region spanning from -537 to -86 increased transcription in both cell lines (Figure 
4.1).
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0.43 ± 0 .08 (3)
0 .29 ± 0.05 (3)
0.23 ± 0.11 (3) 
2.50 ± 0.30 (3)
Fig. 4.1: Deletion analysis of huPA 5’ flanking region
Nested 5' deletions of uPA promoter region are analysed in CV 1 (light blue bars) and PC-3 (orange 
bars) cell lines. CAT values are expressed as relative activity (normalised to 6-galactosidase) ± 
standard deviation with respect to p86 CAT construct set as 1. The number of independent 
experiments are shown in parenthesis.
Next, I prepared internal deletions leaving the enhancer and the minimal 
promoter (-86) intact, in order to analyse the effects of the negative region(s) on 
the enhancer activity (Figure 4.2). In PC-3 cells, deletions of the region -1820 to -537 
minimally (two-fold) increased transcription. However, deletion of the -537 to -86 
region (called S3) caused a stronger increase in CAT activity. I then conclude that 
in this cell line the only two functionally most important regions are the 
enhancer and S3 (Fig. 4.1 and 4.2).
In CVl and HeLa cells, however, regions -1820 to -1428 (SI), -787 to -537 (S2) 
appeared to contribute to the down regulation of transcription with an additive 
effect to that of -537 to -86 (S3). Deletion of SI increased transcription about 2.5 fold 
in CVl and five-fold in HeLa. Deletions of both SI and S2 (-1820 to -537) had an 
about seven fold effect, and deletion of all three increased transcription 20 to 25 
fold. Deletion of either S2 or S3 region alone confirmed their role as cis-acting
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negative regulatory elements with SI and S2 showing greater cell type specific 
activity (compare CVl and HeLa versus PC-3) than S3.
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p 2212 CAT
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------------------------------------------------------  (ASl)
p E787 CAT
-86 +1-660-537
p E660 CAT
-537 -86
p E537 CAT
p EMP CAT
p EAS2 CAT
pEAS3 CAT
p MP CAT
CAT re la tive  activity
CV 1 H e L a P C - 3
Ix Ix Ix
4.6x ± 1.60 (7) 4.9x ± 0.15 (2) 1.51X ± 0.28 (5)
4.Ox ± 0.80 (6) - 1.74X ± 0.34 (5)
7.3x ± 1.70 (4) - 1.88X ± 0.32 (7)
6 .0 x ± 1 .2 0 (4 ) - 1.61X ± 0.34 (6)
21.3X ± 5.00 (7) 24.6X ± 7.00 (4) 10.30X ± 3.90 (7)
2.5x ± 0.04 (7) 2.9x ± 0.20 (3) 1.60X ± 0.05 (3)
3.8x ± 0.60 (4) 5.8x ± 0.70 (2) 5.20X ± 0.90 (4)
3.3x ± 0.20 (5) 5.1x ± 1.80 (9) 0.34X ± 0.10 (4)
Fig. 4.2: Analysis of huPA promoter internal deletions
Constructs carrying internal deletions of huPA 5' flanking region are analysed in CVl, HeLa and PC- 
3 cells. CAT values are expressed as relative activity ± SD, with the full length construct set as 1. 
The number in parenthesis is for independent experiments.
Constructs (E787CAT, E660CAT, E537CAT, and EMPCAT) where the 
enhancer is located downstream the CAT gene showed the same activity, 
excluding that the increased CAT expression was due to a position effect of the 
enhancer closer and closer to the transcription start site (data not shown).
Furthermore, the deletion analysis suggested that S2 activity depends on the 
enhancer, as its activity was not detected in the 5' nested deletions of figure 4.1. SI 
and S3, instead, appear to modulate the activity of the minimal promoter.
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In order to test this possibility I cloned the SI, S2 and S3 regions in front of 
the uPA minimal promoter in the presence or in the absence of the enhancer. As 
it is shown in figure 4.3, in CVl cells all three regions SI, S2 and S3 repress the 
activity of the constructs by the same level either in the presence or in the absence 
of the enhancer. From these data it is possible to conclude that these silencing 
regions suppress the activity of the minimal promoter.
fold rep ression
-1820 -1428
ENH SI
-1820 -1428
-1820
1 . L
ENH
-2212 -1820
ENH
2212 -1820
1 L
787 -537 -86
CAT
-537 -86
S3 MP
537 -86
S3 MP
ENH
86 +1
p ESIMP CAT 3.4 X ± 0.35 (5) -----
p SIM P CAT ------ 4.20  x ±  0.90 (6)
pES2MPCAT 1.8 X ± 0 .30  ( 6 ) ---
pS2M PCAT --- 1.98 x ±  0.30 (6)
pES3MPCAT 2.37 X ± 0.22 (7) ---
p S3MP CAT --- 2.37 X ± 0 .5 0 (4 )
p EMP CAT 1 X ---
pM PC A T --- 1 X
Fig. 4.3: SI, 82 and S3 effect on the uPA minimal promoter and enhancer activity in CVl cells.
The negative regulatory elements 51, 52 and 53 are cloned in front of the minimal promoter in the 
presence or absence of huPA enhancer and their activity is tested in CVl cell line. The values are 
expressed as fold repression (pEMPCAT/pE5MPCAT and pMPCAT/ p5MPCAT, respectively) ± 5D. 
In parenthesis the number of independent experiments is indicated.
S2 has the properties of a silencer
Of the three negative regulatory regions only S2 showed to act in a cell-type 
specific manner, being active only in those cells that do not produce uPA. 1 then 
decided to further characterise the activity of the S2 region cloning the -787 to -537
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region upstream  of the SV40 enhancer/ prom oter driven CAT gene (pCATsil). As 
show n in Figure 4.4, the S2 sequence represses the SV40 enhancer-prom oter in 
CVl and HeLa cells (about 4 fold) but not in PC-3 cells and its function is 
orientation-independent (compare pCAT sil and pCAT sil inv). Similar results 
have been obtained w ith the S2 region cloned downstream  the reporter gene, 
confirm ing that the increased activity does not depend on the relative distance 
w ith respect to the transcription start site. On the contrary, the S2 sequence 
appears to have the properties of a silencer, acting also outside of the uPA gene 
context and in an orientation- and position independent way.
re la tiv e  C A T  ac tiv ity  
05 1 15
SV 40 Promoter CAT SV 40 
Enhancer
SV 40 Promoter CAT SV 40
Enhancer
S2 SV 40 Promoter CAT SV 40
Enhancer
SV 40 Promoter CAT SV 40
Enhancer
SV 40
Enhancer
p CAT control
p CAT ml
p CAT sil inv
p CAT sil3’
p CAT silS'inv
SV 40 Promoter CAT
Q HeLa 
Q CV-1
D  P C -3
Fig. 4.4: Effect of S2 on SV40 promoter/enhancer driven transcription of CAT gene in CVl, HeLa and 
PC-3 cell lines.
Region S2 has been cloned in either orientation and 5' or 3' of SV40 promoter. The constructs are tested 
by transient transfection in HeLa (yellow bar), CVl (red bar) and PC-3 (green bar) cell lines. The 
CAT activity is expressed as relative to the pCAT control construct for each cell line ± standard 
deviation. The data are the mean of 4 independent experiments.
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Silencer S2 is made up of multiple silencing units
Com parison of the S2 sequence of hum an versus m urine and porcine uPA 5' 
flanking regions, shows several interspersed regions of high homology (Fig. 4.5), 
identifying putative m urine and porcine S2 elements.
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Fig. 4.5: Comparison between human uPA S2 and murine and porcine uPA promoters.
Identical residues between human, mouse and pig uPA promoter are indicated by a bar, while a 
rhomboid indicates the same residues between human and porcine uPA promoters. 1 to 6 defines the 
six regions of high homology. Below, the genomic organisation of region 1 to 6 in human, mouse and 
pig uPA 5' flanking region is drawn.
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In the mouse, however, these sequences span a wider region (-1007 to -603) in 
contrast to the porcine and uPA prom oter that encompass 285 and 250 base pairs 
respectively. Regions of non-homology separate the different m odules w ith a 
degree of similarity higher betw een hum an and pig S2 than betw een mouse and 
the two other species.
The putative m urine S2 is characterised by long insertion with respect to pig 
and hum an S2 element. How ever the highest homology resides in the most 
5'part of the elem ent w ith m odule 1, 2 and 3 showing an about 80% homology 
between the three species. Modules 4 and 5, although highly homologous between 
mouse and man, are less conserved in the porcine prom oter, showing the 
presence of inserted and deleted residues. Module 6 is present downstream  
m odule 5 both in mouse and porcine uPA prom oters.
The conserved sequences may represent functionally active regions w ithin 
the S2 silencer. Therefore, I deleted such sequences from the hum an uPA 
regulatory region (deletions A1 to A5, see Fig. 4.5) and analysed the effect in the 
context of both the p2212CAT and S2-SV40 CAT constructs by transfection in CVl 
cells. As shown in Figure 4.6, deletion of any single homology dom ain did not 
significantly affect transcription in the natural context of p2212CAT, w ith the 
possible exception of A5 which m oderately decreased the silencing activity.
However, w hen the same deletions were analysed in the S2-SV40CAT 
construct, where the absolute activity of CAT is one order of m agnitude higher 
than w ith the uPA promoter, significant effects were observed.
Indeed, deletion of anyone of the homology regions led to a decrease in 
silencing activity of at least 50% (pAl to pA5 versus pCAT sil). The combined 
deletion A1+A2 showed a reduction in silencing activity of about 70%, while 
A3+A4 was able to totally abolish the S2 negative effect.
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0.33 ±0.13 (13)3.70•p CAT sil
■PpAi 13.6 ±.3.5 (5) 2.33 0.89 ± 0.07 (6) 1,40
.^ _T pA 2 13.3 ±3.1 (6) 2.38 1.00 ±0.24 (8) 1.23
pA3 13.1 ± 3.6 (5) 2.4 0.71 ± 0.09 (8) 1.73
.,y_rpA 4 11.8 ± 2 .9  (8) 2.68 0.70 ± 0.15 (8) 1.75
pA5 17.2 ± 6.4 (8) 1.84 0.72 ±0.11 (8) 1.70
1.05 ±0.35 (6) 1.17
1.18 ±0.20 (7) 1.05pA3A4
f)-5'half 13.9 ± 4.1 (6) 2.28 1.15 ±0.29 (8) 1.04
tT— T " p.3'haif 16.7 ± 3.8 (6) 1.89 1.48 ±0.32 (9) 0.83
Fig. 4.6: Characterisation of silencer S2
The functional analysis of region 1 to 5 of silencer S2 is made in CVl cells. The activity is indicated 
both as picograms of CAT/unit of 6-galactosidase and fold repression. p2212 CAT is for the deleted 
constructs in the context of huPA2212CAT. pS2-SV40 is for the constructs analysed in the context of 
SV40 enhancer/ promoter driven transcription. In parenthesis the number of independent experiments 
is indicated. (-) is for not tested.
In order to test w hether sequences other than those conserved betw een m an 
and mouse were also involved in silencing, 1 deleted the entire 5’ or 3' half of S2. 
As shown in Figure 4.6, in both cases the activity of the silencer was totally lost 
(p5'-half and p3'-half).
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These data indicate that the conserved as well as non conserved regions have 
a functional significance, but also show that m ultiple regions contribute to the 
activity and that some of them are redundant.
DNasel  footprint ing analysis o fS2
In order to investigate w hether the silencing activity was m odulated by the 
interaction of nuclear proteins to the S2 sequence, DNase 1 footprinting analysis 
was carried out with increasing am ount of nuclear extract from uPA producing 
(PC-3) and not producing (HeLa) cells. Both strands of S2 region were subjected to 
the analysis, that revealed a pattern of protected regions covering alm ost the 
entire 250 bp long S2 fragment either w ith HeLa or PC3 nuclear extract already at 
low concentration of nuclear extract (Fig. 4.7). The protected areas encompass both 
the 5 regions homologous betw een the prom oter of hum an, m ouse and pig uPA 
gene (open red boxes) and some of the sequences in between (Fig. 4.8).
The differences between the PC3 and HeLa extracts reside in the regions 
-627/-600 and -711/-704, where protection is observed only in the presence of HeLa 
nuclear extract, more and more evident at higher concentration of nuclear extract, 
and in some DNase 1 hyper- or hypo-sensitive sites, w ith the -772 hypersensitive 
site, in the lower strand, specific for HeLa nuclear extract. Region 3 does not show 
DNase 1 protection. However, in the absence of nuclear extract, this sequence is 
cleaved by DNase 1 only at position -666 and -657 in the upper strand, and shows a 
few cuts in the lower strand at position -665, -664, -660, -659 and -656 (Fig. 
4.7).Therefore 1 cannot exclude that factor(s) bind this region (see also Discussion).
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Fig. 4.8: Schematic representation of DNase I footprinting of 52 region
A close look of the sequence of region S2 shows the presence of several direct 
and inverted repeats (Fig. 4.9). In particular the sequence between -783/-775 is 
repeated at -762/-754 with the difference in two residues (green type); the one 
spanning region -746/-735 (red type) is present at position -570/ -560, w ith the only 
insertion of an A residue in the former, and -596/-604 in the lower strand; the 
sequence TGATA, that matches w ith the consensus for the GATA-1 binding 
factor, is present in the lower strand at position -688/-692 and -712/-716 and in the 
upper strand between -618/-614 (pink type); brown types show a direct repeat of 
the sequence CAATCCT at position -732/-726 and -699/-693; the CCCCCT motif is 
present at -625/-620 and -598/ -593 ( orange type); the GAAAG sequence (light blue 
type) is in the upper strand between -585/ -581 and in the lower strand at -626/ -629. 
Furthermore, this sequence can be seen as a part of a longer motif that include 
also the red-typed sequences (-746 GGACTTTGTTCC -735; -672 GGAGTFTAAAGG 
-661; -632 TGCCITTCCCCC -621; -581 CTTTCGGC -588 in the lower strand, and 
-570 GGCTTTGTTCC -560).
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The CAAT motif is repeated four times along the entire S2 region and 
precisely at position -774, -732, -699 and -580, while the sequence ATGCCTA (-754/- 
747) is present other two times at position -688/-6S2 and -576/-571 with a 
m ism atch (pink line). The TTTAAA motif, present in box 3, is repeated in the 
lower strand at the border of the same area (-648/-653). Finally, the sequence 
CCATC is present twice (-610/-606 and -561/-557), while sequence protected in 
footprint I is also present in the lower strand at position -605/-614 and -759/-769 
(blue line).
The presence of the same sequences at different locations along the whole S2 
fragm ent would explain why the fragm ent is entirely protected. Furthermore, 
because of this redundancy of sequence motifs, I did not study in detailed all the 
footprints but I focused my attention on those protections that are specifically 
present in HeLa nuclear extract and on those containing know n sequence motifs 
that could be im portant in elucidating the way S2 silences transcription.
7^0 2-740
4-
GTTAACACTTCMTAGpAAGCACCAACjAGTTTATGCCClTASGjACTTTGTTCC CACAATt ICTGTAACATCATATbACGACACCTAA 
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CACCATCAAACAAA'CCCCITiJcTGCCGAAAGCAAT^'^CCCBdcTTTGTT^STCCAC'iGGTT^TGTTd^TG.
H
Fig. 4.9: Direct and inverted repeats in S2 silencer region
The regions protected by HeLa and PC-3 nuclear extracts are in orange and blue boxes, respectively. 
The red boxes indicate the conserved regions between mouse and human uPA. The direct and inverted 
sequences present in huPA S2 are identified by the same colour (as font or line).
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EMSA analysis  o f  the complexes present in HeLa and PCS nuclear extracts
Footprint D /L
Footprint D /L , encompassing region -726/-705, is composed by a part that is 
protected both in HeLa and PC-3 extracts and a part specific for HeLa cells. In order 
to analyse the nature of the complexes protecting these sequences, I perform ed a 
mobility shift assay (EMSA) w ith an oligonucleotide encompassing the region 
-737/-705 (oligonucleotide #1; Fig. 4.10, panel A). Two retarded bands are detected 
in the presence of both HeLa and PC-3 nuclear extracts, but they show a different 
mobility (1,1*, 2, 3). The binding of both complexes is specific as they are competed 
by an excess of 50-fold unlabelled oligonucleotide #1, although the affinity seems 
to be higher for the complexes detected by HeLa extract than by PC-3 (50x vs 500x). 
A careful analysis of the sequences present in the region of footprint D /L  showed 
a similarity w ith the combined binding site for the Drosophila H O X  gene 
Antennapedia (Antp)  and factors belonging to the PBX family of transcriptional 
cofactors (PBC-HOX, Fig. 4.10 panel B; M ann and Chan, 1996). The same sequence 
is present also in yeast in prom oters (i.e. HSG-operator) that are silenced by the 
M atalp /M ata2p complex (M atalp is 65% identical to the hom eodom ain EXD). 
W hen the oligonucleotides OIB and H+P (Fig. 4.10, panel B), which are similar to 
the PBC+HOX site (Berthelsen et a l ,  1988b), are used as com petitor, either of them  
is not able to compete the complexes formed by oligonucleotide #1 in HeLa and 
PC-3 nuclear extracts.
These results tend to exclude the possibility that such factors bind the S2 
silencer. However, the competition analysis should be perform ed in the presence 
of other oligonucleotides resembling more the elem ent present in the HSG- 
operator, where the two half sites of the element are separated by 12 base pairs.
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HSG o p e r a t o r 5 ' TCATGTAAAAATTTAC ATCA 3 '
PBC-HOX s i t e 5 ' CCATNNATCA 3 '
o l i g o  #1 5 ' CCCACAATCCTGTAAC ATCATATCACGACAC 3 '
o l i g o  # 0 IB 5 ' CTCCCTGCCTTCCIT CTGTCA CTCTCAGGTG 3 '
o l i g o  #H+P 5 ' CTCCAATTAGT GCATCAATCAATTCG 3 '
c o n s e n s u s 5 ' C/TC/AATNHATCA 3 ' 
HOX PBX
Fig. 4.10: EMSA analysis of footprint D+L
A: HeLa and PC-3 nuclear extracts are incubated in the presence of labelled oligonucleotide #1 as 
probe (4-)- Competition analysis has been carried out with 5, 50 and 500 fold excess of unlabelled 
oligonucleotides #1 and #OIB and with 5 and 50-fold excess for #H+P. B: sequences of 
oligonucleotides used in this study. The haploid-specific gene operator (HSG operator) is the 
binding site for the Matalp-Mata2p complex; PBC-HOX site is the consensus for PBX-HOX complex 
where the two N are variable nucleotides and are proposed to contribute to HOX specificity; #1 is 
the oligonucleotide used as probe (-736/ -705 in huPA promoter); # OIB and #H+P contain, 
respectively, the uPA promoter binding site for Prepl-Pbx complex and the binding site for Pbx-Hox 
complex as described in Berthelsen e t  a l  (1988a,b ).
The sequence present in oligonucleotide #1 revealed also a 10/13 homology 
w ith the consensus sequence of the yeast mating type silencer to which the 
autonom ous replicating sequence binding factor 1 (ABF-1) binds (Fig. 4.11b). This 
factor has been shown to bind also the silencer of the e-globin gene (Peters et a l ,  
1993). The same sequence matches also with other protected regions in the huPA 
promoter (-613/-601 and -538/-550, Fig. 4.11c). However a competition analysis of
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the complexes formed by oligonucleotide #1 and either HeLa or PC-3 nuclear 
extracts showed that not even 500-fold excess of unlabelled #ABF-1 consensus 
oligonucleotide is able to compete the retarded bands detected by oligonucleotide 
#1 in EMSA (Fig. 4.11a).
HeLa PC-3I—:— ——I r
huPA 5- AGCAOCATCAAAC 3' -6 1 3 /-6 0 1
5 ' GTDGTGATATGAT 3 ' -7 0 8 /-7 2 1
5" ATCACCAACACAA 3' -5 3 8 /-5 5 0
e-glctoin 5 ‘ ATCATnrOGAAG 3'
ABF-1 co n se n su s 5 ' RKTYBMffllBtG 3 '
O lig o  A BF-1 5 ' GICATTTGQITAOG 3'
GTTAACACTT CAATAGGAAÎT CACCAACAGT TTATGCCCTA GGACTTTGTT 
ABF-1________
CCCACAATCC TGTAACATCATATCACGACA CCTAACCCAA TCCTTATCAAG
(5ATA-i
CCCTGTCAA AAACGGACÏT TAAACCAAGC TGCAAATTTTCAGTAATCTGGC 
' , \ l  ABF-1
CITGCCn? TCCCCCTCTG AT.
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: a c c a t  caaacJa a a c c  c c c t t a c t g c c g
N GATA-1
AAAGCAATAAGCCCGGCT TTGTTCCATC CACTGGTTGT GTTGGTGATATC
ABF-1
Fig. 4.11: Competition analysis of footprint D+L w ith ABF-1 binding site
A: EMSA analysis of oligonucleotide #1 in the presence of HeLa and PC-3 nuclear extracts. 
Competition with 5, 50, 500-fold excess of unlabelled oligonucleotide #1 and #ABF-1 consensus. B: 
Comparison between sequences present in huPA promoter, oligonucleotide #1, e-globin silencer and 
ABF-1 consensus. C: Putative binding sites for CATA-1 (red-type) and ABF-1 (black-type) 
transcription factors in huPA S2 promoter region (-787/-538). The footprint M and N are shown in 
square brackets (yellow-type and green-type respectively). The lines above text are for sequence 
present in the upper strand, below is for lower strand. The repeated sequence in the huPA S2 region 
are underline in blue.
The m ost 5’ABF-l site in uPA prom oter differs from the ABF-1 consensus in 
the last three residues at the 3’ of the sequence. It w ould be interesting to test 
w hether the recom binant ABF-1 protein w ould bind the uPA sequence and if the
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m issing competition is due to a different affinity of the protein for non canonical 
binding sites.
Footprint F+M
An oligonucleotide encom passing the region -656/-614 has been used to 
study the complexes binding this area. Two major complexes are detected in FleLa 
nuclear extract (Fig. 4.12a). Only complex 1 seems to be specific as it is competed 
already by a 30-fold excess of unlabelled oligonucleotide. The specificity of the 
complexes has been also tested by competition w ith a series of oligonucleotides, 
showed in fig.4.12b, covering the region of footprint N+G (oligo #3), Fl+I (oligo 
#4), N (oligo #N) and I (#TIE).
1 2 3 4 5 6 7 8 9 10 11
firee
B
GTTAACACTT CAATAGGAAG CACCAACAGT TTATGCCCTA GGACTTTGTT 
CCCACAATCC TGTAACATCA TATCACGACA CCTAACCCAA TCCTTATCAA
#1
GCCCTGTCAA AAACGGACTT TAAACCAAGC TGCAAATTTT CAGTAATCTG
 ----------
GCCTTGCCTT  TCCCCCTCTG ATAGCACGAT CAAACAAACC CCCTTACTGC .
CN #3
CGAAAGCAAT AAGCCCGGCT TTGTTCCATC CACTGGTTGT GTTGGTGATA
TCTGGGGACT GCCACT #HMC #TIE
free
Fig. 4.12: EMSA analysis of footprint F+M
A: Oligo#2, encompassing the region of footprint F+M, is used as probe. Competition by an excess of 
specific unlabelled oligonucleotide is present in lane 2 and 3 (30- and 60-fold). Other competitors are 
oligo #4 (lane 4), oligo #3 (lane 5), oligo #AP-1 (lane 6), oligo #N (lane 9), oligo #5 (lane 10), oligo 
#TIE (lane 11). Lane 8: 50x oligo #2. Lanes 1 and 7: no competitor. B: Oligonucleotides used in EMSA 
analysis. 82 region: -786/-538.
Of all oligonucleotides tested only #N seems to compete complex 1. The 
lower intensity of the complexes in the presence of #TIE-oligo as competitor (Fig.
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4.12a, lane 11) is due to a lower ^^P-oligo #2 loading rather than to a competitive 
effect. The competition by oligo #N might be due to the presence of the CCCCCT 
motif, although in the context of S2 the region covered by #N is not protected by 
HeLa nuclear extract. The same is not true w ith oligo #3 that is not able to 
compete any of the complexes although another motif (GAAAG) is present in 
both oligonucleotides.
Footprint N+G
An oligonucleotide spanning the region of footprint N+G (oligo #3; -613/- 
570) detects in HeLa nuclear extract 5 major and 3 minor complexes (Fig. 4.13, lane 
1), 3 of which (4, 7 and 8) seems to be non specific as they are not competed by an 
excess (30- and 60-fold) unlabelled oligonucleotide (Fig. 4.13, lanes 2 and 3).
1 2 3 4 5 6 7 8 9 10 11
B
GTTAACACTT CAATAGGAAG CACCAACAGT TTATGCCCTA GGACTTTGTT
CCCACAATCC TGTAACATCA TATCACGACA CCTAACCCAA TCCTTATCAA 
#1
GCCCTGTCAA AAACGGACTT TAAACCAAGC TGCAAATTTT CAGTAATCTG----------- g]---------
GCCTTGCCTT TCCCCCTCTG ATAGCACCAT CAAACAAACC CCCTTACTGC
 —
CGAAAGCAAT AAGCCCGGCT TTGTTCCATC CACTGGTTGT GTTGGTGATA
TCTGGGGACT GCCACT #HMG «TIE
Fig. 4.13: EMSA analysis of footprinting N+G in HeLa nuclear extract
A: An oligonucleotide encompassing the region -613/ -570 (ohgo #3) has been used as probe to detect 
complexes in the presence of HeLa nuclear extract. The specificity has been assessed by competition 
analysis with 30 and 60-fold excess specific oligonucleotide (lanes 2 and 3), 50x oligonucleotide #4 
(lane 4), 50x oligonucleotide #2 (lane 5), 50x oligonucleotide #AP-1 (lane 6 and 11)), 50x 
oligonucleotide oligo #TIE (lane 7), 50x oligonucleotide #H (lane 8), 50x oligonucleotide #N (lane 9), 
50x oligonucleotide #5 (lane 10). Lane 1: no competitor. B: Oligonucleotides used in EMSA analysis. 
S2 region: -786/-538._________________________________________________________________________
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Oligo #2 (lane 5), as well as oligo #4 (lane 4), is not able to compete any of the 
complexes. Also an AP-1 consensus oligonucleotide (lanes 6 and 10) shows no 
ability to compete. Oligonucleotide #N, covering part of oligo #3, seems to 
compete two of the non specific complexes (4 and 8; lane 9).
Finally, in the presence of oligonucleotide #FI the intensity of complex 8 
increases, suggesting an increased stability for this complex.
Footprint N
In order to better investigate the footprint specifically observed w ith HeLa 
nuclear extract, the oligo #N, spanning region -621/-593, was used. 5 major 
complexes are detected in HeLa nuclear extract (Fig. 4.14).
1 2 3 4  5 6 7 8 9
free
oligo #N: 5' CTCTGATAGCACCATCAAACAAACCCCCTT 3'
Fig. 4.14: EMSA analysis of region N
The oligonucleotide #N is used as probe to detect complexes in the presence of HeLa nuclear extract. 
The following competitors are used as 50-fold excess oligo #N: #4 (lane 2), #2 (lane 3), #3 (lane 4), 
#TIE (lane 5), #H (lane 6), #N (lane 7), #5 (lane 8), #AP-1 (lane 9). Lane 1: no competitors.
Complex 3 is not specific since none of the oligonucleotide tested compete for 
this binding. Complex 1 and 2 are specific and are competed also by oligo #3 (lane 
4). Complex 4 is competed by oligo #4, #3, #TIE and #AP-1. In the presence of the
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oligo encompassing the region of footprint H {-576/-557) complex 4 disappears, 
substituted by a faster migrating complex (lane 6).
Footprint C+H
Two potential HMG-box containing protein binding sites are found w ithin 
the hum an S2 region: at -782/-771 and at -570/-560 (Fig. 4.15). In mouse and pig 
uPA prom oters, the latter sequence is found downstream  m odule 5, while it 
precedes it in m an (Fig. 4.5, region 6).
-782 -771
GGCTTTGTTCC
-1820 -1428
ENH SI
787 /-660 -537
S3 MP
GGCTTTGTTCC atccac TGGTTGTGTTGGTGAT 
-570 -560 -553  ^  -538
5' CTTTG^A^A 3' HMG-BOX consensus 
-570 GG CTTTG T T CC -560 huPA (proximal) 
-7 8 2  GG/CTTTG T T  CC -771 huPA (distal)
TIE
Fig. 4.15: The HMG-box consensus sequence in the human urokinase promoter 
The two consensus are shown in blue. In red the TIE element
Proteins belonging to this family of transcription factors are listed in Table 
4.2. For some of them (Lef-1) an architectural role, beside the ability of 
transactivate transcription, has been outlined (Giese et at., 1995). For others, like 
SOX-4, a clear role as activators of transcription has been dem onstrated (van de 
W etering et a l ,  1993). To this family belongs the sex-determining factor SRY 
(Sinclair et a i ,  1990), whose potential target genes are starting to be identified 
(Cohen et a l ,  1994). Though these factors can bind the same sequence, some 
specificity has been shown in an in vitro analysis by EMSA (see Table 4.2).
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T h e  H ig h  h/j o b i l i t y  G ro u p  bo x  ( H M G - b o x )  t r a n s c r ip t i o n  fa c t o r s
Protein
LEF-1/TCP la
TCF-1
SRY
SOX-4
(Sry-box)
SOX-5
HMG D om ains Sequence recognition and / or 
DNAsel footprinting
5 CCTTTGAAGCT3' 
5'CCTTTGAAGCr3'
5’CCTTTGTTGCT3’ 
5' CCTTTGTTCr 3' 
5’CTTTGAA3'
5' CTTTGTT 3'
5ATTGTT3' 
5’ CTTTGTT 3’
Table 4.2: The HMG-box family of transcription factors
Biochemical or genetic  
function
• Lymphoid transcription
(preB;proB;Tcell)
• Lym phoid transcription
(T cell lineage)
• Sex determ ination  (testis)
• Lym phoid transcrip tion  (TceU; pre-B)
• m RNA in gonads adu lt mice,
lym phonodes, lung, heart
• Post-meiotic cells in testis
(round sperm atids)
HeLa PC-3 CV-1
1 2 3 4 5 6
free
HMG-oligo: 5' TAAGCCCGGCTl TGTI CC ATCCAC 3'
Fig. 4.16: EMSA analysis of footprint H
The ohgonucleotide spanning the region of footprint H (HMG-oligo) has been used to analyse the 
presence of an HMG-box containing protein in HeLa, PC-3 and CV1 nuclear extract. Lanes 2, 4 and 6: 
the binding is made up in the presence of 30-fold excess unlabelled oligonucleotide. Lanes 1, 3 and 5: 
no competitor.______________________________________________________________________________
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These elements, in the uPA prom oter, are both protected either by HeLa or 
PC-3 nuclear extract. The specificity of such binding has been tested by EMSA 
analysis where an oligonucleotide covering the region present in footprint H 
detects only 1 complex with either HeLa, PC-3 or CV-1 nuclear extracts (Fig. 4.16).
In order to better characterise this complex I wanted to test w hether the same 
oligo was able to bind purified SOX-4, SRY and TCF-1 proteins. At this purpose the 
purified SOX-4 HMC-box and TCF-1 HMC-box were used in band-shift analysis 
(Van de W etering and Clevers, 1992). Only SOX-4 HMC-box was able to recognise 
uPA oligonucleotide (Fig. 4.17).
HI S pel EooRV S tu I  Bam HI
I I L
1II Spe I Eco RV Stu I Bam HI
J I I
aagcccggctttgttcc ate
free
Fig. 4.17: Binding of HMG-box containing proteins to the huPA promoter
The HMG-oligo has been cloned in the tandemly repeated polylinker of pBend2 ( see Materials and 
methods). The Eco RV fragment has been used as probe to detect binding of the purified human SOX-4 
and TCF-1 HMG-boxes. Increasing amount of proteins have been tested. The open arrow indicate the 
retarded complex. The closed arrow indicate the free probe.
As these proteins have the ability to induce a sharp bend in the DNA double 
helix, the same oligonucleotide was tested in a circular perm utation analysis in 
the presence of SOX-4, SRY and TCF-1 HMC-boxes. As shown in Fig. 4.18 (panel
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B), again TCF-1 does not recognises the uPA sequence, while both SRY and SOX-4 
HMG-box do.
Bgl II Spe I Eco RV Stu I Bam HIII Spel EooRV Stu 1 Bam HI
îa^gcccggctttgtta- ate
— C h  
— □ —
- D
B hSOX-4 hSRY hTCF-1
a b e d a b o d e  a b o d e
0.8
0.75
0.65
0.6
0.55
0.50 0.25 0.75
n  hSOX-4 HMG box 
O  hSRY HMG box
Flexure displacem ent
free
Fig. 4.18: Circular permutation analysis of the -576/-5S7 region of the huPA promoter
The HMG-oligo is cloned in the tandemly repeated polylinker of pBend2 plasmid. By using different 
restriction enzymes, circular permuted fragments of 146 bp have been generated (panel A). Panel B: 
Electrophoretic mobility of the circular permuted fragments in the presence of purified hSOX-4, 
hSRY and hTCF-1 HMG-boxes. The arrow indicates the free probe. Panel C: Analysis of the bending 
parameters. The mobility of the protein-DNA complexes (R bound) was normalised to the mobility 
of the corresponding free DNA (R free). The distance of the centre of the oligonucleotide HMG from 
the 5' end of the probe was divided by the total length of the probe (flexure displacement). The 
plotted points are interpolated with a quadratic function (see Materials and Methods).
Furtherm ore these proteins induce, upon binding, a bend in the DNA as 
shown by the different mobility of the complex depending on the different 
location of the oligonucleotide with respect to the ends of the DNA fragm ent (Fig. 
4.18, panel A). No differences in the mobility of the free DNA probes are observed.
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indicating that the sequence is not intrinsically curved. The binding of hSOX-4 
HMG-box, however, caused a deviation of the axis of DNA of about 43°, while 
hSRY HMG-box bends DNA of about 74°C. This results is in agreement w ith the 
published values for SRY (Ferrari et at., 1992, Giese et al., 1992).
A circular perm utation analysis has been also perform ed with the entire S2 
region. A gel electrophoresis analysis of circular perm uted fragm ent at 20 °C and 4 
°C revealed that S2 is not intrinsically curved (Fig. 4.19).
Bg C X E P S St B
I I I I I___I___I___L 52
Bg C X E P S St B
I I I I J I I L
MW Bg C X E P S St B
492 b p -
369 bp—
246 bp—
123 bp—
(S2)
Fig. 4.19: Circular permutation assay of S2
The whole S2 sequence is cloned in the polylinker of pBend2 plasmid. The different fragments are 
generated by the restriction enzymes indicated in the figure. Bg=Bgl II, C=Cla I, X=Xho I, E=Eco RV, 
P=Pvu II, S=Sma I, St=Stu I, B=Bam HI. The draw is not in scale. The length of the fragment is the 
370 bp (249 bp S2 + 121 bp polylinker). The run is performed at 20 °C and 4°C with the same result.
However, binding of SRY-box to these fragments revealed a different 
mobility typical of bent DNA, with an angle of deviation of about 46° (Fig. 4.20).
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Bgl II S p e l  Eco RV Stu I Bam HI Bgl II Spe I Eco RV Stu I Bam HID 11 sp e  1 tc K  st 1 oai
I I I I I 5 2
s 1 tc K  st 1 D n
i  L _ J  I
B S E St Ba
free
Fig . 4.20: Circular permutation analysis of S2-hSRY complex
The whole 82 region has been cloned in the tandemly repeated polylinker of pBend 2 plasmid. The 
autoradiograms shows the complexes formed by fragments generated by different restriction enzymes 
and hSRY purified HMG-box (open arrow). B=Bgl II; S=Spe I; E= Eco RV; St= Stu I; Ba= Bam HI.
All these results suggest that a protein belonging to the SRY-SOX family 
m ight recognise and bind the sequence present in the urokinase prom oter, and 
induce a bending not only locally but of all fragment, although there is no direct 
evidence that the factor present in HeLa and PC-3 nuclear extract is indeed 
belonging to the HMG-box family of transcription factors.
Footprint I
At -553/-538 there is a conserved TIE element (TGFfil Inhibitory Element), 
tandemly repeated in the opposite orientation, which in the m ouse is found at 
-666. The TIE element has been show n to be involved in silencing of several genes 
(Kerr et a l ,  1990; Pietenpol et a l ,  1991; see Appendix 1). Furthermore two other 
TIE-like sequence are present in the lower strand at position -769/-760 and -613/- 
604 (Table 4.3). Of these elements only one appears to be protected (-547/-538) in 
DNase I footprinting by either HeLa or PC-3 extract (footprint I), although this 
protection is not so clear in the lower strand for PC-3 extract. The most 5' part does
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not show any protection, while the -613/-604 is protected only with extracts from 
HeLa cells (footprint N).
TIE consensus 5' GNNTTGGtGa 3'
huPA 5' TGGTTGTGTTGGTGA 3' - 553/-53S
5' TGATGGTGC 3' - 605/-613
5' TGTTGGTGC 3' - 7597-767
Table 4.3: Sequences of TIE-like element present in huPA promoter
In order to analyse the role of the TIE element, an EMSA analysis, in the 
presence of HeLa nuclear extract, has been performed with two oligonucleotides, 
#TIE and #4, spanning regions -555/-531 and -566/-537 respectively. Both 
oligonucleotides contain the TIE element. As show n in Fig. 4.21 (panel A and B) 
three complexes (la, 2a, 3a and lb , 2b, 3b respectively) are formed with either 
oligonucleotides, although they behave differently to competition analysis. Band 
la  is not completely competed by the unlabelled TIE oligonucleotide (lane 5, panel 
A), showing partial lack of specificity, while 50 fold excess of unlabelled oligo #4 
completely competes complex lb  (lane 2, panel B). Complexes 2a and 3a, formed by 
#TIE, on the other hand, are self-competed and, hence, specific, while only the 
faster migrating complex detected by #4 (complex 3b) is competed out by the 
homologous unlabelled oligonucleotide. The specificity of such retarded bands is 
further assessed by the lack of competition by oligonucleotides covering the most 
3'-half of S2 (panel C). Complex 3a is competed by #3, #N and #4 (lanes 4, 7 and 2 
respectively), while complex 3b shows only a partial competition by #3 (lane 4). In 
the presence of #N and #TIE (lane 5 and 7, panel B) the mobility of the complex 3b 
changes, becoming faster, with a greater effect in the presence of #TIE than #N as
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well as competition by #H of complex 3a (lane 6, panel A). Complexes 3a and b are 
not competed by #2 (lanes 3, panel A and B).
1 2 3 4 5 6 7  8 9 1 2 3 5 6 7 8
la  ' 
2a '
3a
free-
lb
2b
3b
free
B
GTTAACACTT CAATAGGAAG CACCAACAGT TTATGCCCTA GGACTTTGTT
CCCACAATCC TGTAACATCA TATCACGACA CCTAACCCAA TCCTTATCAA 
#1
GCCCTGTCAA AAACGGACTT TAAACCAAGC TGCAAATTTT CAGTAATCTG
n
GCCTTGCCTT TCCCCCTCTG ATAGCACCAT CAAACAAACC CCCTTACTGC
CGAAAGCAAT AAGCCCGGCT TTGTTCCATC CACTGGTTGT GTTGGTGATA
#4; 5 ' CTTTGTTCCATCCACTGGTTGTGTTGGTGAT 3'
n N: 5' CTCTGATAGCACCATCAAACAAACCCCCT 3'
« H: 5' GGCTTTGTTCCATCCACTGGTTG 3'
«TIE; 5' ACTGGTTGTGTTGGTGATATCTGGG 3'
«2: 5- CTGCAAATTTTCAGTAATCTGGCCTTGCCTTTCCCCCTCTGAT 3'
«3; 5 ' AGCACCATCAAACAAACCCCCTTACTGCCGAAAGCAATAAGCCCGG 3'
«AP-1: 5' GCCTATAGCATCTCTGACTCAGTCTGTCCCC3'
TCTGGGGACT GCCACT »HMG «TIE
Fig. 4.21: Competition analysis of TIE and #4 oligonucleotides
- #TIE (panel A) and 32p _ #4 (panel B) are incubated in the presence of HeLa nuclear extract.
A: Lane 1: no competitor; lane 2: #50-fold excess #4; lane 3: 50-fold excess #2; lane 4: 50-fold excess #3; 
lane 5: #T1E; lane 6: #H; lane 7: #N; lane 8: #AP-1; lane 9: #5. B: Lane 1: no competitor. Lane 2: 50-fold 
excess specific competitor. Oligo #2, #3, #N, #H, #T1E, #AP1 are used as competitors in lanes 3-8, 
respectively. C: Map of the oligonucleotides, used as competitors, in 82 region. D: The sequences of 
the oligonucleotides used are shown.
The specificity of complexes detected by #HE is further assessed by point 
m utation analysis, of those residues that, according to the consensus (see table 4.3, 
capital letters, and table 4.4) may be im portant for TIE function (Fig. 4.22, panel A).
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#TIE 5' ACTGGTTGTGTTGGTGATATCTGGG 3' -5 5 5 /-5 3 1
irut 1 S' 3'
nut 2 5' 3'
n u t 3 5' 3'
nut 4 5' 3'
#TIE rev 5' TCCACTGGTTGTCT ATCT 3' A543/537
#TIE d ir 5' CCAC GTCTTGGTGATATCT 3' A552/548
#5 5' TGATATCTGGGGACTGOCACT 3' -5  4 1 /-5  21
Table 4.4: Oligonucleotides used in the study of footprint I
B
1 2 3 4 5 6 7 8 9  10
free
- I ' " ^
free
Fig. 4.22: EMSA analysis of region I (TIE region)
The oligonucleotide termed TIE, encompassing the region of footprint 1, has been used as probe to 
detect complexes in the presence of HeLa nuclear extract. Panel A: the specificity of binding has been 
tested by competition analysis using 50 fold excess of the following oligonucleotides: wt TIE (lane 2), 
mutant 1 (lane 3), mutant 2 (lane 4), mutant 3 (lane 5), mutant 4 (lane 6), TIE dir (lane 7), TIE inv 
(lane 8), AP-1 (lane 9) and oligo #5 (lane 10). Lane 1: no competitor. Panel B: The affinity of the 
complexes for the wt oligonucleotide has been evaluated by competition with 5, 50 and 500-fold 
excess of unlabelled oligonucleotide as indicated in the figure.
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Mutant 1, 2, 3 were unable to compete for binding of bands 1 and 2 but not for 
band 3, while mutant 4 was able to compete all bands (lanes 3-6, panel A). The 
affinity was tested by competition of 5, 50 and 500 fold excess oligonucleotide (Fig. 
4.22, panel B). Furthermore oligonucleotides containing only half of the entire TIE 
sequence (#TIE dir and #TIE rev) are not able to compete any of the bands, as well 
as an oligonucleotide (#5) spanning region -541/-521. An AP-1 consensus 
oligonucleotide competes complex 3a.
These data are confirmed by direct binding of the mutant oligonucleotides to 
the HeLa nuclear extract, showing the increased affinity of the three complexes for 
mutant 4 (Fig. 4.23).
TIE wt TIEml TIEm2 TIEm3 TIEm4
 1 I---------
HeLa NE
3*- m
free
Fig . 4.23: EMSA analysis of TIE mutant oligonucleotides at different extract concentration
The TIE wt and the four mutants have been used as probes in EMSA in the presence of increasing 
amount of HeLa nuclear extract. (4-): no extract.
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When the same oligonucleotide (#TIE) is used with nuclear extract from PC- 
3 (Fig. 4.24), besides complex 1 and 2, an additional band, with intermediate 
mobility is present (complex 4). As for HeLa, band 1 is not completely competed by 
the unlabelled oligonucleotide, unlike the lower and the intermediate bands. 
Band 4 behaves as bands 1 and 2 in point mutation analysis as it is not competed 
by mutant 1, 2 and 3 and is completely competed by mutant 4. Furthermore PC-3 
nuclear extract does not show the fastest band detected in HeLa (complex 3).
PC-3 HeLa
1 r
TIE m l m2 m 3 m4
free
Fig. 4.24: EMSA analysis of TIE-binding protein in PC-3 nuclear extract
The TIE oligonucleotide is used as probe in the presence of an equal amount of PC-3 and HeLa nuclear 
extract. The specificity of the retarded complex with PC-3 NE has been tested by competition with 
50-fold excess of unlabelled homologous oligonucleotide and TIE mutants. The retarded complexes 
present in both extracts are indicated by the black full arrows. The PC-3 specific and HeLa specific 
complexes are indicated by the white open arrow (4) and the black thin arrow (3) respectively._____
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Recently it has been reported that Spl is a member of a multigene family 
whose members have similar if not identical DNA binding activities (Hagen et a l ,  
1992; Kingsley and Winoto, 1992). Furthermore, in v ivo  transfection experiments 
show that Spl-mediated transcriptional activation of Spl responsive promoters 
are repressed by Sp3 (Hagen et a l ,  1994). Sp2 and Sp3 have been shown to bind to 
both GC- and GT-box sequences (Kingsley and Winoto, 1992; Hamann et al., 1994).
The TIE element resembles the binding site for GT-box binding proteins. 
Therefore, an oligonucleotide specific for Sp3 binding (Hagen et a l ,  1994) has been 
used in EMSA analysis to test whether it was able to compete for TIE binding and 
viceversa. As shown in Fig. 4.25 (panel A) the GT-oligo is not able to compete the 
binding to TIE oligonucleotide in neither HeLa or PC-3 extracts, and binding of 
GT-box oligonucleotide by HeLa nuclear extract is not competed by #TIE (Fig. 4.25, 
panel B).
Hfiha PC=3_
1 2 3 4 5 6
B
H p l . a  
7 8 9
& #  #  #
* * 2  msm
'■ 1
GT-box: 5' AGCrTCCCTrCGGCTCTCGCTTCACG 3'
32*-#TIE 32 K  #GT-box
Fig. 4.25: GT-box competition analysis
Panel A: #TIE oligo is used as probe. Lanes 1 and 4: no competitor. Lanes 2 and 5: 50-fold excess 
unlabelled #TIE; lanes 3 and 6: 50-fold excess #GT-box unlabelled oligo. Panel B: The binding is made 
using #GT-box ohgo as probe. Lane 7: no competitor; lane 8 and 9: 50-fold excess of #GT-box and #TIE, 
respectively. Panel C: #GT-box ohgonucleotide sequence (uteroglobin promoter; Hagen e t  a l . ,  1994).
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Since the HMG-like consensus sequence is recognised by both HeLa and PC-3 
nuclear extract and because of the structural role ascribed to these factors, I wanted 
to investigate the role of HMG in TIE binding in both extracts. For this purpose an 
oligonucleotide encompassing both sequences (-571/-538) is used in EMSA (#TIE- 
HMG). Again, in the presence of HeLa nuclear extract two complexes are detected, 
while in PC-3 an additional, intermediate band is present (Fig. 4.26, lanes 1).
HeLa PC-3
1 2 3 4 5 6 7 8  1 2  3 4 5 6 7 8
#TIE #TIE-HMG #TIE #TIE-HMG 
Fig. 4.26: Comparison between #TIE and #TIE-HMG
The #TIE (lanes 1-4) and the composite #TIE-HMG (lanes 5-8) oligonucleotides are used as probes in 
the presence of HeLa or PC-3 nuclear extracts. Lanes 1 and 4 do not contain competitor DNA. lanes 2 
and 6: 50-fold excess unlabelled #TIE. Lanes 3 and 5: 50-fold excess unlabelled #TIE-HMG; lanes 4: 50- 
fold excess oligo #GT-box; lanes 8: 50-fold excess #HMG-oligo. The black arrows indicate the 
complexes formed by #TIE, the clear arrows those formed by #TIE-HMG.
The mobility of these complexes is however slightly faster compared to the 
TIE oligonucleotide, although the length of the oligonucleotide is longer than that 
of TIE. The specificity of the complexes is tested by competition with an excess of
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unlabelled oligonucleotide as indicated in Fig. 4.26. It must be noted that HMG 
oligonucleotide (lanes 8) does not compete at all any of the complexes indicating 
that either proteins recognising the HMG consensus do not contribute to the 
binding, or that their affinity for the short, HMG-specific, oligonucleotide is much 
lower. The faster migration of the complexes might, in fact, suggest the formation 
of a structurally different DNA conformation, such as bent DNA, that migrates 
faster in a polyacrylamide gel.
Functional analysis  o f  the TIE element
When the entire TIE element (A5; Fig. 4.6) was deleted either from the 
context of the full length 2212uPACAT construct or pCATsil, the silencing activity 
of S2 was reduced by 40-50% (Fig. 4.6). On the other hand, mutations 1, 2, 3 and 4 
in TIE sequence, when analysed by EMSA, showed different binding properties in 
the presence of HeLa nuclear extract (Fig. 4.22 and Fig. 4.23). Therefore I decided to 
investigate the function of the TIE element by inserting the four mutations in the 
context of both the full size uPA CAT construct (Fig. 4.27, panel A) and of the 
construct containing only the enhancer and the -787/+1 region (Fig. 4.27, panel B), 
and transfecting them in CV-1 cells.
Unexpectedly, none of the mutants had lost its silencing activity (Fig. 4.27); 
actually, they had gained a better repression activity in the full size constructs. 
Only mutant 3, in the E787CAT context, shows a slight increase in CAT 
transcription (Fig. 4.27, panel B).
I have then tested the TIE-like sequence of uPA in the SV40 CAT system in 
CVl cells: as shown in Fig. 4.28, this element (pTIE CAT) acted as a silencer in both 
orientations and in a copy number-dependent manner (p2xTIE and p4xTIE). The 
presence of the adjacent HMG-box proteins binding site marginally increased the 
silencing activity (pTIE/HMG CAT).
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2212 m utl mut2 mut3 mut4
T--
787 enh m utl
I ■ "
mut2 mut3 mut4
Fig. 4.27: Transient transfection analysis of TIE mutants in CV-1 cells
Point site mutations have been inserted in the TIE element in the context of the full length promoter 
2212uPACAT construct (panel A) and of the E787CAT construct (panel B). The different plasmids 
have been transfected in CV-1 cells. The data are the mean + /-  SD of at least two independent 
experiments.
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Fig. 4.28: Effect of TIE and HMG-box consensus regions on SV40 CAT driven transcription in CV 1 cell 
line
The oligonucleotide TIE, encompassing the region -558/-537, has been cloned in front of SV40 
promoter in pCAT control plasmid, in single (p TIE CAT) or multiple copies with different 
orientation respect to the direction of transcription (p 2xTIE and p 4xTIE). The p TIE/HMG CAT 
construct contains the oligonucleotide spanning the region-568/-529. The data are the mean of three 
independent experiments ± standard deviation.
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A single-strand DNA-binding activity (footprint H+I)
In some preparations of labelled oligo #4 DNA the fast migrating complex 3b 
(Fig. 4.21, panel B) was not detected. Although the double strand probe was always 
gel purified after labelling, a contamination by single strand oligonucleotide 
cannot be excluded. I then tested whether the presence of the fast migrating 
complex was due to an activity recognising the single strand rather than double 
strand DNA. For this purpose I used, as source of proteins, a H eparin Sepharose 
column enriched fraction, eluting at 200 mM KCl (fraction W; see Materials and 
Methods), in which only one activity, comigrating with complex 3b, was detected 
by double strand oligo #4 (Fig. 4.29, compare lanes 1 and 3).
1 2 3 4 5 6
1 —
2 —
IHII
Fig. 4.29: EMSA analysis of HeLa fraction W
Oligo #4 double strand form is used as probe. Lanes 1 and 2: binding in the presence of HeLa nuclear
extract. Lanes 3-6: binding in the presence of fraction W (see methods). Complexes are competed by
30-fold excess oligo #4 double strand (lane 2 and 4), #4 upper strand (lane 5), and #4 lower strand
(lane 6). Lanes 1 and 3: no competitor is added.
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Surprisingly, the binding of proteins present in fraction W was not competed 
by an excess of unlabelled double strand oligo #4 (Fig. 4.29, lane 4). On the contrary 
either the upper or lower strand of oligo #4, used separately as competitors, were 
able to compete the binding of the complex to the double strand, labelled 
oligonucleotide (Fig. 4.29, lanes 5 and 6).
In order to address the specificity of such binding I extended the analysis 
using as probes, in EMSA experiments, either the labelled upper or lower strand 
of oligo #4. As shown in Fig. 4.30 the labelled upper strand (panel A) detects 4 
major complexes (lane 1), all of which are competed by a 30-fold excess of 
unlabelled homologous oligonucleotide, as well as by the lower, complem entary 
strand (lanes 2 and 3). The competition by the upper strand of #TIE oligo changed 
the mobility of complex 3, showing the same behaviour of the double strand 
form w hen used as competitor of the double strand labelled oligo #4 probe (see 
Fig. 4.21 panel B, lane 7). The lower strand of #TIE competes all complexes (Fig. 
4.30, lane 5). Both the double strand forms of oligo #4 and #TIE do not change the 
binding capability of the proteins to the single strand DNA (lane 6 and 7).
The specificity is tested by point m utation analysis where a m utation in the 
TIE sequence partially competes the binding to the oligo wt (lane 8; #4 mut: 5' 
CTTTGTTCCATCCACTGGTTaTaTTGGTGAT 3'). The m utation  in the 
corresponding residues of the lower strand does not change the capability of 
competing (lane 9). Neither the upper or double strand form of oligo #H competes 
any of the complexes (lanes 10 and 12); only the lower strand of oligo #H totally 
competes complexes 1, 3 and 4 and partially complex 2 (lane 11). Finally, the 
double strand #4 does not bind any protein in this fraction (lane 13).
When the lower strand is used as probe (panel B) two complexes are detected 
(lane 14). Both are specific as they are competed by an excess of the same 
unlabelled oligonucleotide (lane 16) as well as by the upper strand of oligo #4
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(lane 15). Surprisingly the lower strand of #TIE oligo does not compete any of the 
complexes (lane 18), while the upper one induces a slight shift of complex 1 (lane 
17). Again oligo #4 and #TIE oligonucleotide, in their double strand form, were 
not able to compete the binding to the lower strand of oligo #4 (lanes 19 and 20). 
The m utation in the TIE elem ent (#4 mut) completely im paired the ability of 
specific competition, while the m utation in the corresponding position of the 
upper strand did not (lanes 22 and 21, respectively). Oligo #H upper strand and 
double strand form compete only complex 2 (lanes 23 and 25), while #H lower 
strand does not compete any of the complexes (lane 24).
upper strand
■DS
lower strand
1 2 3 4 5 6 7 8 9 10 11 12 13
DS
14 1516 1718 19 20 2122232425 26
1 —
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f —
Fig. 4.30: EMSA analysis with single-strand DNA probes
The upper and lower strand of oligo #4 are labelled and used as probes in the presence of Fraction W 
(see Methods; lanes 1 and 14). Competition analysis is performed with 50-fold excess of the 
following unlabeUed oligonucleotides: oligo #4 upper strand (lanes 2 and 15), #4 lower strand (lanes 3 
and 16), #TIE upper strand (lanes 4 and 17), #TIE lower strand (lanes 5 and 18), #4 double strand 
(lanes 6 and 19), #TIE double strand (lanes 7 and 20), #4 upper strand mutant (lanes 8 and 21), #4 
lower strand mutant (lanes 9 and 22), #H upper strand (lanes 10 and 23), #H lower strand (lanes 11 
and 24), #H double strand (lanes 12 and 25). Lanes 13 and 26: the probe used is #4 double strand (DS). f 
is for free DNA.
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To better characterise this activity I decide to perform a southwestern 
experiment using as probes the upper and lower strand of oligo #4 (Fig. 4.31). In 
the presence of the upper strand, two proteins of about 45 and 30 KDa are detected 
(Fig. 4.31, panel A), specifically competed by a 30-fold excess of unlabelled 
oligonucleotide (Fig. 4.31, panel B). The labelled lower strand detected only the 30 
KDa factor. The double strand form did not detect any protein.
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Fig. 4.31: Southwestern analysis of proteins binding oligo #4
After separation on a 10% SDS-PAGE the proteins of fraction W are blotted on a nitrocellulose filter 
and renatured (see methods). The binding is performed with the upper, lower or double strand (DS) 
form of oligo #4 (panels A) in the presence of 30-fold excess of the same unlabelled oligonucleotide 
(panels B).
The competition by either strand could be explained either by the formation 
of double strand so that the labelled strand is sequestered in the double strand 
form, or by the real binding of the factor to the opposite strand. It seems that both 
the upper and lower strand bind the 30 KDa protein, while only the upper strand 
recognise the 45 KDa factor. The com petition delim its the binding to the area 
comprised between footprint H and I. The reason why binding is not detected in
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footprinting experiments could be due to the instability of single strand region 
w hen DNA is in its linear form.
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5. D iscussion
This thesis has focused on the mechanisms that regulate the expression of 
the urokinase type plasminogen activator (uPA) and in particular about the 
negative m echanisms involved. The evidences accum ulated in the past years 
about the existence of a negative control of uPA expression (Grimaldi et a l ,  1986, 
Hofstetter et al., 1987) led me to try to dissect and characterise the elements 
involved in this process. A previous analysis of the huPA prom oter activity in 
two cell lines expressing uPA (HT1080 and A-1251; Verde et al., 1988) already 
indicated the existence of elements involved both in the activation and in the 
negative m odulation of uPA expression. I decided to extend this analysis to cell 
lines that do not express uPA in order to identify cell-specific cis-acting regulatory 
elements. For this purpose three cell lines, two not producing (CVl and HeLa) and 
one producing high constitutive levels of uPA (PC-3) have been used to analyse 
constructs in which the transcription of the reporter gene CAT is under the 
control either of the uPA minim al prom oter (MP), in the presence or in the 
absence of the enhancer (EMPCAT and MPCAT respectively) or the full length 
prom oter (2212uPACAT). The result show n in Table 4.1 confirms that the 
sequences between the enhancer and the MP contain cell-specific m odulatory 
elem ent.
The 5’-nested deletions analysis and the transient transfections w ith 
constructs carrying internal deletions of the uPA 2212 long regulatory region 
identified at least three regions playing different roles in the silencing of uPA gene 
in different cell lines (Fig. 4.1 and Fig. 4.2), nam ed SI, S2 and S3. The presence of 
region SI, located between -1870 and -1428, was already described by Verde et al. 
(1988) that m apped the negative regulatory element between -1824 and -1572 bp 
from the start site of transcription. This region comprises the two NF-kB elem ents
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(-1580 and -1865) that m ediate the induction of uPA by phorbol esters and TNF in 
FlepG2 cells and HT 1080 (Hansen et a l ,  1992) and by TP A in HeLa cells (-1865; 
N ovak et al., 1991). Furthermore, it has been described that a repressor acting 
through the NF-kB site at -1865 bp could counteract the induction (Novak et a i ,  
1991). In the 5' nested deletions analysis, as well as in the internal deletions 
analysis, this element behaved differently, being active in CVl and HeLa cells but 
not in PC-3 (Fig. 4.2). However the activity of this negative regulatory element is 
not restricted to cell lines that do not produce uPA, as it is shown by the analysis 
of deletion in HT1080 and A1251 (Verde et al., 1988). From this we can conclude 
that SI does not act in a cell-type specific m anner (Fig. 5.1).
S3 region, that has never been described before, also lacks specificity being 
active in all cell lines tested.
The presence of region S2 was hypothesised in the work by Cannio et al. 
(1991), that m apped the region between -660/-537. Furthermore the author 
claimed that the activity of the silencer was dependent on the presence of the 
enhancer and he m apped this activity between -537/-301. However, as already 
m entioned, the constructs used in  this analysis contained several cloning 
mistakes, that challenged the results. The subject of this thesis allowed me to 
characterise the region responsible of a negative m odulation of uPA gene 
transcription, m apping it to a wider region of 250 bp, between -787/-537. The cell 
type specificity is confirmed as S2 is active in cell lines that do not express uPA 
(see Fig. 5.1).
The cell-type specificity of this element has also been confirmed by transient 
transfection analysis in HepC2 cell line, where uPA is expressed at a low basal 
level, but in which its expression can be induced upon treatm ent w ith phorbol 
esters. In this case S2, that in HeLa and CV-1 cells works as a specific negative
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regulatory element, here may act as a positive element (Fig. 6.7, appendix 1, and 
Fig. 5.1).
-2212 -1870 -1428 -787 -537
p huPA2212 CAT
S2
N .D .
N .D .
ENH SI
+++ (2.5x) 
+++ (3.Ox)
+++ (4.0x) 
+++ (4.0x) 
+++ (3.7x)
SI, S2 and S3 indicate the different negative regulatory regions identified in the huPA promoter. 
The activity of the silencers is indicated by black (+). In parenthesis is indicated the fold of 
repression evaluated as CAT activity of the full length construct 2212 CAT over the value of the 
deleted constructs. In red (+) is the level of uPA produced in each cell line (indicated in blue). N.D. 
is for not tested.
S3 MP CAT
cell line uPA
N .D . HT 1080 -H -
N .D . A 1251 ++
++++ (lOx) PC-3 -H -+
+++ (4.5x) C V l -
+++ (5.8x) HeLa -
+++ (4.6x) H epG 2
activities
As already m entioned, the activity of constructs w ith the enhancer cloned 
dow nstream  the CAT gene would exclude that the increased CAT expression was 
due to a position effect of the enhancer closer and closer to the transcriptional start 
site.
The other effect described in the paper of Cannio et al. was the enhancer 
dependence of the silencer activity. Since the effect of region S2 on transcription 
was more evident w hen studied as internal deletion (Fig. 4.2) than in the 5’ nested 
deletions analysis (Fig. 4.1), I wanted to test whether S2 was working only in the 
presence of the enhancer, i.e. 82 is able to repress the enhancer activity. However 
the experiment shown in Fig. 4.3 seems to exclude this possibility as 82 is able to
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suppress the transcription in the presence or absence of the enhancer by the same 
level, as well as SI and S3. The difference can be explained considering that the 
enhancer is not totally silent in CVl cells, in transient transfection assay, (the 
-2212 construct activity is 2.5 fold higher than -1870 construct. Fig. 4.1), such that in 
the context of the full length construct (Fig. 4.2) the absolute level of CAT is 
higher, giving the possibility to detect little differences in CAT expression that are 
not detected, at least in a significative m anner, in the absence of the enhancer. We 
can then conclude that S2 acts directly on minimal promoter, probably 
influencing the assembly of a competent pre-initiation complex. This hypothesis 
is sustained by studies carried out in my laboratory by Ibanez and Grippa on the 
chrom atin structure of uPA 5' regulatory region (Ibanez, 1997). According to them 
the DNasel and Micrococcal nuclease I (MNasel) analysis indicated that the 
chrom atin structure of uPA prom oter depends on the transcriptional state of the 
gene. In cells not producing uPA (as HeLa) almost all the 5’ flanking region results 
inaccessible to nuclease digestion indicating the presence of DNA tightly packed in 
a higher order nucleosomal structure. In PC-3, on the other hand, the regulatory 
region is more accessible to DNasel and MNasel, indicating a general loosening of 
the chrom atin structure. In particular hypersensitive sites have been m apped 
w ithin the enhancer (HS4), the silencer S2 region (H6) and the MP (HS7). In HeLa 
HS6 and HS7 are not present, suggesting that the MP is in a compacted chrom atin 
structure inaccessible to the basal transcription machinery (Fig. 5.2).
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Fig. 5.2: Schematic representation of DNase I hypersensitive sites of the huPA promoter in HeLa 
and PC-3 cell lines.
Since S2 showed a cell-type specific activity I wanted to further characterise it 
by testing whether the negative regulatory element could act as silencer. The 
analysis of the effect of S2 on the SV40 heterologous prom oter activity led me to 
conclude that S2 was effectively a silencer as it works in an orientation and 
position-independent m anner (Fig. 4.4).
Due to the high conservation of uPA regulatory elements among different 
species (see hum an, mouse and pig prom oters; Rorth et a l ,  1990, Cassady et a l ,  
1991) I searched for the presence of S2 in the mouse and porcine 5'-flanking 
region, to confirm an im portant role for 82 in the regulation of the expression of 
uPA in different species. The finding of highly homologous sequences between 
mouse, pig and hum an uPA prom oters indicated that 82 can be considered as 
constituted by 6 modules, highly conserved between the three species, and 
separated by sequences that diverge (Fig. 4.5). The genomic organisation of these 
modules is more similar betw een pig and m an w ith the difference of m odule 6 
that in m an precedes m odule 5 while in pig, as well as in m ouse uPA prom oter, is 
located dow nstream  it. Furthermore, in mouse, the m odules span a w ider region 
than in m an and pig (-400 bp vs 250 bp of huPA 82 and 285 bp of pig uPA 
promoter; Fig. 5.3).
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Fig. 5.3: Genomic organisation of silencer S2 in human and murine uPA
The DNasel protection data gave an im portant clue in the understanding 
how S2 could work. The finding that almost the entire 250 bp long region is 
protected by HeLa nuclear extract (Fig. 4.7 and 4.8) m ight explain why the deletion 
of any single m odule does not im pair completely the silencing function of S2 (Fig. 
4.6). This suggests a redundancy of elements present in this silencer, that may 
have evolved by a series of duplications of sm aller modules. This hypothesis is 
sustained by the presence of direct and inverted repeats along the whole S2 (Fig. 
4.8) and here sum m arised in Fig. 5.4. Some of these repeated sequences appeared 
to be always protected in any or almost any location they are present: CCATC in 
footprint N and G; TGTTGGTGAT in footprint I and N; AAGCCG footprint B and 
E and at the border of footprint G; CTTTGTTCC sequence is in footprint G and H; 
CAATCCT at positions -730 and -700 at the border of footprint D and E, and are at 
least present once w ithin the regions hom ologous to the m urine and porcine uPA 
prom oter (Fig. 5.4).
Of these, only region 3 appears not to be protected at all and furtherm ore the 
naked DNA is cut by DNase I at a few position in the lower strand and in the 
upper strand (Fig. 4.7).
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Fig. 5.4: Schematic representation of repeats in the 52 region of huPA promoter
Each repeat is represented by a sphere of the same colour. The light blue boxes indicate the protected 
regions; the red boxes indicate the regions homologous between human and murine uPA promoter. For 
the detailed sequence see Fig. 4.9.
The presence of stretches of A and T residues suggests that the helical 
conformation of this part of the silencer is different from that of the rest of DNA 
of S2, although the electrophoretic mobility experiments of S2 circular perm uted 
fragments excluded that this modification results in intrinsic curved DNA (Fig. 
4.19). It has been dem onstrated that this kind of sequence array is not efficiently 
cut by DNasel (Drew and Travers, 1985; Drew, 1991), but it shows the peculiarity to 
be bendable by external forces like interaction w ith the histone octam er or w ith 
proteins that induce a curvature in the DNA. The high conservation of this 
m odule betw een mouse, pig and hum an, then, w ould argue for an im portant role 
of the local DNA conformation for S2 activity, suggesting that the entire 
conformation of S2, rather than one particular sequence, is im portant for S2 
silencing activity, a conformation that can be induced by the binding of factors that 
stabilise this structure.
The com parison of the complexes detected by different oligonucleotides, 
some of which overlapping w ith each other or containing the same sequence (Fig. 
5.5), and the analysis of the competition also argue for the hypothesis of
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redundant elements in S2. Table 5.1 sum m arises the results of EMSA and 
competition analysis from experiments showed in Fig. 4.12, 4.13, 4.14 and 4.21.
GTTAACACTT CA ATAGGAAG CACCAACAGT TTATGCCCTA GG ACTTTGTT 
CCCACAATCC TGTAACATCA TATCACGACA CCTAACCCAA TCCITATCAA
F!
GCCCTGTCAA AAACGGACTT TAAACCAAGC TGCAAATTTT CAGTAATCTG
GCCTTGCCTT TCCCCCrCTG ATAGCACCAT CAAACAAACC CCCITACTGC
nU  -------------------- W
CGAAAGCAAT AAGCCCGGCT TTGTTCCATC CACTGGTTGT GTTGGTGATA
        . —
#HMG — ■ ■ ■■
TCTGGGGACT GCCACT
UH ffTIE
Fig. 5.5: Schematic representation of the oligonucleotides used in the EMSA analysis of the 
nucleoproteic complexes detected by DNase I footprinting.
prob< # 2 #3 #N #TIE # 4
comp: Cl c2 c l  c2 c3 c4 c5 c6 c7  c8 c l  c2 c3 c4 c5 c l  c2 c3 c l  c2 c3
# 2 4- + — — — — — — — — - — — i — — — — — -
# 3 — — + + + “ + + + - 4- - - - + t
#N — — - - - + - + 4- - 4- 4- " • + - - r^
#TIE - - - + - 4 - 4 - 4 - - - i
# 4 — — — — — — — — — — - — — 4- - - - 4- 4- - +
#H - . . . . . " + + - - - ;  ■ - - 4
Table 5.1: Cross-competition analysis.
The arrows indicate a down shift in the mobility of the complex. (+) indicates competition; (-) no 
competition; (+/-) partial competition; (++) increased intensity, c = complex; comp = competitor.
Each oligonucleotide (oligo #3, #4, #TIE and #N) detects in HeLa nuclear 
extract many complexes, some of which are specific, as shown by homologous 
competition. Some of these oligonucleotides are able to compete the binding of 
one or more complexes to each other. The analysis of the sequences (table 5.2) 
showed that oligo #3, #4, #TIE, #N and #H share the sequence CCATC that in
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oligo #TIE and #4 is found in the lower strand w ith a m ismatch (CCAAC instead 
of CCAXC). Oligo #4 contains a second one in the upper strand.
#N 5' CTCTGATAGCA CCATC AAACAAACCCCCT 3'
#TIE 5' ACrCGTTCT GÏTGG TGATATCTGGGG 3'
#4 5' CnTGTT CCATCCACrGGTTGT GITGG TGAT 3'
#H 5' GGCTTTGTT CCATC CACTGGTTGT 3'
#3 5' AGCA CCATCAAACAAACCCCCTTACTGCCGAAAGCAATAAGCCCGG 3'
Table 5.2: Sequence comparison of the oligonucleotides used in this study
The CCATC sequence is shown in bold in either orientation. This sequence is also present at position 
-764/-760.
W hen oligo #TIE is used as competitor, it is able to compete complex 4 
detected by #N and complex 3 detected by #4 (3b). In the latter case the com petition 
gave rise to a faster mobility of complex 3. This could be explained by the titration 
of one of the two putative factors bound to their cognate sequence in oligo #4, or 
by the binding of some other factors that is m utually exclusive with that bound by 
the CCATC sequence. Competition by #4 of complex 3 generated by #1IE (3a), that 
contains only one CCATC motif, w ould argue for the first hypothesis as this has 
just one binding site for the CCATC sequence. The increased mobility of complex 
3 detected by #TIE (3a) and complex 4 detected by #N in the presence of oligo #H 
as competitor can be explained only hypothesising that other factors are bound to 
the oligonucleotides (Fig. 5.6). In particular, oligo #N contains the sequence 
TTTGTT, in the lower strand, nearby the CCATC motif. It can be hypothesised that 
the binding to this element (that is the consensus for the HMG-box containing 
protein) is m utually exclusive w ith respect to the binding to the CCATC sequence, 
while for #TTE the sequence that is partially overlapped can be the binding site for
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another factor. For #4 again this can be due to the titration of one complex a n d /o r  
binding of other factors.
-644AC ^CAA^aCCCrTACTGCCGAAAGCAATAAGCCO
#3
ATC-534
#N #TIE
#H
Fig. 5.6: Model of the putative DNA binding protein interacting with the region covered by 
oligonucleotides #3, #N, #4, #TIE and # H .
The blue sphere would recognise the CCATC sequence; the grey one would bind the sequence TTTGTT 
and the pink one would bind the region in common between ohgo #TTE and #H.
Most of the protected areas w ith FleLa nuclear extract are the same with PC-3 
nuclear extract, w ith the exception of footprints L, M and N (Fig. 4.7). The band- 
shift analysis w ith oligonucleotides covering most of S2 region, seems to indicate 
that the nature of the complexes may indeed differ. Oligo #1 (-726/-705) detects 2 
complexes in HeLa and PC-3 but they show different mobility (Fig. 4.10, complex 1 
vs 1*). Complex 2 is not present in PC-3 while complex 3 is lacking in HeLa 
nuclear extract
Furtherm ore, w hen the TIE element, protected by PC-3 and HeLa nuclear 
extracts in DNase I footprinting, is studied by EMSA analysis, different complexes 
are detected in the two cases: complex 1 and 2 are common for both nuclear 
extract, complex 3 is specific for HeLa, while complex 4 is present only in PC-3 (Fig. 
4.24). It cannot be excluded that complex 4 is formed through protein-protein 
interaction that do not alter the binding of other factors as detected by DNase I 
footprint. Complex 3, on the other hand, that behaves as complex 3 detected by #4
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(Fig. 4.21, panel B), could be formed by the factors binding the CCAAC sequence 
present in the lower strand of #TIE.
The binding to the cognate site for the proteins of the FIMG box family in the 
presence either of FleLa or PC-3 nuclear extracts, as detected by DNase I 
footprinting (Fig. 4.7) and EMSA analysis (Fig. 4.16), and the evidence that factors 
belonging to this family can indeed bind the element present in uPA prom oter 
(Fig. 4.18 and 4.20) do not exclude that the binding of these factors, in vivo,  occurs 
only in PC-3.
The faster mobility of the oligo encom passing the HMG+TIE elements 
compared to the #TIE alone (they show the same pattern of complexes) m ight be 
explained by the binding of a factor to the FIMG element that, upon binding, bends 
DNA, giving a structure that runs faster in a polyacrylamide gel (Fig. 4.26). The 
architectural role evidenced for the HMG box proteins, allowing the assembly of a 
com petent complex able to transactivate transcription, supports this hypothesis. 
The missing binding by TCF-1 FIMG-box, in the experiments of Fig. 4.17 and 4.18, 
might be explained by the different affinity of this protein for the sequence present 
in huPA  prom oter (TCF-1 binds preferentially 5' CCTTT G A AGCT 3' sequence 
than 5' GGTTTGTTCC 3') although I cannot exclude that a problem  of degradation 
of the protein occurred.
A single-strand DNA binding protein in the huPA promoter
The EMSA analysis of the complexes formed by HeLa nuclear extract, in the 
presence of single strand DNA probes, has led to the interesting finding that a 
protein w ith a higher affinity for single strand DNA rather than double strand 
form of S2 region could be present in this cell line. Recently, several papers 
described the existence of sequence-specific single strand DNA binding activities 
in different prom oters involved in either positive or negative transcriptional 
regulation. Single strand DNA have been described in c-myc, fi-globin, PDGF A,
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EGF receptor and decorin prom oters (Santra et ah, 1994, Kato et ah, 1991, Siebenlist 
et ah, 1984, Chen L. et ah, 1993) and among eukaryotic single-strand DNA binding 
proteins are FBP, STR, MF3, p70, ERDP-1 (Kato et ah, 1991, Lin et ah, 1993, Duncan 
et a I., 1994, Altiok and Groner, 1994).
Table 5.3 summarises the results of the EMSA analysis, in the presence of 
HeLa nuclear extract, using either the upper or lower strand of #4 as probes (Fig. 
4.30).
Both the upper and the lower strand detect more than one complex; 
however the southw estern analysis (Fig. 4.31) has revealed that the upper strand 
binds two polypeptides of 40 and 30 KDa, w ith a greater affinity for the former, 
while the lower strand binds only the 30 KDa protein. The presence of m ultiple 
complexes can be due to the form ation of m ultim ers a n d /o r  of higher order 
nucleoproteic complex.
Com petition of either strand w ith their complementary strands (as full 
length or as part of the entire oligonucleotide sequence) abolishes the binding of 
all complexes probably due to the formation of double strand form of DNA rather 
than to a sequence specific competition (Fig. 4.30, lanes 3 and 15). Competition of 
either strand w ith an excess of unlabelled hom ologous oligonucleotide, on the 
other hand, has showed that neither the 5’ part or the 3' part of the 
oligonucleotides are able to compete any complex, suggesting that the binding 
requires m ost of the sequence present in oligo #4 (compare competition by #TIE 
and #H; Fig. 5.7).
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probe # 4  upper # 4  lower
compet. c l c2 c3 c l c2
# 4  upper + 4- 4- 4- 4-
# 4  lower + 4- 4- 4- 4-
#TIE upper - V - 4 4-
#TIE lower 4- 4- 4- - -
# 4  upp mut ± ± 4- 4- 4-
# 4  low mut 4- 4- 4- - -
#H upper - - - - 4-
#H lower 4- ± 4- - -
# 4  DS - - - - -
#TIE DS - - - - -
#H DS - - - - -
Table 5.3: Cross-competition analysis of single strand probes
The arrows indicate a down-shift in the mobility of the complex. (+) indicates competition; (-) no 
competition; (+/-) partial competition; (++) increased intensity, c = complex; compet. = competitor.
5' CTTTGTTCCATCCACrGGTTGTGTTGGTGAT 3' #4 upper
5' ACTGGTTGTGTTGGTGATATCTGGG 3' #TIE upper
5' CTTTGTTCCATCCACTGGTTaTaTTGGTGAT 3'
5' GGCTTTGTTCCATCCACTGGTTG 3'
5' ATCACCAACACAACCAGTGGATGGAACAAAG 3'
5' CCCAGATATCACCAACACTTCCAGT 3'
5' ATCACCAAtAtAACCAGTGGATGGAACAAAG 3' 
5"CAACCAGTGGATGGAAGAAAGCC 3'
#4 upp mut 
#H upper
#4 lower 
#TIE lower 
#4 low mut 
#H lower
Fig. 5.7: Sequences of the oligonucleotides used in the EMSA analysis of single strand DNA binding 
proteins
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In particular the 3' part of the oligonucleotide is im portant for the binding as 
a m utation of this region (#4 mut), either in the upper or lower strand, partially 
im paired the competition by oligo #4. Furthermore, the upper strand of 
oligonucleotide #N is able to compete the binding of complex 2 detected by the 
upper strand of oligonucleotide #4 (data not shown). Oligo #N contains the 
sequence CCATC, suggesting the involvem ent of this element in the recognition 
of DNA by the 40 KDa single strand DNA binding protein. Since this sequence is 
present also in the -764/ -760 region it is not excluded that more than one region in  
the S2 silencer can prom ote the form ation of single strand region as show n in the 
model of fig. 5.8.
The binding of the 40 and 30 KDa factors can prom ote or simply stabilise 
single strand regions that would prevent the binding of transacting factors to 
double strand DNA Fig. 5.8). The binding of these factors to single strand DNA can 
result in a local torsional stress that can alter the topology of this region of the 
prom oter prom oting the form ation of higher order nucleoprotein complexes 
resulting in a compact chrom atin structure. The faint protection in the 
corresponding TIE element in DNase I footprint (Fig. 4.7) could be due to the 
form ation of single strand regions that w ould become more evident w hen a 
supercoiled template is used instead of a linear fragm ent of DNA.
This model is supported by the recent finding of a family of DNA and RNA 
binding proteins, the Y box factors, with the protein YB-1 as a member. It has been 
show n that YB-1 repress interferon-y-induced transcription of class II hum an 
major histocompatibility (MHC) genes (Ting et al., 1994) by binding its cognate 
sequence in the DRA prom oter as single strand templates.
It has been hypothesised that YB-1 can repress transcription by inducing or 
stabilising single strand regions in the DRA prom oter preventing loading a n d /o r  
function of other DRA-specific transactivating factors.
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HMG-bo
HMG.
HMG-
Fig. 5.8: Proposed model for the binding of single strand DNA binding protein in S2.
The blue and green spheres (plain colour) indicate the high affinity binding sites for the 30 and 40 
KDa proteins, binding oligo #4, detected in southwestern experiment. The hatched blue and green 
spheres indicate the low affinity binding sites. The binding of these proteins would prevent the 
binding of other factors, like the HMG-box containing proteins, important for the activation of 
transcription in cell lines producing uPA (see text).
The biochemical characterisation of this protein showed that its MW is 
between 33-34 KDa. Furthermore it has been detected in HeLa nuclear extract, by a 
anti-YB-1 antisera, a band of approximately 45 KDa consistent w ith the reported 
m olecular mass for another protein belonging to this family, named dbpB, of 42 
KDa (Spitkovsky et a l ,  1992). The sequence bound by these factors resembles the 
CCATC sequence of uPA prom oter being CAATC. Furthermore, three putative 
binding sites for YB-1 are present in uPA S2 at position -776/-771, -731/-726, and 
-698/-693 (Fig. 5.9).
-787 TB-1
GTTAACACTT CAATAGGAAG CACCAACAGT TTATGCCCTA GGACTTTGTT
ABF-1YB-1 YB-1
CCCACAATCC TGTAACATCATATCACGACA CCTAACCCAA TCCTTATCAAG
GATA-1
CCCTGTCAA AAACGGACTT TAAACCAAGC TGCAAATTTTCAGTAATCTGGC 
GAT-tVl ABF-1
YB-1
CTTGCCTT TCCCCCTCTG ATAGCACCAT CAAACAAACC CCCTTACTGCCG
□ATA-1N
AAAGCAATAAGCCCGGCT TTGTTCCATC CACTGGTTGT GTTGGTGATATC
ABF-1 -535
Fig. 5.9: YB-1 and CCATC binding sites in S2
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This might suggest that one or more proteins belonging to this family could 
indeed bind the S2 silencer of huPA prom oter.
The TIE element is involved in S2 silencing ac t iv i ty
Several line of evidence indicate that the TIE behaves as a functional silencer 
module. W hen deleted from the context of the full length prom oter the 
transcriptional activity increases by about 1.5-2 fold (Fig. 4.6). When one copy of 
TIE is cloned in front of the SV40 prom oter it is able to repress SV40 driven 
transcription by about 1.5 fold (Fig. 4.28, pTIECAT). The increasing copy num ber 
represses the transcription up to 3 fold (p2xTIE and p4xTIE) and is independent of 
the orientation of the single elements. The analysis of four different m utants in 
TIE sequence (mut 1, m ut 2, m ut 3 and m ut 4) by EMSA (Fig. 4.22b and 4.23), 
showed that only complex 1 and 2 were affected in m ut 1, 2 and 3, while m utant 4 
showed an increased affinity for the three complexes. The in v ivo  analysis of 
these m utants, in the context of the full length prom oter and E787CAT constructs 
(Fig. 4.27), gave an unexpected result as none of the m utations affect the silencing 
activity of S2 apart from m utant 3 in  E787CAT context. Indeed the repressive 
capability seems to be increased. If this can explain the behaviour of m utant 4, that 
shows higher affinity for factors present in HeLa nuclear extract, concerning the 
other m utants the result can be explained by considering complex 3: none of the 
m utants in fact has lost the ability to compete for the form ation of complex 3 
formed by the binding to the CCATC sequence, although two of these m utations 
(m ut 1 and m ut 2) falls in the CCAAC sequence present in the lower strand of 
#TIE (Table 5.6). M utant 1 gives rise to the sequence recognised by YB-1 protein, 
while m utant 2 restores the T residue at position 4 bu t changes position 2. The 
absence of competition by the 3 complexes with #TIE rev and #TIE dir could be 
due to the lack of CCAAC sequence in TIE rev, and to the absence of flanking
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sequences im portant for the binding of nuclear factors to the CCAAC sequence in 
the case of TIE dir (see table 4.4).
1 2  3 4 5 6 residues position
5' CCAACA 3' #TIE lower strand
S' CCAATA 3' #TIE m uti lower strand
S' CGATCA 3' #TIE mut2 lower strand
Table 5.6: Mutants in TIE element
Furtherm ore, in the context of the whole S2, the other CCATC motifs are 
present, so it cannot be excluded that in order to see an effect all the sequences 
should be m utated. Then it w ould have been im portant to test these m utations in 
the context of the TIE elem ent controlling SV40 driven transcription.
A hierarchy of protein-DNA interaction in uPA promoter S2 region
A  more detailed analysis of the S2 region (Fig. 4.11) revealed the presence of 
putative binding-sites for factors belonging to the GATA family of transcription 
factor and for the yeast ABF-1 factor. The interesting feature of these sites is their 
organisation, as they resemble that found in the e-globin silencer (Peters et a l,  
1993), where the binding of the YYl factors prevents the binding of the erythroid 
specific GATA-1 factor (Fig. 5.10).
In the case of the S2 region, the putative binding sites for ABF-1 and GATA-1 
overlap or are in the vicinity of the CCATC sequence (see Fig.11c and fig. 5.10). An 
oligonucleotide with the consensus for ABF-1 is however not able to compete the 
complexes formed by oligonucleotide #1 that encompasses the m ost 5’ ABF-1 site 
(Fig. 4.11a), but it cannot be excluded that other oligonucleotides with a sequence
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derived by the consensus but carrying different residues, can have different 
affinities for these factor.
5' AGATGGATATCATTTTGGAAG 3' s e n se
3 ' TCTACCTATAGTAAAACCTTC 5' a n tis e n se
GTTAACACTT CAATAGGAAG CACCAACAGT TTATGCCCTA GGACTTTGTT 
ABF-1
CCCACAATCC TGTAACATCATATCACGACA CCTAACCCAA TCCTTATCAAG 
GATA-1
CCCTGTCAA AAACGGACTT TAAACCAAGC TGCAAATTTTCAGTAATCTGGC 
G A T A p ABF-1 -|
CTTGCCTT TCCCCCTCTG At AGCACCAT cIa  ACAAACC CCCTTACTGCCG 
- t  N 3- 9ATA-I
AAAGCAATAAGCCC GGCT TTGTTCCATC CACTGGTTGT GTTGGTGATATC
ABF-1 -535
Fig. 5.10: The e-globin silencer and huPA S2.
Panel A: The organisation of the e- globin silencer. The black bars indicate the DNasel footprint of 
the sense and antisense strand (From Peters et al. -1993 - JBC: 268, 3430-3437). Panel B: The huPA S2 
silencer. The putative binding sites for CATA- 1 and ABF-1 are indicated. In green the CCATC or 
CCAAC motif, and in orange the binding sites for a putative HMC-box containing proteins.
However, the presence of such overlapping putative binding sites for 
transcription factor m ight be im portant for the com petition betw een the 
form ation of an activating or inhibiting complex.
Furtherm ore the CAATC sequence is the binding site for NF-Y, C/EBP and 
CTF/N Fl transcription factors. Recently it has been show n that NF-Y binding is 
im portant for transactivation of the invariant chain prom oter, by prom oting the 
assembly of a stereo specific nucleoprotein complex involving 250 bp of DNA 
sequence. The presence of the histone fold-like motifs in this factor led to the 
speculation that a static nucleosome like particle is formed carrying in proximity 
enhancer and proximal prom oter sequences (Linhoff et a l ,  1997).
If we hypothesise a role for topological constraints in the form ation of a 
correct DNA conformation in the S2 region, it w ould be interesting to study the 
effect of the silencer in the context of the genomic DNA, by stable transfection. 
Right now I can only speculate that S2 might work by freezing particular DNA
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conformations that include the stabilisation of single stranded regions by the 
binding of specific single-strand DNA binding proteins, preventing the binding of 
transcriptional activators (Fig. 5.11, FleLa). The inaccessibility of DNasel, as 
revealed by experiments of chromatin mapping in FleLa and PC-3 cells, might be 
due either to regions that are rarely cut by DNasel (poly dA-dT tracts) or by the 
formation of a higher order structure in which nucleosomes and other non- 
nucleosomal DNA binding proteins bind and pack the DNA in a close 
conformation (Fig. 5.11, HeLa).
HeLa
^^9
PC-3
Fig. 7.11: Model for the assembly of negative or positive nucleoprotein complex at S2 
In HeLa cells the binding of single strand DNA binding protein prevent the loading of 
transactivators to S2 and allows the packing the DNA in a compact nucleosomal structure. 
Furthermore, in synergism with other regions (i.e.S3) and through the binding of repressor or 
corepressor molecules, the assembly of a competent pre initiation complex is blocked, thus preventing 
the transcription of the gene. In PC-3 cells, the binding of architectural proteins (i.e. HMG-box 
containing protein) would result in disruption of chromatin driving the assembly of a competent pre­
initiation complex and the interaction of transactivators with the basal machinery through looping 
of intervening sequences.
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On the other hand in PC-3 cells the hypersensitivity detected in 
correspondence of the region of silencer S2 might be interpreted as due to a 
different nucleoprotein complex in which, for example, HMG family proteins and 
nucleosomes bind, allowing, through DNA looping, the interaction of sequences 
located upstream the S2 and the basal promoter elements (Fig. 5.11).
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6. Appendix 1: Negative regulation of uPA by 
TGF-fil
Introduction
Transforming growth factor Cl (TGF-Cl) is a hormonally active polypeptide 
belonging to a large super family of secreted factors that comprises the three TGF-C 
isoforms (TGF-Cl, -C2 and -C3, each encoded by a separate gene), the activins, the 
bone morphogenetic proteins and many other secreted factors that are all thought 
to play major roles in differentiation and tissue morphogenesis (Derynck et al., 
1988, Massague', 1990). The high degree of evolutionary conservation of the 
closely related TGF-Cs from Drosophila and Caenorhabditis elegans to humans 
and their widespread expression in embryonic as well as adult tissues suggests an 
important role for these factors.
A variety of biological activities that affect cell proliferation and 
differentiation in many cell types have been ascribed to these factors. They 
stimulate the proliferation of various mesenchymal cell types, but act as a growth 
inhibitor of many other cell types, including epithelial cells. Furthermore, when  
present at high concentration, they induce the synthesis of extracellular-matrix 
proteins (Penttinen et al., 1988), modulate the expression of matrix proteases and 
protease inhibitors (Lund et al., 1987, Gerwin et al., 1990, Lund et al., 1991), 
increase integrin expression and thus enhance cell adhesion (Ignotz et a l ,  1989). 
TGF-Cs also affect mesenchymal differentiation and at low concentration are very 
potent chemotactic agent for several cell types, especially monocytes and 
fibroblasts (reviewed in Roberts and Sporn, 1990; Postlethwaite et a l ,  1987). 
Several are the observations that in v ivo  TGF-Cs action is largely growth 
inhibitory (Silberstein and Daniel, 1987) as shown for the early phase of liver
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regeneration following partial hepatectomy (Russell et al., 1988), lymphoid and 
myeloid cell proliferation (Goey et a l ,  1989, Fontana et al., 1989).
The signalling mechanisms leading to changes in proliferation by TGF-C are 
likely to be different in cells that are growth stimulated versus those that are 
growth arrested by TGF-C. Recently the SMAD family of signal transducer proteins 
has been identified as key components in either activation or inhibition of TGF-Cs 
signal transduction pathways (reviewed in Heldin et a l ,  1997). Following 
phosphorylation and activation by receptor-kinases, SMAD complexes translocate 
into the nucleus where, either directly or in complex with other proteins, affect 
transcription of specific genes in response to TGF-C.
Furthermore, ligand stimulation of the receptors increases the expression of 
the inhibitory SMADs, that may have a negative-feedback role in signal 
transduction.
Most studies of TGF-C induced growth inhibition have focused on its effect 
on the cell-cycle machinery. Several lines of evidences show that TGF-Cl can 
inhibit DNA synthesis occurring 12 hr following stimulation of quiescent cells 
when added at any point prior to the G l/S  boundary (Howe et al., 1991, Laiho et 
al ,  1990). One target candidate of TGF-Cl, even in late Gl, could be the c-myc gene 
the expression of which has been shown to be necessary for kératinocytes 
proliferation (Pietenpol et al., 1990b). c-myc gene is induced rapidly upon 
induction with EGF in many cell types and its expression remains elevated 
throughout Gl and during early S phase (Coffey et al., 1988). TGF-Cl rapidly 
reduces c-myc mRNA and protein and cycloheximide treatment has shown that 
protein synthesis is required for this effect. The block in c-myc expression occurs at 
the level of transcription initiation (Pietenpol et al., 1990b). Furthermore it has 
been demonstrated that DNA-tumour virus transformed cells become resistant to 
the growth-inhibitory effect of TGF-Cl (Pietenpol et al., 1990a) and in particular c-
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myc mRNA expression is no longer suppressed. These DNA-tumour virus 
oncoproteins bind the product of the retinoblastoma gene (pRB) blocking its 
growth-suppressive activity, and this leads to an aberrant growth control (Munger 
et a l ,  1989). It appears then that TGF-Cl-induced growth inhibition is a 
consequence of pRB-mediated suppression (direct or indirect) of c-myc 
transcription.
TGF-Cl would act maintaining pRB in its underphosphorylated form, 
necessary for the blocking of cell cycle in GO/Gl phase (Laiho et al., 1990). It has 
been proposed that the effect on pRB phosphorylation is indirect, involving a 
direct inhibition of the synthesis of cyclins and associated cyclin-dependent 
kinases and induction of inhibitors of cyclin-CDK complexes (Geng and Weinberg, 
1993, Ewen et al., 1993, Derynck, 1994).
As already mentioned, the block in c-myc expression by TGF-Cl occurs at the 
level of transcription initiation. A cis-acting regulatory element responsible for 
the TGF-Cl suppression has been identified (position -100/+71 relative to the PI 
transcription start site), suggesting that the synthesis or modification of a protein 
that binds to this cis-acting element could be the target of the mechanism through 
which TGF-Cl inhibits cell proliferation. Furthermore, Matrisian and 
collaborators described a cis-acting element in the promoter of the rat 
transin/stromelysin gene that mediates the TGF-Cl suppression of its expression 
(Kerr et al., 1990). This element, termed Transforming growth factor Inhibitory 
Element (TIE), mediates the repression of EGF-induced expression of the gene 
(Kerr et al., 1988). The inhibition occurs at transcriptional level through binding of 
a c-fos containing complex to this element.
The same element is present twice in the human c-myc gene (but one is 
outside the 5' region shown to be necessary for TGF-Cl suppression of c-myc 
transcription while the other is also required for regulation by pRB; Pietenpol et
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al., 1991) as well as in the promoters of other genes known to be suppressed by 
TGF-fil as human collagenase (Angel et al., 1987, Edwards et al., 1987), mouse 
elastase (Stevenson ef al., 1986), MRP/proliferin (Connor et al., 1989) and human 
urokinase (see Table 6.1).
P r o m o t e r S p e c i e s S e q u e n c e
TRANSIN rat -709 GAGTTGGTGA
ELASTASE mouse -572 GAGTTGGTGA
COLLAGENASE human -246 GAATTGGAGA
MRP/PROLIFERIN mouse -1004 GCCTTGGTGT
c-myc human -87 GGCTTGGCGG
Consensus GNNTTGGtGa
Table 6.1: Comparison of promoter region from TGF-fil inhibited genes
Nucleotides position is relative to the major start site of transcription (P2 in the case of c-myc). N= 
any nucleotide; capital letters = invariant nucleotides; small letters = preferred nucleotide (From 
Kerr e t  a l . - 1990 - Cell 267-278)
The TIE element present in the human urokinase promoter lies in the 
region of silencer S2 (-553/-537) as a partially overlapped and inverted repeat of 
the TIE consensus (Fig. 6.1).
TGF-fil induces PAI-1 transcription and modulates the transcription of uPA 
in a manner that varies with the cell type. The availability of cell lines 
synthesising different levels of uPA provide a good experimental system to test 
the effect of TGF-fil on uPA gene expression. In particular, in order to address 
whether TIE plays a role in the regulation of uPA gene expression two cell lines, 
one expressing high constitutive level of uPA (PC-3) and one expressing a low
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basal level of uPA but inducible by phorbol-ester treatment (HepG2), have been 
chosen.
-1820 -1428 787 -660 -537 -862 2 1 2
a t c c a c T G G T T G T G T T G G T G A T
- 55 3  ► - 5 3 8
i---------
T I E
-709 GAGTTGGTGA -700 transin
■553 TGGT1ETCTTGGTGA -538 huPA
5 'GNNTTGGtGa 3' TIE consensus
Fig 6.1: The TIE element in the human urokinase promoter
Upper: mapping of TIE in the human urokinase promoter. The arrows indicate the partial 
overlapped and inverted organisation of the element. Lower: comparison of the urokinase sequence 
with that from transin promoter and consensus. In black outlined is the left and inverted TIE element; 
in red is the right and direct repeat. The red outlined character represent the overlapped region 
between the left and the right part of the element.
Materials and M ethods
DNA manipulations
The BamHI- Bgl II fragment from human uPA cDNA (Riccio et a l ,  1985) and 
the BamHI fragment from human uPA receptor (uPAR) cDNA (Roldan et a l ,  
1990) were cloned in the BamHI-Bgl II sites and in the BamHI site of pSP73 
plasmid (Promega) to give respectively pT7-uPA and pSP6-uPAR constructs (Table 
6.2). DNA was purified by caesium chloride gradient and linearized with the 
appropriate restriction enzyme. After digestion DNA was phenol extracted once 
and ethanol precipitated and resuspended in an appropriate volume of distilled 
water.
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Sma110
Table 6.2: pT7-uPA and pSP6-uPAR maps
Sma 1562
Bam HI636
BooRV
BamHI 45
SP6 prom
huPAR
huPA
SP6-UPAR 17 pro
3055 bp
huPA
Hndlll
All the constructs used for transient transfections are described in Materials 
and Methods (previous section).
Cell culture, RNA extraction and Northern blot analysis
HepG2 and PC-3 cells were grown in Dulbecco's modified Eagle medium  
(DMEM) containing 10% foetal calf serum (ECS) to a confluent state. Cells were 
serum starved overnight in DMEM containing 0.5% ECS prior to addition of TCF- 
61 (Boehringer Mannheim; 5 ng/m l) and PMA (100 ng/m l). RNA was extracted at 
different times as described in the figures, according to the method described by 
Chomczynski and Sacchi, 1987. RNA (PC-3:10 ^g per lane, HepC2: 20 pg per lane) 
was sized fractionated on a 1.2% agarose gel containing 6.6% formaldehyde. The 
RNA was then transferred to nylon membrane (Costar) by electrotransfer in the 
following buffer (Ix TAE: 10 mM Tris-HCl, 5 mM sodium acetate, 0.5 mM EDTA, 
pH 7.8) for 4 hours at 40 volts and cross-linked to filter with a Stratagene cross­
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linker. Radiolabelled probes were obtained by in vitro  transcription of Smal 
linearized pT7-uPA and of pSP6-uPAR using T7 and SP6 polymerases respectively 
(Promega). The Pst 1 fragment of mouse glyceraldehyde-3-phosphate deydrogenase 
(GAPDH) cDNA and the Bgl II/ Sad fragment from human PAI-1 cDNA (Ginsburg 
et a l ,  1986) were labelled by random priming (Rediprime, Amersham) and used 
for normalisation of sample RNA loading. Filters were then pre-hybridised in 
mixture containing 50% formamide, 6x SSPE, 5x Denhardt's, 0.5% SDS, 100 
m g/m l DNA carrier (MB DNA, Boehringer Mannheim) at 42 °C for 2 hours. 
Hybridisation with riboprobe was performed in the presence of 10% dextran- 
sulphate at 42 °C for 12-16 hours. The probe in excess was removed by washing the 
filters in 3x SSPE/0.1% SDS for 20’ at 65 °C followed by 2 washing in 0.3x 
SSPE/0.1% SDS at 65 °C for 30’ each.
The filters were then exposed with intensifying screens at -80 °C for period 
from 30’ (18S) up to 4 days (uPA and p53 probes). mRNA level was quantified by 
densitometric analysis (Molecular Dynamics,SF, ImageQuant Software).
Transient transfection analysis
HepG2 cells were transfected by the calcium-phosphate method. 
Approximately 10  ^HepG2 cells/reporter construct were seeded in a 10 cm dish the 
day before transfection in DMEM containing 10% ECS. 4 hours before transfection 
medium was changed. 15 pg target construct DNA and 1.5 pg of EFlalpha-lacZ 
plasmid DNA were used per each plate. After 16 hours, the precipitate was 
removed and the cells were trypsinized and split in three 6 cm plates in DMEM 
containing 10% FCS and allowed to attach for 6-8 hours. For TGF-fil and TP A 
treatment, medium was changed to DMEM containing 0.5% FCS overnight. The 
day after TP A at 100 ng/m l and TGF-fil at 5 ng/m l (or otherwise indicated in the 
legend of the figures) diluted in DMEM were added to the cells (control cells 
received respectively DMSO and PBS). After 8 hours cells were harvested and
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processed for protein extraction (Sambrook et al., 1989). CAT amount was detected 
by a non radioactive CAT-ELISA kit (Boehringer Mannheim) and the amount was 
normalised to fi-galactosidase activity.
Results
Effect ofTGFfil on uPA expression in PC3 cells
It has been reported that the prostate derived adenocarcinoma PC3 cells 
secrete predominantly TGF-fi2 isoform but relatively little TGF-fil protein, 
although TGF-fil mRNA level is higher than that of TGF-fi2 (Bang et al., 1992, 
Ikeda et al., 1987). On the other hand TGF-fil has a certain antiproliferative effect 
on this cell line (Reyes-Moreno et at., 1995). In order to clarify whether the uPA 
promoter was sensitive to the inhibitory action of TGF-fil and hence whether the 
constitutive high level of uPA was due to a lack of TGF-fil isoform activation the 
cells have been treated with 5 ng/m l of TGF-fil and RNA extracted at different 
time points has been analysed by Northern analysis. Up to 24 hours treatment did 
not change the level of uPA mRNA (Fig. 6.2). Flowever hybridisation of the same 
blot with a probe specific for PAI-1 revealed an increase in the level of mRNA 
with a peak at 4 hours after addition of TGF-fil as described for other cell lines 
(Lund et at., 1987, Gerwin et a l ,  1990).
TGF-fil inhibits TP A induction ofuPA mRNA in HepG2 cells
TGF-fil is able to counteract the effect of several mitogens. In order to 
understand whether the TIE element plays a role in the uPA promoter I tested 
whether TGF-fil might be involved in the suppression of TP A induced expression 
of uPA gene in FIepG2 cells. In this cell line uPA gene expression is under the 
control of the inducible enhancer located 2 Kb upstream of the start site. These 
cells do not express constitutively high levels of uPA but its expression is induced
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by treatment with PMA (phorbol-myristate acetate) reaching a maximum 
expression level at 8 hours after induction as shown by a northern blot analysis of 
total RNA prepared at varying times after addition of PMA (Fig. 6.3; Nerlov et a l ,  
1992). When cells were simultaneously treated with TGF-Cl and PMA a reduction 
in the level of uPA mRNA by about 4 fold was observed (Fig. 6.3), suggesting that 
TGF-fil was able to counteract PMA effect on uPA gene expression.
0 2 4 8 12 24 hours
GAPDH
PAI-1
B
0.6
;  0.5. 
m
PAI-< 0.4
uPA
Fig. 6.2: Northern blot analysis of uPA and PAI-1 expression in PC-3 cells 
Total RNA was isolated by PC-3 cells treated with 5ng/m l of TGF-61 for the times indicated. Panel 
A: autoradiograms of Northern blots. For PAI-1 both mRNAs (3.2 Kb and 2.3 Kb) were detected by 
the same probe. Panel B: quantification of uPA and PAI-1 mRNAs by densitometric scanning. The 
values are expressed as relative to GAPDH (gIyceraldehyde-3-phosphate dehydrogenase). For 
PAI-1 values of both mRNAs are summarised.
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TGF-fil + TPA TPA
 1 r  I- - - - - - - - - - - - - - - - - - - 1
2 4 8 12 24 2 4 8 12 24 hrs
# # #  “ f A  I
GAPDH
■ •►TPA
0 ♦ TPA/TPA-tTQf-81
Fig. 6.3: Time course analysis of TGF-61 effect on uPA expression in HepG2 cells 
Confluent HepG2 cells were treated either with TPA (100 ng/ml) or TPA (100 ng/ml) and TGF-Cl (5 
ng/ml) for the times indicated. RNA was extracted and analysed by Northern blot. Panel A: 
autoradiograms of hybridisation with human uPA and glyceraldehyde-3-phosphate deydrogenase 
(GAPDH) probes. Panel B: scanning densitometric analysis of the film. The values are referred as 
uPA/GAPDH. Panel C: the values are expressed as TPA/TPA+TGF61 (fold repression).
The same result was obtained when cells were pretreated with TGF-fil, 2 and 
3 hours before PMA addition (fig. 6.4).
B
# #
hrs
TGF-Bl
TPA
uPA
GAPDH
■  2h 
□  3h
TGF-61
PMA
Fig. 6.4: Effect of TGF-61 pretreatment on TPA induction of uPA mRNA
HepG2 cells were pretreated with 5 ng/m l of TGF61 prior to addition of TPA (100 ng/ml). RNA was 
extracted after 8 hours of TPA induction. Panel A: autoradiograms of uPA and GAPDH 
hybridisation. Panel B: scanning densitometric analysis of the film. The values are expressed as 
TPA/TPA+TGF61 (fold repression).
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As shown in fig. 6.5, the effect was already obtained at picomolar 
concentration of TGF-fil (0.1 ng /m l) and did not increase w ith  increasing am ount 
of inhibitor added (up to 10 ng/m l).
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Figure 6.5: Titration of TGF61 concentration on TPA-induced uPA expression
HepG2 cells were treated with different amount of TGF-61 as indicated in the figure together with 
100 ng/m l of TPA. RNA was extracted after 8 hours of treatment. Panel A: autoradiograms of uPA 
and GAPDH hybridisation. Panel B: scanning densitometric analysis of the film. Values are 
expressed as TPA/TPA+TGF-Gl (fold repression).
TGF-fil alone did  not seem to have any effect on the basal level of uPA 
mRNA, although I cannot exclude that it was not possible to detect any reduction 
due to the too low level of uPA mRNA in unstim ulated cells (data not shown). 
Furtherm ore, TGF-fil and PMA, when added sim ultaneously, decreased PMA- 
stim ulated uPAR mRNA level in HepG2 cells (fig. 6.6), confirming that TGF-fi 
plays an im portant role in the fine regulation of the uPA-uPAR m ediated 
extracellular proteolysis.
Appendix 1: Negative regulation o fu P A  by TGF-fil 147
2 4 8 12 24 2 4 8 12
'm
uPAR
GAPDH
15
TOF-Bl+TPA
TPA
Fig. 6.6: Time course analysis of TGF-61 effect on uPAR expression in HepG2 cells
HepG2 cells were treated with TPA and TGF-61 as described in Fig, 6.3. Autoradiograms of
hybridisation with human uPAR and glyceraldeyde-3-phosphate dehydrogenase (GAPDH) probes
and scanning densitometric analysis of the film are shown.
Transient transfection analysis of inhibition of TPA induced uPA promoter 
driven transcription
In order to find out the element(s) that m ediate the effect of TGF-fil on TPA 
induction of uPA, and in particular w hether the TIE element is involved, a series 
of constructs, carrying deletions of the uPA 5' flanking region fused to CAT 
reporter gene, have been tested in transient transfection of unstim ulated and 
TPA-stimulated, in the presence or absence of TGF-fil, HepG2 cells. As shown in 
fig. 6.7 the full length construct (2212uPACAT) responded to TPA with a ~ 4-fold 
increase in CAT level. The sim ultaneous presence of TGF-fil decreased this value 
by about two fold. Deletion of regions SI (-1820/-1428) and S3 (-537/-86) under 
unstim ulated conditions increased the basal level of transcription of about 3.5 and 
4.5-fold respectively over that of the full length construct, in agreem ent w ith the 
presence in these regions of cis-acting negative elements. These constructs were 
still able to respond to TPA induction although w ith a lower efficiency than wild- 
type (2212uPACAT) construct (2.9 and 2 fold respectively), but no inhibition by 
TGF-f^l of TPA-stimulated CAT activity is observed. On the other hand construct 
AS2, carrying the deletions of the TIE containing region, decreased the basal level
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of transcription by about 3-fold, indicating the existence of a positively acting 
element. This construct was highly inducible by TPA (8.8-fold) and was still 
repressible by TGF-fil (~2 fold).
ü
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A.S1 3.70 ± .7  10.9 ±1
. ,S? 0.32 ± .08 2.83 ± .4
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LMP 2.80 ± .6  16.9 ± .7
ESI 0.62 ± .01 2.7 ± .5
FS2 5.83 ± .04 18.1 ± .5
E5? 0.83 2.6
2.9 11 ±2.7 1.20 ± .07
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6.0 18.2 ± .40 1.01 ± .1
4.3 3.2 ± .13 1.03 ± .04
3.1 20 ±4.9 1.11 ± .26
3.1 4.5 1.73
Fig. 6.7: Transient transfection analysis of uPA promoter activity in HepG2 cells 
Plasmid constructs carrying different portions of uPA promoter region were tested in transient 
transfection in HepG2 cells. The cells were treated either with 100 ng/ ml of TPA (blue solid bars) or 
with 100 ng/ ml of TPA and 5 ng/m l of TGF-61 (green solid bars). Red bars: untreated cells. Values are 
normalised to 6-galactosidase activity and they are the means ± standard deviation of at least 2 
independent experiments.
W hen CAT transcription was driven by uPA enhancer and m inim al 
prom oter the basal level was 2.8 fold higher than the full length construct and it 
responded to TPA induction by increasing the level of CAT of -6  fold, w ith no 
effect by TGF-fil treatment. Transfection with ESI CAT, ES2CAT and ES3CAT 
constructs (carrying either region SI, S2 or S3 cloned in front of the m inim al 
prom oter in EMP based plasmid) confirmed the result obtained w ith the deleted 
constructs, w ith SI and S3 repressing transcription by about 4.5 and 3.5 fold respect 
to EMP construct, and S2 inducing by about 2 fold. All the constructs were TPA 
inducible (~ 3 fold) but surprisingly none of them responded to TGF-fil treatment.
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D iscussion
The widespread action of the TGF-fi family of polypeptides, affecting cell 
proliferation and differentiation through either stim ulatory or inhibitory grow th 
signals, suggest an im portant role for these factors. This makes the unravelling of 
the m echanism  of their action a major goal in all areas of the research involving 
cell-cycle control studies, differentiation, cell-cell interaction, cell m igration and 
hence tissue rem odelling and inflamm ation.
The identification of the TIE as cis-acting element involved either in cell- 
cycle control, by mediating the effect of TGF-fil on c-myc expression (Pietenpol et 
al., 1990 a,b) and in the control of cell migration, by interfering w ith the synthesis 
of extracellular proteases (Kerr et al., 1990), led me to ask w hether the presence of 
the TIE in the uPA prom oter, and in particular in the S2 region, m ight play a role 
in the regulation of the expression of uPA gene.
Previous report (Grimaldi et al., 1986) indicated that uPA expression is 
m odulated by factors that influence cell grow th in norm al m urine cells and in 
particular that uPA mRNA expression increases rapidly following stim ulation of 
quiescent, GO, cells by mitogenic agents. This effect is an early cellular response to 
grow th stim ulation (1-3 hours) and is due in part to increased transcriptional 
activity of the gene.
The observation by the group of Moses (Pietenpol et al., 1990 a,b) that the 
action of TGF-fil on c-myc expression is mediated by the product of the 
retinoblastom a gene (pRB), led me to search for cell lines other than HeLa, where 
the presence of the papillom a virus oncoproteins has a blocking effect on RB 
growth-suppressive activity.
I then chose two cell lines, one expressing high constitutive level of uPA 
(PC-3) and one expressing a low but inducible basal level of uPA (HepG2).
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The northern blot analysis, however, did not revealed any effect of TGF-fil 
on uPA mRNA expression in PC-3, although a certain antiproliferative effect was 
described (Reyes-Moreno et a l ,  1995). The missing effect was specific for uPA since 
TGF-fil was able to increase the level of PAI-1, as described previously (Fig. 6.2; 
Lund et a i ,  1987; Gerwin et a l ,  1990).
Previous report indicated that TGF-fil had no effect on proliferation of 
HepG2 cells (Chapekar et a l ,  1989); however, it is able to counteract the TPA 
induction of uPA mRNA, as shown by the N orthern blot analysis of Fig. 6.3. 
Transfection experiments in HepG2 cells w ith the full length prom oter indicated 
that the -2212 bp 5' flanking region contains all the information necessary to 
m ediate TGF-fil action on TPA inducibility (Fig. 6.7, 2212uPACAT), bu t sequences 
other than TIE, and located in areas different from S2, seem to be involved in this 
regulation (Fig. 6.7, see ASl and AS3 versus AS2). The opposite experiment, where 
SI, S2 and S3 were cloned in front of the m inim al prom oter and in the presence 
of the enhancer, seemed to indicate that m ultiple elements cooperate to TGF-fil 
down-regulation of uPA induction by TPA (Fig. 6.7, ESI, ES2, ES3) as none of 
them, w hen present alone, responded to TGF-fil treatm ent.
This would suggest that sequences lying in regions other than S2 (e.g. SI and 
S3) m ediate the TGF-fil effect on TPA induction of uPA gene, and in particular 
that a cross-talk between these elements occurs. It would be interesting to perform 
a detailed analysis by nested deletions of these regions in order to find out the 
sequences responsible for the TGF-fil inhibitory effect of uPA expression.
It would be also interesting to study the antiproliferative effect of TGF-fil in 
other cell lines, in order to ask w hether the same m echanisms that regulate c~myc 
expression can be involved in uPA dow nregulation in the cell-cycle.
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7. Appendix 2: Negative regulation of uPA by p53 
Introduction
The product of the tum our suppressor gene p53 has been implicated in 
normal cell proliferation and neoplastic transform ation (reviewed in Ko and 
Prives, 1996). Both m utation or absence of expression of p53 lead to a transformed 
phenotypes in a num ber of cell systems and pathologies. Rearrangements and 
deletions of the p53 gene have been described in the hum an leukaem ia cell line 
HL-60 (Wolf et al., 1985) and in the osteogenic sarcoma cell line SAOS-2 (Masuda 
et a l ,  1987) as well as in Friend virus induced m urine leukaem ia (Chow et al., 
1989, Mowat et a l ,  1985), and in hum an tum ors like colon (Baker et a l ,  1989) and 
lung (Takahashi et al., 1989) carcinomas. Introduction of the norm al p53 gene 
into p53-deficient tum our cells suppresses transform ation and tum origenesis 
(Levine et al., 1991) and inhibits proliferation of many types of cells causing them 
to arrest at G l/S  (Johnson et al., 1993, Livingstone et a l ,  1992).
p53 plays m ultiple roles in cells: while dispensable for viability, induced 
expression of w t p53, for example by DNA-damaging agents, leads to cell cycle 
arrest and apoptosis, protecting the genome from accumulating excess mutation.
p53 contains a strong transcriptional activation dom ain and is capable of 
inducing the expression of genes bearing a p53 binding site consisting of two 
copies of the 10 bp sequence 5’PuPuPuC(A/T)(T/A)GPyPyPy3' separated by up to 
13 bp (Funk et al., 1992, Kem et a i ,  1991), but also strongly inhibits transcription 
from many genes lacking p53 binding sites (c-fos, c-jun, IL-6, bcl-2) through a direct 
interaction w ith specific (Agoff et al., 1993) or general transcription factors (TBP, 
TAFs, TFIIH; Mack et a l ,  1993, Lu and Levine, 1995). Several genes containing p53 
binding sites have been already identified. Among these the muscle creatin kinase
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(W eintraub et a l ,  1991), GADD45 (Kastan et a l ,  1992), MDM2 (Wu et al., 1993), 
p21/W AF-l (El-Deiry et a l ,  1993), cyclin G (Okamoto and Beach, 1994) and Bax 
(Miyashita and Reed, 1995).
Cellular transform ation often results in a dram atic increase in the 
production of plasm inogen activators and in particular of uPA. Previous reports 
indicated that the expression of uPA is m odulated by factors that influence cell 
grow th in norm al m urine cells, and in particular that uPA mRNA expression 
increases rapidly following stimulation of quiescent, GO, cells by the com petent 
mitogenic agents (Grimaldi et a l ,  1986). uPA mRNA increase is an early cellular 
response to grow th stim ulation w ith a peak after 1-3 hours and is due, at least in 
part, to increased transcriptional activity of the gene, as show n by run-on analysis 
and does not require new protein synthesis as dem onstrated by treatm ent with 
cycloheximide. The elevation of uPA mRNA is transient and is restricted to the 
GO/Gl phase.
I w anted therefore to investigate w hether the transient elevation of uPA is 
regulated by the tum our suppressor gene p53, leading to a linkage between 
inactivation of p53, increased cell proliferation and synthesis of uPA.
Materials and M ethods
Cell culture
T98G and GM47 cells are grow n in Earle's m inim al essential m edium  
containing 10% foetal calf serum (FCS; GIBCO) at 37 °C. The cell lines were kindly 
provided by Dr. M. Fiscella (NET, Bethesda).
Cell cycle studies
Cells are arrested in GO/Gl phase of the cell cycle by allowing them to grow to 
confluence followed by incubation for 3 days in m edium  containing 0.5% FCS.
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The cells are stimulated to reenter the cell cycle by trypsinizing and replating at a 
1:4 split ratio in m edium  containing 10% FCS w ith and w ithout the addition of 
dexam ethasone (final concentration 1 pM).
RNA isolation and Northern hlot analysis
Total RNA was extracted from cells by guanidine isothiocyanate m ethod 
(Chomczynski and Sacchi, 1987). RNA (10 pg per lane) was denatured w ith 6.3% 
form aldehyde/50% form am ide and then size fractionated on a 1.2% agarose gel 
containing 6.6% form aldehyde. The RNA was then transferred to nylon 
membrane (Costar) by electrotransfer in the following buffer (Ix TAE: 10 mM Tris- 
HCl, 5 mM sodium  acetate, 0.5 mM EDTA, pH  7.8) for 4 hours at 40 volts and 
cross-linked to filter w ith a Stratagene cross-linker. Radiolabelled probes were 
obtained by in vitro  transcription of Smal linearized pT7 RNA uPA, containing 
the BamHI-Bgl II fragm ent of hum an uPA cDNA, and of H ind III linearized pT7 
RNA 18S (Ambion) using T7 polymerase (Promega). The p53 cDNA probe was 
excised by pCMVp53 wt (pC53-SN3) containing the BamHI fragment of h u m an  
p53 (described in Kem et al., 1992) and labelled by random  prim ing (Rediprime, 
Amersham). Filters were then pre-hybridized in mixture containing 50% 
formamide, 6x SSPE, 5x Denhardt's, 0.5% SDS, 100 pg / ml DNA carrier (MB DNA, 
Boehringer M annheim) at 42 °C for 2 hours. Hybridization w ith riboprobe was 
performed in the presence of 10% dextran-sulphate at 42 °C for 12-16 hours. The 
probe in excess was rem oved by washing the filters in 3x SSPE/0.1% SDS for 20' at 
65 °C followed by 2 washing in 0.3x SSPE/0.1% SDS at 65 °C for 30’ each.
The filters were then exposed w ith intensifying screens at -80 °C for period 
from 30' (18S) up to 4 days (uPA and p53 probes). mRNA level was quantified by 
densitometric analysis (Molecular Dynamics,SF, Im ageQuant Software).
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Results
The hum an T98G cell line derived from a glioblastom a m ultiform  tum our 
has been a good tool for studies involving the control of gene expression during 
the cell cycle. In particular these cells can become arrested in GO/Gl phase under 
stationary phase conditions (serum starvation) and can be induced to re-enter the 
cell cycle by trypsinization and dilution. A clone derived by the parental T98G, 
containing the wild-type p53 gene under the control of the MMTV 
dexamethasone-inducible prom oter (GM47) is used to investigate w hether uPA is 
regulated in the cell-cycle and in particular if the product of p53 gene plays a role 
in the regulation of uPA expression. For this purpose both the parental T98G and 
the GM47 derived clone have been grow n in the presence or absence of the 
horm one dexam ethasone and the expression of uPA mRNA has been evaluated 
by N orthern blot analysis. As show n in Fig. 7.1 uPA is induced upon re-entry in 
the cell cycle with a peak after 6 hours, from replating in serum -containing 
m edium , of exponential grow th (panel A), both in the parental and the stable 
transfected cell lines. In the presence of dexamethasone, which induces the p53 
expression at 6 hours after addition (panel B), the expression of uPA mRNA in 
the parental T98G cell line is m axim um  at 6 hours after serum  and 
dexamethasone addition, followed by a fast decrease already at 8 hours upon 
horm one addition. In the GM47 derived clone how ever the m axim um  level of 
uPA is reached after 4 hours of growth, correspondingly to overexpression of wt 
p53, followed by a reduction in the uPA mRNA level similar to that of the 
parental cell line T98G. This result w ould suggest that uPA mRNA is regulated 
during the cell-cycle in these cells, w ith p53 overexpression influencing the 
kinetic of uPA expression restricting it to an earlier stage of the cell cycle, after 
which the negative effect of dexam ethasone treatm ent plays a major influence on 
uPA gene expression.
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Fig. 7.1: Northern blot analysis of uPA mRNA expression
Total RNA was isolated from parental T98G and GM47 cells at the times indicated. Panel A: 
untreated cells; Panel B: cells treated with 1 dexamethasone for the times indicated. Zero time 
are cells trypsinized after three days of serum starvation. The arrows indicated the 2.4 Kb transcript 
of human uPA, the 2 Kb transcript of 18 S (panel A and B) and the 2 Kb transcript (wt) or 2.8 Kb 
endogenous (end) p53 mRNA in GM47 cells (panel B). Panel C: graphic representation of the 
densitometric analysis of the northern blot-experiment.
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D iscussion
uPA is synthesised by a variety of tissues, including cells of the central 
nervous system (Masos and Miskin, 1996), where uPA is thought to play a pivotal 
role in the tissue-rem odelling process among which neurite outgrow th (Krystosek 
and Seeds, 1981).
The m ost common and m alignant brain  tum our, glioblastom a m ultiform e, 
is characterised by necrosis, vascular proliferation, and invasion in the 
surrounding norm al brain tissues (Russel and Rubinstein, 1989). Increased uPA 
activity has been already observed in vitro  in an astrocytoma cell line and 
associated w ith the invasive properties of glioblastoma in vivo. By comparing 
hum an astrocytoma, glioblastomas and norm al brain tissues it has been 
evidenced that the higher uPA activity detected in m alignant tum our cells 
correlates w ith increased uPA mRNA level (6 and 20 fold higher than in norm al 
brain). Both uPA protein and mRNA are localised w ithin astrocytomas and 
endothelial cells and are localised near vascular proliferation zones and at the 
leading edges of tum ours in glioblastomas. The increased uPA expression suggest 
that uPA may contribute to the invasion of m alignant astrocytomas into adjacent 
norm al brain tissues and to tum our angiogenesis (Yamamoto et a l ,  1994).
Previous data (Grimaldi et a l ,  1986) have show n that increased uPA mRNA 
level in response to m itogens is an early event due in large part to increased 
transcriptional activity of the gene, restricted to the GO/Gl phase of the cell-cycle. 
The analysis of uPA expression in a glioblastoma cell line (T98G), bearing a 
m utated p53 protein, indicated that uPA is induced upon reentry of the cell in  the 
cell-cycle, with a peak after 6-8 hours. A clone overexpressing a wild-type p53 
protein under the control of the MMTV inducible prom oter (GM47), showed that 
uPA expression is reduced and restricted to 1-4 hours after induction (Fig. 7.1,
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appendix 2). The increased uPA mRNA follows the induction of p53 expression 
(already evident at 2 hours upon reentry in the cell-cycle; Fig. 7.1), suggesting a 
role of p53 in the regulation of uPA.
p53 expression is induced by treatm ent w ith dexamethasone (Mercer et a l ,  
1990). Although the negative effect of glucocorticoids on uPA gene expression has 
been extensively described (Medcalf et a l ,  1988, Flenderson and Kefford, 1993), it is 
possible to exclude that the effect seen in the clone GM47 is due to dexam ethasone 
as the parental cell line (also treated w ith dex) behaves as the control, in which 
only the solvent for dexamethasone has been added.
Recently regulation of uPA by p53 has been described and the element 
responsible for this effect has been m apped in the region of the enhancer. No 
binding sites for p53 are however present in this region, although their presence is 
not required for the p53 repressing activity (Kunz et a l ,  1995). Two binding sites 
for p53 have been how ever identified in the region of the huPA prom oter 
upstream  of the enhancer (position -5045/-5036 and -5021/-5012), recently cloned 
in our laboratory (Ibanez-Tallon, 1997).
It w ould be very interesting to understand the link betw een p53 expression 
and uPA regulation. The T98G cell line has proved useful for studies on the 
regulation of the cell cycle and in particular on the correlation betw een m utations 
in p53 tum our suppressor gene, loss of control of cessation of proliferation, 
induction of uPA expression and high invasive potential of this kind of tum our. 
However the induction of wild type p53 protein expression by dexamethasone, 
could be a limit to unravel the exact mechanisms of action of p53 on uPA 
downregulation, as we cannot exclude an overlapping effect due to the hormone.
Another useful system to study the p53 effect on uPA gene transcription 
could be a BALE/c-Val5 cell line (El-Deiry et a l ,  1993), a BALB/c 1 derived cell line 
stably expressing a p53 mutant, Val 135, carrying a tem perature-sensitive
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m utation at Val 135, which behaves as a m utant at 37°C and as the wild type at 
32°C (Ginsberg et al., 1991). The Balb/c 1 cell line does not contain endogenous p53 
(Harvey and Levine, 1991). Once an effect by p53 on uPA gene expression is 
identified, a transient transfection analysis, using the uPA promoter-CAT 
constructs, w ould be useful in order to identify the element m ediating this effect 
a n d /o r if the repression occurs through the inhibition of the assembly of a 
competent pre-initiation complex at the start site of transcription.
Conclusions and perspectives_________
8 . Conclusions and perspectives
Due to its high destructive potential, uPA expression requires tight 
regulation. The fact that in the organism  uPA is synthesised by very few cell types 
and only under particular stimuli gives a major im portance to the negative 
regulation of uPA w ith respect to activation. The discovery of cell lines that 
transcribe uPA in a constitutive or inducible m anner and others in w hich the 
transcription of the gene is silenced, indicates that the control of the expression 
requires that one or more elements cooperate in the m odulation or total 
inhibition of the gene, for example driving the form ation of a compact chrom atin 
structure. The studies presented in this thesis have showed that a complex array 
of regulatory sequences, in addition to the enhancer and m inim al prom oter, 
appear to regulate uPA transcription, some of which are cell-type specific (Table 
5.1).
SI and S3 could act as m odulators of uPA gene expression, in response to 
different stimuli, in those cell line that express uPA. In the cell lines not 
expressing uPA S2 plays the major role in the silencing of transcription and 
probably in cooperation w ith SI and S3 directs the formation a compacted 
chrom atin structure that leads to the complete silencing of the gene.
A detailed characterisation of region SI and S3, by the m ean of deletion and 
m utation analysis, should clarify the role of these regions in the regulation of 
uPA gene and in the cooperation w ith S2.
Generation of clones of cell lines stable transfected w ith full length 
promoter-CAT plasm id DNA would be a good tool to study the involvem ent of 
chrom atin organisation on the activity of S2 together w ith chrom atin studies of 
this region of the endogenous uPA gene prom oter.
Conclusions and perspectives_________ leo
In the future the purification of the factors bound to S2 and cloning of their 
cDNA w ould allow a clarification of the model according to different 
transcriptional status of uPA gene.
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